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Abstract 
Regulation of gene expression in macrophage immune response 
Kaur Alasoo 
Gene expression quantitative trait loci (eQTL) mapping studies can provide mechanistic insights 
into the functions of disease-associated variants. However, many eQTLs are cell type and 
context specific. This is particularly relevant for immune cells, whose cellular function and 
behaviour can be substantially altered by external cues. Furthermore, understanding 
mechanisms behind eQTLs is hindered by the difficulty of identifying causal variants. We 
differentiated macrophages from induced pluripotent stem cells from 86 unrelated, healthy 
individuals derived as part of the Human Induced Pluripotent Stem Cells Initiative. We 
generated RNA-seq data from these cells in four experimental conditions: naïve, interferon-
gamma (IFNɣ) treatment (18h), Salmonella infection (5h), and IFNγ treatment followed by 
Salmonella infection. We also measured chromatin accessibility with ATAC-seq in 31-42 
individuals in the same four conditions. We detected gene expression QTLs (eQTLs) for 4326 
genes, over 900 of which were condition-specific. We also detected a similar number of 
transcript ratio QTLs (trQTLs) that influenced mRNA processing and alternative splicing. 
Macrophage eQTLs and trQTLs were enriched for variants associated with Alzheimer’s disease, 
multiple autoimmune disorders and lipid traits. We also detected chromatin accessibility QTLs 
(caQTLs) for 14,602 accessible regions, including hundreds of long-range interactions. Joint 
analysis of eQTLs with caQTLs allowed us to greatly reduce the set of credible causal variants, 
often pinpointing to a single most likely variant. We found that caQTLs were less condition-
specific than eQTLs and ~50% of the stimulation-specific eQTLs manifested on the chromatin 
level already in the naive cells. These observations might help to explain the discrepancy 
between strong enrichment of diseases associations in regulatory elements but only modest 
overlap with current eQTL studies, suggesting that many regulatory elements are in a ‘primed’ 
state waiting for an appropriate environmental signal before regulating gene expression. 
 
  
 4 
 
  
 5 
Declaration of Originality 
This dissertation is the result of my own work and includes nothing which is the outcome of work 
done in collaboration except as declared in the beginning of each chapter. t is not substantially 
the same as any that I have submitted, or, is being concurrently submitted for a degree or 
diploma or other qualification at the University of Cambridge or any other University or similar 
institution. I further state that no substantial part of my dissertation has already been submitted, 
or, is being concurrently submitted for any such degree, diploma or other qualification at the 
University of Cambridge or any other University of similar institution. This dissertation does not 
exceed the word limit set by the Degree Committee for the Faculty of Biology. 
 
Signature: 
 
Date: 
 
Kaur Alasoo 
September 2016 
 6 
  
 7 
Acknowledgements 
First, I am grateful to many people who have inspired and nurtured my passion for 
science. I thank Hedi Peterson for drawing me into the field before I had even finished 
my first semester at the university. I thank Phaedra Agius for introducing me into 
machine learning and teaching me that it is completely normal in research not to know 
beforehand what works and what does not. I thank Prof. Jaak Vilo for supporting and 
guiding me during my undergraduate years, Harri Lähdesmäki for letting me play with 
new and exciting data, and Isabel Sá-Correia for giving me an independent 
experimental project with no prior experience. All of these experiences gave me the 
necessary skills and confidence to help me realize that research was what I wanted to 
do. 
 
Many people have made the four years of my PhD studies such a rewarding and 
stimulating experience. Over the past four years, fair and constructive feedback from my 
supervisor Daniel Gaffney has greatly improved the clarity and focus of my research 
and writing. I also greatly value the independence that I had in shaping the projects that 
I was working on. I thank my co-supervisor Gordon Dougan for accepting me to his lab 
even though I had never seen neither human nor a bacterial cell before. Subhankar 
Mukhopadhyay was very patient in explaining both intricacies of immunology as well as 
basics of cell culture. Finally, most of the experimental work presented in this thesis 
would not have been possible without the dedication and hard work of Julia Rodrigues. 
Thank you, Julia, for not giving up even when cells were dying and differentiations 
failing. I will always remember the fruitful discussions with other members of the 
Gaffney on a wide range of experimental on computational topics. 
 
I have received great advice from many other people on the campus. Leopold Parts has 
been a great mentor by listening to my ideas, thinking about them hard and asking 
important questions. Conversation with Leo have made me to reconsider my 
experimental design more than once, ultimately allowing me to answer more important 
questions.  
 8 
 
Last but not least, I am most grateful to my family. Aitäh isale nende õhtuste 
matemaatika ja füüsika olümpiaadiülesannete lahendamiste eest, mis olid küll väga 
põnevad, aga millega ma ise alati esimesel katsel hakkama ei saanud. Aitäh vennale, 
õele, vanaemadele, vanaisadele, tädile ja teistele suurtele ja väikestele sugulastele 
pidevalt meelde tuletamast, kui hea on kodus olla. Aitäh, Maret, et oled minu kõrval 
olnud ja mind toetanud kogu selle aja. 
 
  
 9 
Table	of	Contents	
1	 Introduction	...................................................................................................................	13	
1.1	 Regulation	of	cell	type	and	condition	specific	gene	expression	............................................	14	
1.1.1	 Principles	of	cell	type	specific	TF	binding	...........................................................................	15	
1.1.2	 Signal	dependent	TFs	bind	to	established	enhancers	........................................................	16	
1.1.3	 Role	of	signal	dependent	TFs	in	establishing	new	enhancers	............................................	17	
1.1.4	 Long	range	interactions	between	cell	type	specific	and	signal	dependent	TFs	..................	17	
1.2	 Macrophage	biology	in	the	context	of	immune	response	....................................................	19	
1.2.1	 Signalling	pathways	activated	by	lipopolysaccharide	and	interferon-gamma	...................	19	
1.2.2	 Macrophage	response	to	Salmonella	infection	..................................................................	21	
1.3	 Tissue	culture	models	of	macrophage	biology	.....................................................................	21	
1.3.1	 Differentiating	macrophages	from	human	induced	pluripotent	stem	cells	.......................	22	
1.4	 Genome-wide	profiling	of	gene	expression	and	chromatin	accessibility	...............................	23	
1.4.1	 RNA	sequencing	..................................................................................................................	23	
1.4.2	 Chromatin	state	profiling	...................................................................................................	25	
1.5	 Genetics	of	molecular	traits	.................................................................................................	27	
1.5.1	 Genetics	of	gene	expression	...............................................................................................	27	
1.5.2	 Genetics	of	chromatin	states	..............................................................................................	29	
1.5.3	 Using	eQTLs	to	interpret	GWAS	associations	.....................................................................	32	
1.6	 Outline	of	the	thesis	............................................................................................................	33	
2	 Comparison	of	monocyte-derived	and	iPSC-derived	macrophages	..................................	35	
2.1	 Introduction	........................................................................................................................	35	
2.2	 Methods	..............................................................................................................................	36	
2.2.1	 Samples	..............................................................................................................................	36	
2.2.2	 Cell	culture	and	reagents	....................................................................................................	37	
2.2.3	 Flow	cytometry	...................................................................................................................	39	
2.2.4	 RNA	extraction	and	sequencing	.........................................................................................	40	
2.2.5	 RNA-seq	data	analysis	........................................................................................................	41	
2.3	 Gene	expression	variation	between	iPSCs,	IPSDMs	and	MDMs	............................................	45	
2.3.1	 Global	patterns	of	gene	expression	....................................................................................	45	
2.3.2	 Differential	expression	analysis	of	IPSDMs	vs	MDMs	.........................................................	47	
2.3.3	 Mechanisms	underlying	differences	between	MDMs	and	IPSDMs	....................................	51	
2.4	 Global	variation	in	alternative	transcript	usage	...................................................................	54	
2.4.1	 Identification	and	characterisation	of	alternative	transcription	events	.............................	56	
2.5	 Discussion	...........................................................................................................................	61	
3	 Large-scale	differentiation	of	macrophages	from	human	iPSCs	.......................................	65	
3.1	 Introduction	........................................................................................................................	65	
3.2	 Methods	..............................................................................................................................	67	
3.2.1	 Cell	culture	and	reagents	....................................................................................................	67	
3.2.2	 Macrophage	stimulation	assays	.........................................................................................	69	
 10 
3.2.3	 RNA	sequencing	..................................................................................................................	69	
3.2.4	 Flow	cytometry	...................................................................................................................	72	
3.3	 Large-scale	differentiation	of	macrophages	for	genomics	assays	.........................................	75	
3.3.1	 Variability	in	success	rate	...................................................................................................	76	
3.3.2	 Variability	in	the	duration	of	the	differentiation	................................................................	77	
3.3.3	 Variability	in	cell	numbers	..................................................................................................	79	
3.3.4	 Variability	in	macrophage	purity	........................................................................................	79	
3.4	 Variability	in	gene	expression	data	......................................................................................	81	
3.4.1	 Technical	variability	between	RNA-seq	samples	................................................................	81	
3.4.2	 Variance	component	analysis	of	the	RNA-seq	data	...........................................................	82	
3.4.3	 Detecting	hidden	sources	of	variation	................................................................................	85	
3.4.4	 Reproducibility	of	differentiation	.......................................................................................	87	
3.5	 Variability	in	cell	surface	marker	expression	........................................................................	89	
3.6	 Discussion	...........................................................................................................................	90	
4	 Genetics	of	gene	expression	in	macrophage	immune	response	......................................	93	
4.1	 Introduction	........................................................................................................................	93	
4.2	 Methods	..............................................................................................................................	95	
4.2.1	 Gene	expression	analysis	....................................................................................................	95	
4.2.2	 Gene	expression	QTL	mapping	...........................................................................................	97	
4.2.3	 Alternative	transcription	analysis	.......................................................................................	99	
4.2.4	 Transcript	ratio	QTL	mapping	...........................................................................................	104	
4.2.5	 Overlap	analysis	with	the	NHGRI-EBI	GWAS	catalogue	....................................................	105	
4.2.6	 QTL	replicability	between	conditions	...............................................................................	105	
4.3	 Quantifying	gene	expression	and	alternative	transcription	................................................	105	
4.3.1	 Differential	expression	analysis	reveals	expected	pathways	...........................................	107	
4.4	 Genetics	of	gene	expression	..............................................................................................	110	
4.4.1	 Gene	expression	QTL	mapping	.........................................................................................	110	
4.4.2	 Transcript	ratio	QTL	mapping	...........................................................................................	111	
4.4.3	 Concordance	of	QTLs	detected	by	different	methods	.....................................................	112	
4.4.4	 Condition	specificity	of	eQTLs	and	trQTLs	........................................................................	113	
4.5	 Case	study:	genetics	of	IRF5	transcription	..........................................................................	117	
4.6	 Overlap	with	GWAS	hits	....................................................................................................	121	
4.7	 Discussion	.........................................................................................................................	123	
5	 Genetics	of	chromatin	accessibility	in	macrophage	immune	response	..........................	125	
5.1	 Introduction	......................................................................................................................	125	
5.2	 Methods	............................................................................................................................	128	
5.2.1	 ATAC-seq	..........................................................................................................................	128	
5.2.2	 ChIP-seq	data	analysis	......................................................................................................	130	
5.2.3	 Chromatin	accessibility	QTL	mapping	...............................................................................	133	
5.3	 Quantifying	chromatin	accessibility	...................................................................................	135	
5.3.1	 Differential	chromatin	accessibility	between	conditions	.................................................	136	
 11 
5.3.2	 Overlap	with	ChIP-seq	signals	..........................................................................................	138	
5.4	 Genetics	of	chromatin	accessibility	....................................................................................	140	
5.4.1	 Fine	mapping	putative	causal	variants	.............................................................................	142	
5.4.2	 Assessing	condition-specificity	of	caQTLs	.........................................................................	145	
5.4.3	 Condition-specific	dependent	peaks	................................................................................	149	
5.5	 Linking	chromatin	accessibility	to	the	transcriptome	.........................................................	150	
5.5.1	 Linking	caQTLs	to	eQTLs	...................................................................................................	151	
5.5.2	 Using	caQTLs	to	fine	map	causal	variants	for	GWAS	hits	.................................................	154	
5.6	 Discussion	.........................................................................................................................	155	
6	 Conclusions	..................................................................................................................	159	
6.1	 Using	iPSC-derived	cells	to	map	QTLs	for	molecular	traits	..................................................	159	
6.2	 Alternative	transcription	QTLs	...........................................................................................	160	
6.3	 Information	flow	from	DNA	to	protein	..............................................................................	162	
6.4	 What	are	we	going	to	do	with	all	of	the	QTLs?	...................................................................	163	
7	 References	...................................................................................................................	167	
 
 
 
 
 12 
  
 13 
1 Introduction 
Virtually all cell types in the human body contain exactly the same DNA. In spite of this, human 
cells exhibit extraordinary functional, morphological and molecular diversity. This diversity is 
particularly evident in the human immune system: B-cells specialise in producing antibodies 
while macrophages in different tissues are able to phagocytose and kill invading bacteria, to just 
illustrate two of the many cell types. In addition to each cell type exhibiting specific phenotype 
and function, they must also be plastic enough to respond to various changes in their 
environment. This is particularly important for immune cells that must repel invading viruses and 
bacteria while minimising damage to the host. For example, tissue macrophages must produce 
inflammatory cytokines and reactive oxygen species only when they detect bacteria but 
intestinal macrophages have to limit these responses to avoid reacting to commensal bacteria 
with excessive inflammation (Krause et al., 2015). Underlying these cell type specific functional 
differences are unique gene expression profiles that are precisely regulated in response to 
changes in the environment. 
 
Most human traits and complex diseases have a heritable component (Visscher et al., 2008) 
and genome-wide association studies (GWAS) have identified thousands of genetic loci 
associated with those traits. Since over 90% of these loci are in the non-coding regions of the 
genome and highly enriched for chromatin marks specific to gene regulatory elements (Maurano 
et al., 2012), an emerging consensus is that they likely influence disease risk by regulating gene 
expression levels in one or more cell types and conditions. This observation in turn has led to a 
surge in studies to identify genetic variants that are associated with gene expression levels. 
While gene expression quantitative trait loci (eQTL) mapping experiments have identified 
thousands of regulatory variants, they have, to date, explained only a small fraction of GWAS 
associations and have also highlighted that considerable proportion of eQTLs are cell type and 
context specific. Thus, to create a complete catalogue of gene regulatory variation in humans, 
we need to measure gene expression levels in larger numbers of individuals, cell types and 
conditions.  
 
However, constructing a comprehensive catalogue of human regulatory variation has been 
limited by the relative inaccessibility of most cell types and the large number of environmental 
stimuli potentially relevant for each cell type (Xue et al., 2014). However, scalable cell culture 
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systems based on human induced pluripotent stem cells (iPSCs) have the potential to overcome 
these limitations and identify functional regulatory variants in many more cell types and cell 
states. In this thesis, I will establish an iPSC-derived macrophage model to study the genetics of 
context specific gene expression and apply it to understand how genetics shapes gene 
expression in human macrophages in response to interferon-gamma stimulation and Salmonella 
infection. 
 
In this introductory chapter, I will give an overview of our current understanding of the principles 
and mechanisms that regulate cell type and context specific gene expression by focussing on 
key studies performed in macrophages and B-cells. I will describe how macrophages sense and 
respond to changes in their environment and introduce experimental and computational 
techniques that are widely used to measure gene expression and chromatin state. Next, I will 
introduce iPSC-derived macrophages as a scalable system to study context specific gene 
expression. Finally, I will give an overview of how genetic variation influences gene regulation 
and how these studies can be used to interpret disease associations. 
1.1 Regulation of cell type and condition specific gene 
expression 
One of the first examples of gene expression controlled by environmental signals is the lac 
operon in Escherichia coli that contains three genes required for lactose import and metabolism 
(Jacob and Monod, 1961). The lac operon has two regulatory mechanisms. First, in the absence 
of lactose, lactose repressor protein strongly binds to a short DNA sequence downstream of the 
promoter and prevents the transcription of the operon. The second control mechanism is the 
catabolite activator protein that, in the absence of glucose, binds to a specific 16 base pair (bp) 
sequence upstream of the lac promoter and assists RNA polymerase binding to the DNA. Thus, 
the expression of the lac operon is highest when lactose is present in the environment and there 
is no glucose. This seminal study highlighted how sequence specific factors regulated by 
external signals can regulate gene expression. 
 
The basic principle of sequence specific transcription factors (TFs) binding to DNA and thereby 
activating or repressing gene expression is also conserved in eukaryotes and many of the 
sequence motifs have already been identified (Weirauch et al., 2014). However, an extra layer 
of complexity is that, in contrast to prokaryotes, eukaryotic DNA is located in the nucleus and 
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tightly packed around the nucleosomes. This adds two additional levels of regulation. First, 
since protein synthesis happens in the cytoplasm, the localisation of TFs can be regulated as 
well. For example, the NF-κΒ complex is normally sequestered to the cytoplasm and is only 
localised to the nucleus after the repressor proteins have been degraded (Verma et al., 1995). 
Secondly, because nucleosomes have much stronger affinity for DNA than single TFs do, a 
single instance of a TF motif is usually not sufficient for a TF to bind (Polach and Widom, 1996). 
Recent studies have highlighted the importance of collaborative interactions between TFs in 
competing with nucleosomes and establishing active regulatory elements (Deplancke et al., 
2016; Heinz et al., 2010). 
1.1.1 Principles of cell type specific TF binding 
Since gene expression is regulated by TFs, to understand cell type specific gene expression we 
first need to understand the principles of cell type specific TF binding. Genome-wide profiling of 
TF binding has led to three key observations: (1) different factors in the same cell type often 
bind to the same locations (MacArthur et al., 2009), (2) the same factor in different cell types 
can often have different binding sites (Odom et al., 2004) and (3) the same biological processes 
(such as self-renewal) can be regulated by distinct set of regulatory elements in different cell 
types (Soucie et al., 2016). To illustrate possible mechanisms behind these observations, I will 
now focus on PU.1 - a key TF required for both B-cell and macrophage differentiation in vivo, 
that shares approximately half of its binding sites between the two cell types (Heinz et al., 
2010). 
 
(Heinz et al., 2010) sought to identify what underlies the cell-type specific binding pattern of 
PU.1. They found that macrophage specific PU.1 binding sites were co-enriched for AP-1 and 
C/EBPβ motifs, two additional factors that are required for macrophage development and 
function (Friedman, 2007). Conversely, B-cell specific PU.1 binding sites were enriched for 
motifs of E2A, EBF1 and OCT2 - three factors that are known to play important roles in B-cell 
development and function (Medina and Singh, 2005). Furthermore, they showed that knock-out 
of E2A leads to loss of PU.1 in B-cells at sites where the E2A motif is present and that can be 
rescued by inducible expression of E2A in knock-out cells. Similarly, PU.1 knock-out in 
macrophages led to reduced binding of C/EBPβ at loci where both of the binding sites were 
present. Together, this evidence indicates that cell type specific enhancers are established by 
collaborative binding of a small number of cell type specific pioneer TFs that are able to 
compete with the nucleosomes. 
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The second line of evidence to support this model of collaborative binding of cell type specific 
pioneer TFs comes from a follow-up study of macrophage enhancers in two genetically distinct 
inbred mouse strains (Heinz et al., 2013). They found that PU.1 motif mutations in one strain 
resulting in strain-specific loss of PU.1 binding were frequently associated with corresponding 
loss of C/EBPα binding. Conversely, they also found that mutations in the C/EBP motif leading 
to the loss of C/EBPα binding were similarly associated with the loss of PU.1 binding. 
1.1.2 Signal dependent TFs bind to established enhancers 
A second key observation is that although different cell types often respond to the same 
extracellular signal by activating the same signalling pathways and TFs, the binding sites that 
these TFs occupy are often cell type specific. One proposed mechanism that could explain this 
observation is that TFs activated by external signals may largely bind to enhancers that have 
been previously established by cell type specific pioneer TFs. Some of the evidence for this 
comes from an early study which found that 34% of the oxysterol-responsive nuclear receptor 
Liver X Receptor beta (LXRβ) binding sites colocalised with PU.1 binding sites in macrophages 
and LXRβ binding was reduced at these sites in PU.1 deficient cells (Heinz et al., 2010). On the 
other hand, PU.1 binding at these sites was not affected by LXRβ knock-out, indicating that 
LXRβ is not directly involved in establishing cell type specific enhancers.  
 
In a follow up study, Heinz et al (Heinz et al., 2013) used two genetically distinct inbred mouse 
strains to study the strain specific binding of NF-κΒ after TLR4 activation. They found that 61% 
of NF-κΒ binding sites in the activated cells were already bound by either PU.1 and/or C/EBPα 
in the naive condition. Furthermore, most strain-specific NF-κΒ binding sites were bound by 
PU.1 or C/EBPα only in the strain that showed NF-κΒ binding. Finally, they were able to 
attribute 34% of strain-specific NF-κΒ binding events to mutations in AP-1, PU.1 or C/EBPα 
binding motifs and only 9% to mutations in NF-κΒ binding motifs. These observations suggest 
that the landscape of NF-κΒ binding sites after TLR4 activation are largely predetermined by 
enhancers occupied by PU.1, AP-1 or C/EBPα TFs in the naive state where no active NF-κΒ is 
present in the nucleus.  
 
In summary, these studies highlight a hierarchy between cell type specific pioneer factors that 
establish enhancers in closed chromatin regions and TFs activated by external signals that 
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predominantly bind to pre-established enhancers. Similar results have also been described for 
TGFβ (Mullen et al., 2011), BMP and Wnt pathways (Trompouki et al., 2011). 
1.1.3 Role of signal dependent TFs in establishing new enhancers 
While most signal-dependent TF binding occurs at pre-established enhancers, Ostuni et al 
showed that up to 15% of the enhancers activated by LPS were undetected in the unstimulated 
cells (no PU.1 binding or H3K4me1 histone modification signal) (Ostuni et al., 2013). They 
referred to these elements as latent enhancers and they found that different stimuli each 
activated a distinct set of latent enhancers. To mechanistically study the latent enhancers they 
focussed on IFNɣ stimulation. They found that, although STAT1 was phosphorylated within 10 
minutes after IFNɣ stimulation, latent enhancers were only established hours after stimulation, 
suggesting that nucleosomes might act as a barrier inhibiting TF binding. They observed that 
although many latent enhancers contained PU.1 binding motifs and displayed PU.1 binding after 
stimulation, there was no PU.1 binding in the naive state. Furthermore, they found that PU.1 
motifs in the latent enhancers had considerably lower binding affinities than motifs in constitutive 
enhancers, indicating that PU.1 binding at these sites depended on stimulus-specific cofactors. 
Thus, while the hierarchical enhancer activation model is conceptually useful, signal dependent 
TFs can also facilitate the eviction of nucleosomes and the binding of cell type specific TFs. One 
apparent distinction between these different modes of regulation, as illustrated by the IFNɣ 
example, is that pre-existing enhancers can facilitate cellular responses on the order of minutes 
while remodelling nucleosomes can take hours. 
1.1.4 Long range interactions between cell type specific and signal 
dependent TFs 
The evidence presented so far has relied on two different types of experimental approaches. 
The first relied either on deleting or ectopically expressing specific TFs and looking at the effects 
of these changes on the binding profiles of other TFs. The second approach relied on subtler 
perturbations caused by segregating variants disrupting TF binding sites between different 
mouse strains. However, because both of these approaches resulted in changes to thousands 
of TF binding events, they were limited to looking at average genome-wide effects on 
overlapping regulatory elements and were not able to reliably identify if TF binding at any one 
specific locus affected TF binding at other regulatory elements further away. Detecting these 
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individual effects can be achieved by QTL mapping approaches or directly disrupting single TF 
binding sites by precise genome editing. 
 
Evidence that cell type specific TFs can influence the binding of signal-induced TFs at 
neighbouring enhancers comes from an elegant study of an enhancer cluster upstream of the 
WAP gene in mouse mammary tissue (Shin et al., 2016). The enhancer cluster consists of three 
elements E1, E2 and E3 and the 1000-fold induction of the WAP gene during mouse pregnancy 
depends on all of them. The E1 enhancer has binding sites for three TFs: ELF1, NFIB and 
STAT5A. STAT5A binding can be observed at E1 during early pregnancy prior to transcriptional 
activation of the WAP gene. However, WAP transcription is induced only after STAT5A is also 
bound at the E2 and E3 enhancers. Intriguingly, the authors found that jointly disrupting ELF1, 
NFIB and STAT5A binding sites in the E1 enhancer not only abolishes the enhancer, but also 
prevents the E2 and E3 enhancers from being established later during pregnancy and, in turn, 
the gene from being transcriptionally activated. Thus, the E1 enhancer contains binding sites for 
tissue-specific TFs ELF1 and NFIB and acts as a ‘seed’ enhancer for the neighbouring E2 and 
E3 enhancers that only contain binding sites for STAT5A. 
 
In summary, the DNA in eukaryotic cells is tightly wrapped around the nucleosomes and 
collaborative interactions between multiple TFs are often needed to evict nucleosomes and 
establish accessible chromatin. Overlapping sets of TFs are often expressed in multiple cell 
types (such as PU.1 in B-cells and macrophages) and cell type specific binding is achieved by 
regulating the expression level of individual TFs as well as the pool of available cofactors. 
Transcription factors activated by multiple signalling pathways (IFNɣ, TLR4, TGFβ, Wnt, etc.) 
predominantly bind to regulatory elements pre-established by cell type specific factors, although 
over prolonged periods of time they might also contribute to establishing new enhancers. The 
extent of this is likely to depend on the exact TFs being activated and their intrinsic ability to 
compete with nucleosomes (Romanoski et al., 2015). Finally, as the example of the WAP gene 
suggests, TF binding at one locus can also facilitate the binding of TFs at other regulatory 
elements multiple kilobases (kb) away. The mechanisms by which this happens have not yet 
been elucidated. 
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1.2 Macrophage biology in the context of immune response 
Macrophages are key phagocytic cells associated with innate immunity, pathogen containment 
and modulation of the immune response (Murray and Wynn, 2011; Wynn et al., 2013). 
Macrophages have multiple receptors to recognise pathogen-associated molecular patterns 
such as toll-like receptors (TLRs), nod-like receptors (NLRs) and RIG-i like receptors 
(Mogensen, 2009). Macrophages also respond to regulatory signals produced by other cells 
such as interferon-gamma (IFNɣ), interferon-beta (IFNβ), interleukin-4 (IL-4), interleukin-10 (IL-
10), tumour necrosis factor (TNF) and many others (Xue et al., 2014). In the following section I 
will give a more thorough overview of macrophage response to bacterial lipopolysaccharide, 
IFNɣ and Salmonella infection, because these three stimuli are the main focus of the rest of the 
thesis. 
1.2.1 Signalling pathways activated by lipopolysaccharide and interferon-
gamma 
Lipopolysaccharides (LPS) are a component of the outer membrane of gram-negative bacteria. 
Macrophages recognise LPS via the TLR4 receptor on their cell surface (Medzhitov and Horng, 
2009). Ligand binding to TLR4 leads to the activation of the Myd88 dependent pathway that 
culminates with the activation of NF-κB and AP-1 transcription factors that recognise specific 
sequence motifs in the nucleus (Takeuchi and Akira, 2010) (Figure 1.1). This pathway is also 
shared with other toll-like receptors such as TLR2, TLR3 and TLR9. In addition, TLR3/4 
activation also leads to the activation of Myd88-independent pathway culminating with the 
activation of interferon response factors 3 and 7 (IRF3/7) transcription factors that recognise the 
canonical interferon-response element (ISRE) motif (Doyle et al., 2002).  
 
One of the genes activated by IRF3/7 is IFNB1 that codes for IFNβ protein (Doyle et al., 2002). 
IFNβ is secreted by the cells where it is then recognised by interferon-alpha receptor (IFNAR). 
Activation of IFNAR predominantly leads to activation of the ISGF3 complex composing of 
STAT1, STAT2 and IRF9 that recognises the same ISRE motif (Ivashkiv and Donlin, 2014).  
 
Interferon-gamma (IFNɣ) is an inflammatory cytokine produced by T-cells and natural killer (NK) 
cells (Schroder et al., 2004). IFNɣ binding to the IFNɣ receptor leads to the phosphorylation of 
STAT1 and formation of STAT1 homodimers that bind to the gamma-activated sequence (GAS) 
motif (Platanias, 2005). One of the immediate targets of STAT1 is IRF1 transcription factor that 
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is involved in the cooperative regulation of gene expression of many target genes (Ramsauer et 
al., 2007) including the master regulator of major histocompatibility complex (MHC) class II 
genes CIITA (Reith et al., 2005).  
 
 
Figure 1.1: Main signalling pathways activated in macrophages after Salmonella infection 
and IFNɣ stimulation. Macrophages recognise LPS on the Salmonella cell wall via the TLR4 
receptor (Medzhitov and Horng, 2009). Ligand binding to multiple TLRs such as TLR2, TLR3, 
TLR4 and TLR9 leads to downstream activation of NF-κB and AP-1 transcription factors 
(Takeuchi and Akira, 2010). However, TLR3/4 activation also leads to specific activation of the 
IRF3 transcription factor and downstream antiviral response genes (Doyle et al., 2002). IFNɣ, on 
the other hand, activates signal transducer and activator of transcription 1 (STAT1) and IRF1 
TFs. 
 
Thus, different environmental signals lead to the activation of distinct signalling pathways and 
downstream TFs that are responsible for specific changes in gene expression (Xue et al., 2014). 
Furthermore, simultaneous activation of multiple signalling pathways can have synergistic 
effects on gene expression, leading to activation of genes that are not activated by either of the 
stimuli alone (Qiao et al., 2013). 
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1.2.2 Macrophage response to Salmonella infection 
Macrophages recognise many different components of Salmonella including LPS (TLR4), 
flagella (TLR5), fimbrae/pili, peptidoglycan (TLR1/2, NOD2), bacterial DNA (TLR9) and type III 
secretion systems (T3SS) (NLRC4) (de Jong et al., 2012). In addition, Salmonella can also 
directly modulate macrophage immune response by releasing effector molecules encoded via 
the type III secretion systems that can promote bacterial uptake and intracellular survival 
(Haraga et al., 2008).  
 
Salmonella infection and LPS stimulation induce similar transcriptional response in mouse 
macrophages (Rosenberger et al., 2000), suggesting that LPS plays an important role in early 
response to bacterial infection (4 hours). Similarities between Salmonella and LPS response 
have also been observed in human macrophages where the core transcriptional response was 
conserved between many different species of bacteria and bacterial components (such as LPS) 
and this response was predominantly mediated by TLR4 and TLR2 signalling (Nau et al., 2002). 
This is not to say that differences in response between live bacterial infections and LPS 
stimulation do not exist. For example, Mycobacterium tuberculosis is able to actively suppress 
interleukin-12 (IL12) production (Nau et al., 2002). Rather, it suggests that in common 
experimental designs of bulk infections (resulting in only 20-30% of macrophages being 
infected) early response (the first few hours) is dominated by TLR signalling and other signalling 
mechanisms have either weaker effects or influence smaller proportion of cells. Single cell RNA-
seq is a promising approach to address this question. 
1.3 Tissue culture models of macrophage biology 
Commonly used model systems to study macrophage biology have included macrophage-like 
leukemic cell lines such as THP-1 (Tsuchiya et al., 1982), primary macrophages derived from 
model organisms and primary human macrophages differentiated from blood monocytes. 
Although these cells have provided important insights into macrophage-associated biology, they 
have some limitations. Immortalised cell lines often have accumulated multiple genetic 
aberrations and can exhibit functional defects compared to primary cells such as impaired 
cytokine production upon LPS stimulation (Adati et al., 2009; Schildberger et al., 2013), while 
multiple functional differences exist between macrophages from different species (Schroder et 
al., 2012). Additionally, human monocyte derived macrophages (MDMs) can be difficult to 
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obtain in sufficient numbers for repeated experimental assays and it is currently challenging to 
introduce targeted mutations into their genomes, limiting their utility in genetic studies. 
1.3.1 Differentiating macrophages from human induced pluripotent stem 
cells 
A promising alternative approach is to differentiate macrophages directly from human induced 
pluripotent stems cells (iPSCs). The key advantage of the iPSC-based system is that it is 
possible to produce large numbers of cells from almost any genetic background (both natural 
and engineered), provided that the genetic background does not interfere with macrophage 
differentiation itself. The simpler protocol that we have used throughout this thesis relies on 
spontaneous formation of embryoid bodies (EBs) followed by directed differentiation in the 
presence of interleukin-3 (IL-3) and macrophage colony stimulating factor (M-CSF) (Karlsson et 
al., 2008; Lachmann et al., 2015; van Wilgenburg et al., 2013). Alternative approaches avoid the 
EB formation step and directly differentiate macrophages from pluripotent stem cells using a 
combination of multiple factors (BMP4, VEGF, SCF, TPO, Flt3, bFGF, M-CSF) (Yanagimachi et 
al., 2013; Zhang et al., 2015).  
 
Early studies established that macrophages differentiated from induced pluripotent stem cells 
(IPSDMs) recapitulated many aspects of primary macrophage biology. They exhibited a 
transcriptomic signature specific to myeloid cells and expressed many macrophage specific cell 
surface markers including CD14, CD16, CD206 and CD68 (Karlsson et al., 2008; van 
Wilgenburg et al., 2013). In addition, IPSDMs were able to endocytose low-density lipoprotein 
(LDL), phagocytose opsonised yeast particles, produce specific cytokines in response to LPS 
stimulation and respond differentially to IFNɣ and IL-4 stimulation (Karlsson et al., 2008; van 
Wilgenburg et al., 2013). Patient-derived IPSDMs have successfully been used to model many 
monogenic disorders such as chronic granulomatous disease (Jiang et al., 2012) and Tangier 
disease (Zhang et al., 2015). However, at the outset of this work it was not yet clear how similar 
were IPSDMs to MDMs on the transcriptome level. 
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1.4 Genome-wide profiling of gene expression and chromatin 
accessibility 
1.4.1 RNA sequencing  
RNA sequencing (RNA-seq) is a widely used method to measure genome-wide gene 
expression profiles (Marioni et al., 2008). Since the majority of the RNA in most cells is 
ribosomal, either ribosomal RNA (rRNA) depletion or poly-A pulldown is often used to enrich for 
messenger RNA, after which the RNA is fragmented, reverse transcribed, PCR-amplified and 
sequenced using short read technologies. Each step in the workflow can introduce its own set of 
biases, some of which have been quite well characterised. For example, rRNA depletion can 
lead to large variation in read coverage across gene bodies while poly-A pulldown tends to 
introduce 3’ bias (Lahens et al., 2014). On the other hand, PCR often preferentially amplifies 
sequences with higher GC content in a manner that varies from sample to sample (Benjamini 
and Speed, 2012). Finally, RNA fragmentation process can lead to preferential sequencing of 
fragments with specific start and end positions (Roberts et al., 2011a) i.e. fragment start and 
end positions are not uniformly distributed across exons. While 3’ bias can often be minimised 
experimentally by ensuring that the RNA is intact before sequencing, multiple computational 
approaches have been developed to estimate and correct for GC-content and fragment biases 
(Benjamini and Speed, 2012; Hansen et al., 2012; Roberts et al., 2011a). 
Quantifying gene expression levels 
The first step in RNA-seq analysis is the quantification of gene expression levels. This has 
traditionally been done by first aligning reads to the reference genome using a splice-aware 
short read aligner that is able to also align reads across known and novel splice junctions. One 
of the first splice-aware aligners was TopHat (Trapnell et al., 2009), but it has since been 
surpassed both in speed and accuracy by newer aligners such as STAR (Dobin et al., 2013) 
and HISAT (Kim et al., 2015). After alignment, reads overlapping known gene annotations from 
databases such as GENCODE (Harrow et al., 2012) can be counted using multiple available 
tools such as featureCounts (Liao et al., 2014) or HTSeq (Anders et al., 2015). Reference 
genome alignments are also useful for visualising read coverage across the gene body. 
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Quantifying alternative transcription 
Many human genes express multiple alternative transcripts that can differ from each other in 
terms of function, stability or subcellular localisation of the protein product (Carpenter et al., 
2014; Wang et al., 2008). Considering expression only at a whole gene level can hide some of 
these important differences. Alternative transcription includes alternative promoter usage, 
alternative splicing, where middle exons are selectively included or excluded, and alternative 
polyadenylation. Two complementary approaches are often used to quantify changes in 
alternative transcription. One approach is to estimate the relative expression levels of all known 
transcripts of the gene that can best explain the observed RNA-seq read patterns across the 
gene body. The first methods that adopted this strategy were Flux Capacitor (Montgomery et al., 
2010), MISO (Katz et al., 2010) and cufflinks (Roberts et al., 2011b; Trapnell et al., 2013). 
These were later improved upon by more accurate methods such as mmseq (Turro et al., 2011) 
and BitSeq (Glaus et al., 2012) that outperformed their predecessor on independent benchmark 
datasets (Kanitz et al., 2015). A major limitation of these methods has been their computational 
complexity that can prevent them from being applied to studies with large numbers of samples. 
Newer quantification methods such as Sailfish (Patro et al., 2014), kallisto (Bray et al., 2016) 
and Salmon (Patro et al., 2016) omit the explicit reference genome alignment step and quantify 
gene expression levels directly using transcriptome sequences. This has been shown to 
dramatically reduce the time required for quantification.  
 
Even though the computational requirements have largely been resolved, important biological 
challenges still remain. First, genes often have multiple annotated transcripts that only differ 
from each other by a small amount of sequence, making it challenging to accurately estimate 
their expression from short read sequencing data. Secondly, many transcript annotations in the 
most comprehensive Ensembl database (Yates et al., 2016) are still incomplete and have either 
their 3’ or 5’ ends missing. Finally, many genes still have missing transcripts that have not been 
annotated. For example, a long gene might have three alternative promoters, two alternatively 
spliced exons and four alternative 3’ ends. If we make the assumption that most of these events 
are regulated independently, then this gene should have 2*3*4 = 24 alternative transcripts, but 
usually only a subset of these are present in the database. The assumption of independence is 
not completely unrealistic, because for example promoter selection and alternative splicing are 
regulated by independent molecular mechanisms (Barash et al., 2010). 
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A commonly used alternative analysis is to ignore the full transcript annotations and try to 
identify individual alternative transcription events independently. Two of the pioneers of this 
approach were DEXSeq (Anders et al., 2012) and MISO (Katz et al., 2010). DEXSeq aims to 
identify individual exons that are differentially expressed within a gene and as a result does not 
require the alternative exons to be previously annotated. MISO estimates the relative 
expression of alternative transcription events consisting of annotated alternative exons and their 
neighbouring exons. As a result, it is limited to annotated alternative exons but it can also take 
advantage of informative reads mapping to exon-exon junctions that are ignored by DEXSeq. 
Finally, LeafCutter (Li et al., 2016b) detects and quantifies clusters of alternatively excised 
introns directly from the read alignments by focussing on reads mapping to exon-exon junctions. 
In principle, this can be done without using reference transcript annotations, although in practice 
reference transcripts are usually still used during the read alignment phase to aid the detection 
of exon-exon junctions. 
Quantifying allele-specific expression 
In addition to total gene expression level, RNA-seq data can also provide information about the 
relative expression of the gene from the maternal and paternal chromosomes. This is possible 
when an individual is heterozygous at sites within the gene body, making it possible to count the 
number of RNA-seq reads that come from each allele. Allele-specific expression has been 
shown to increase the power to detect gene expression quantitative trait loci (eQTLs) (van de 
Geijn et al., 2015; Kumasaka et al., 2016). However, a major challenge is reference mapping 
bias - reads containing the non-reference allele can be less likely to be mapped than reads 
containing the reference allele. This is because read alignment algorithms penalise mismatches 
and reads containing the alternative allele will have at least one mismatch by definition. The 
simplest approach is to use a set of ad hoc rules to filter out variants that are likely to exhibit 
strong reference bias (Castel et al., 2015). A second approach is to deal with the issue at the 
time of read alignment either by using personalised reference genomes (Rozowsky et al., 2011) 
or editing the reads (van de Geijn et al., 2015). Finally, it is possible to use computational 
methods such as RASQUAL (Kumasaka et al., 2016) that explicitly model reference mapping 
bias. 
1.4.2 Chromatin state profiling 
As highlighted above, gene expression is predominantly regulated by the binding of transcription 
factors (TFs) to the promoters and distal regulatory elements. TF binding to a specific site often 
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leads to increased chromatin accessibility at the site as well as to covalent modification of 
nearby histones (Henikoff and Shilatifard, 2011). Hence, TF binding can be measured either 
directly using ChIP-seq or indirectly by measuring the levels of histone modifications (ChIP-seq) 
or chromatin accessibility (DNAse-seq (Furey, 2012), ATAC-seq (Buenrostro et al., 2013)) at the 
locus. 
ChIP-seq 
Chromatin immunoprecipitation followed by sequencing is a technique to identify the binding 
locations of specific proteins on the DNA (Furey, 2012). It is commonly used to detect the DNA 
binding locations of either TFs or modified histones. In ChIP-seq, proteins are first crosslinked to 
the DNA using formaldehyde, the DNA is then sheared and antibodies against a specific protein 
are used to selectively enrich for fragments that are bound by the protein of interest. Finally, the 
fragments are constructed into a library and sequenced. 
Chromatin accessibility 
The classical method to locate accessible chromatin regions has been DNAse I digestion 
followed by sequencing (DNAse-seq) (Bell et al., 2011). However, a major limitation of DNAse-
seq has been its requirement for large numbers of cells and laborious and complicated 
experimental protocols. Consequently, most existing DNAse data has been generated by large-
scale projects such as ENCODE (Neph et al., 2012) and Roadmap Epigenomics (Roadmap 
Epigenomics Consortium et al., 2015) in a small number of labs. This has changed recently with 
the introduction of ATAC-seq technique, which can be reliably performed even at the single cell 
level, and takes only a single day to complete (Buenrostro et al., 2013, 2015). ATAC-seq relies 
on Tn5 transposase that is used to insert Illumina sequencing adaptors into native chromatin. 
When Tn5 is used on intact nuclei this results in sequencing adaptors being preferentially 
integrated into regions of accessible chromatin. 
Data analysis 
After the reads have been aligned to the reference genome, the first steps is identifying regions 
(‘peaks’) that show either more protein binding or chromatin accessibility than the genome-wide 
background. Many different peak calling algorithms exist, but one commonly used method is 
MACS2 (Zhang et al., 2008b). Once the regions have been identified, we can quantify total and 
allele-specific signal using the same approaches that are used for RNA-seq data. 
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1.5 Genetics of molecular traits 
Genome wide association studies (GWAS) have identified thousands of genetic variants 
associated with various human traits and diseases. For example, as of 12 June 2016 the 
NHGRI-EBI GWAS catalog contains 21,941 unique variant-trait associations from 2457 studies 
(Welter et al., 2014). These variants lie predominantly in non-coding regions of the genome, 
making it difficult to identify the gene that is being affected as well as the relevant tissue and cell 
type for the disease (Maurano et al., 2012). However, GWAS variants are also enriched in gene 
regulatory elements (Farh et al., 2014; Maurano et al., 2012; Trynka et al., 2013) with different 
traits often showing enrichments in specific cell types and tissues, suggesting that many of the 
GWAS variants act by regulating the expression level of some nearby genes.  
 
Moreover, emerging evidence suggests that the gene closest to the GWAS variant is not 
necessarily regulated by it. For example, a variant in the first intron of the FTO gene that has 
been associated with body mass index was only recently found to regulate the expression of 
IRX3 and IRX5 genes that are up to 1 Mb away from the variant (Claussnitzer et al., 2015). 
These long-range interactions can be quite common, as illustrated by a recent joint analysis of 
GWAS summary statistics for multiple traits and blood eQTL data from 5,311 individuals (Zhu et 
al., 2016). They identified 126 genes where the GWAS signal and eQTL signal where consistent 
with a shared causal variant, and found that in ~60% of the cases the regulated gene was not 
the one closest to the lead GWAS variant. Hence, for variants that are further away from genes, 
distance might not be reliable, and additional information is necessary to identify the most likely 
target genes. One promising approach for linking GWAS hits to their target genes has been 
eQTL mapping studies. Intuitively, if the same genetic variant is associated with both the 
expression level of gene A and the risk of disease B then this can provide a hypothesis that the 
genetic variant might influence disease B via gene A. 
1.5.1 Genetics of gene expression 
Large-scale eQTL mapping studies have revealed that common variants regulating gene 
expression are ubiquitous. One of the largest human studies involving whole blood RNA-seq 
data 922 individuals identified at least one eQTL for 79% of the genes with quantifiable 
expression level (Battle et al., 2014). However, it remains unclear why most of these variants do 
not seem to have deleterious effects on organismal fitness. One possibility is that many of the 
eQTLs are buffered at the protein level. In support of this theory, shared eQTLs and protein 
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QTLs (pQTLs) identified in human lymphoblastoid cell lines (LCLs) tend to have smaller effect 
sizes on the protein level (Battle et al., 2015). Similar buffering effects have also been observed 
for pQTLs identified in Arabidopsis (Fu et al., 2009) and mouse (Chick et al., 2016; Ghazalpour 
et al., 2011). Alternatively, high variability in the expression levels of some genes might be 
tolerated without significant effect on the organismal fitness (Keren et al., 2016).  
 
Early on, it was identified that genetic variation influences gene expression in a cell type specific 
manner. Gene expression QTL mapping in three human tissues (adipose tissue, skin and LCLs) 
showed that on average 29% of the local eQTL were tissue-specific with substantial variation of 
sharing between different tissues (Nica et al., 2011). This has led to multiple individual eQTL 
mapping studies in various human cell types (monocytes (Fairfax et al., 2012), neutrophils 
(Naranbhai et al., 2015), B-cells (Fairfax et al., 2012), T-cells, to name a few) as well as large-
scale consortium efforts such as the Genotype-Tissue Expression (GTEx) (The GTEx 
Consortium, 2015) project that aims to perform RNA and genome sequencing on 44 tissues 
collected from up to 500 post-mortem donors. The relatively high cell type specificity of eQTLs is 
perhaps unsurprising given that patterns of TF binding that regulate gene expressions are highly 
cell type specific as highlighted above and even the same biological processes can be regulated 
by distinct sets of regulatory elements in different cell types (Soucie et al., 2016). 
 
However, an aspect that has gotten relatively less attention is that genetic effects can also be 
modulated by the environment that the cells are in. Early on, Smith and Kruglyak showed that 
many eQTLs in yeast were specific to the environment that the cells were grown in (ethanol 
versus glucose) (Smith and Kruglyak, 2008). Similar condition-specific genetic effects were later 
observed in mouse macrophages stimulated with either LPS or oxidized phospholipids (Orozco 
et al., 2012). The first human studies were performed on LCLs stimulated with glucocorticoids 
(N=114) (Maranville et al., 2011) and primary dendritic cells (N=65) infected with Mycobacterium 
tuberculosis (Barreiro et al., 2012). These have been followed by several studies involving 
different immune cells and additional stimuli (Table 1). 
 
Table 1: Selection of eQTL studies looking at gene-environment interactions in 
stimulated human cells. 
Study Cell type Stimulations Sample size 
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(Maranville et al., 
2011) 
Lymphoblastoid cell 
lines (LCLs) 
Glucocorticoids 114 individuals 
(Barreiro et al., 
2012) 
Dendritic cells Mycobacterium 
tuberculosis 
65 individuals 
(Fairfax et al., 
2014) 
Monocytes LPS (2h), LPS (24h), 
IFNɣ (24h) 
261-414 individuals 
(Lee et al., 2014) Dendritic cells LPS (5h), influenza 
(10h), IFNβ (6.5h) 
534 individuals 
(Kim et al., 2014) monocytes LPS (1.5h) 137 individuals 
(Çalışkan et al., 
2015) 
Peripheral blood 
mononuclear cells 
(PBMCs) 
Rhinovirus infection 98 individuals 
 
 
This area is still relatively underexplored given that for each human cell type there could be tens 
of relevant individual stimuli or combinations of stimuli that can modulate the effects of genetic 
variants on gene expression. Furthermore, the effect of a single stimulus can depend on the 
time when it was measured (Fairfax et al., 2014), thus increasing the number of relevant 
experimental conditions even further. With that many experimental conditions, obtaining enough 
cells from controlled genetic backgrounds becomes a major challenge. However, if efficient 
differentiation protocols are available, then iPSCs can be used to produce large numbers of 
differentiated cells from any cell type. 
1.5.2 Genetics of chromatin states 
A major limitation of eQTL mapping studies is that due to linkage disequilibrium we are mostly 
unable to identify the single most likely causal variant. This can severely hamper our ability to 
understand the principles of gene regulation and, as a consequence, means that even if we 
have a strong evidence of co-localisation between GWAS hit and an eQTL we might still not 
understand the molecular mechanism that gives rise to both of the traits.  
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A promising approach is to use the same QTL mapping approach to search for genetic variants 
that are associated with the activity of regulatory elements (i.e. regulatory QTLs). An advantage 
of regulatory QTLs is that they often reside within the same regulatory element, making it easier 
to predict the most likely causal variant (Degner et al., 2012; Ding et al., 2014). The activity of 
regulatory elements can be characterised by either measuring the levels transcription factor 
(TF) binding, histone modifications (both measured by ChIP-seq) or chromatin accessibility 
(measured by DNase-seq or ATAC-seq). Until recently, all of these approaches were limited by 
either complicated experimental protocols and/or the requirement of large number of cells, 
making it feasible to perform regulatory QTL mapping experiments only in LCL and in relatively 
small number of individuals. This has changed with the introduction of ATAC-seq technique that 
can be reliably performed on as few as 5,000 cells and takes only a single day to complete 
(Buenrostro et al., 2013). 
 
TF binding as measured by ChIP-seq is the most specific measurement, but this also means a 
separate experiment needs to be performed for each TF of interest. In addition, not all TFs have 
reliable ChIP-seq antibodies available and generally a large number of cells are required for a 
successful experiment (>10 million). Profiling the levels of histone modifications hides the 
identity of specific TFs, but can still reveal if the regulatory element is in a repressed, poised or 
active state. Finally, DNase-seq or ATAC-seq only reveal which regions of the chromatin are 
open or closed, but require only a single experiment, and in the case of ATAC-seq work on a 
very small number of cells and generally have higher resolution than histone ChIP-seq 
experiments. A selection of recent chromatin QTL studies is presented in Table 1.2. 
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Table 1.2: summary of recent chromatin QTL mapping studies. 
Study Cell type Phenotype Sample size 
(Kasowski et al., 2010) LCL NF-κB ChIP-seq 
RBP2 (Pol II) ChIP-seq 
10 individuals 
(Degner et al., 2012) YRI LCL DNAse-seq 70 individuals 
(Kasowski et al., 2013) LCL H3K27ac, H3K4me1, 
H3K4me3, H3K36me3, and 
H3K27me3 
CTCF 
SA1 (cohesin subunit) 
19 individuals 
(Kilpinen et al., 2013) LCL Histones: H3K4me1, 
H3K4me3, H3K27ac, 
H3K27me3 
TFs: TFIIB, PU.1, and MYC 
RPB2 (Pol II) 
2 trios + 8 individuals 
(subset of assays) 
(McVicker et al., 2013) YRI LCL H3K4me1, H3K4me3, 
H3K27ac, and H3K27me3 
Pol II 
10 individuals 
(Ding et al., 2014) CEU LCL CTCF ChIP-seq 51 individuals 
(Kumasaka et al., 2016) CEU LCL ATAC-seq 24 individuals 
(Grubert et al., 2015) YRI LCL H3K4me1, H3K4me3, 
H3K27ac 
75 individuals 
(Waszak et al., 2015) CEU LCL PU.1, RBP2 (Pol II)  
H3K4me1, H3K4me3, 
H3K27ac 
47 individuals 
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1.5.3 Using eQTLs to interpret GWAS associations 
If the same genetic variant is associated both with expression level of gene A and increased risk 
of disease B then this can provide a mechanistic hypothesis that the expression level of gene A 
influences the risk of disease B. However as highlighted above, eQTLs are extremely common 
and because of strong LD between variants there is often a large number of variants that are 
significantly associated with either gene expression level and/or disease risk. As a result, it is 
easy to get random overlaps between eQTLs and GWAS hits where the two associations are 
driven by different causal variants.  
 
To overcome this limitation, different approaches have been developed that compare the 
association patterns of two traits across many variants and try to identify if they are likely to be 
driven by the same causal variant. Although the amount of molecular QTL studies has been 
steadily increasing, the number GWAS hits that can be readily explained by eQTLs has still 
remained relatively small. A study of 49 type 1 diabetes loci and monocyte eQTLs from 1,370 
individuals identified 21 cases where the data was consistent with a shared causal variant 
driving both traits (Wallace et al., 2012). However, when a newer Bayesian colocalisation test 
(Giambartolomei et al., 2014) was applied to ten immune-mediated diseases and gene 
expression data from multiple immune cell types, it was able to identify only six confident 
colocalised associations (Guo et al., 2015). This is an active area of research and newer 
methods are continuously being developed and applied to ever larger data sets (Chun et al., 
2016; Hormozdiari et al., 2016; Zhu et al., 2016). 
 
Multiple factors might be responsible for the limited success of using eQTLs to interpret GWAS 
hits. One possible reason is that the disease relevant eQTLs might be active in very specific cell 
types and conditions and the limited eQTL studies that have been performed thus far have been 
unable to uncover them. Another reason is that if there are many variants that are in high LD 
with the causal variant, then even if the two traits have almost identical association profiles it is 
statistically impossible to distinguish if they are likely to be driven by the same causal variant or 
two different causal variants (Zhu et al., 2016). Finally, the disease-associated variants might 
affect other aspects of gene expression such as splicing, that are not captured by current eQTL 
mapping studies (Li et al., 2016c). 
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1.6 Outline of the thesis 
The second chapter of the thesis focusses on establishing human iPSC-derived macrophages 
as a model system to study innate immune responses. To this end, I compared the 
transcriptomes of human monocyte-derived and iPSC-derived macrophages (IPSDMs) before 
and after stimulation with LPS. I showed that IPSDMs are broadly similar to MDMs and exhibit a 
conserved response to LPS. I also analysed alternative promoter usage and 3’UTR shortening 
in LPS response both in MDMs and IPSDMs. 
 
The aim of the third chapter was to establish IPSDMs as a suitable model to study and discover 
the functions of common genetic variants. I first characterised the reliability and reproducibility of 
our macrophage differentiation protocol by analysing results from 138 macrophage 
differentiations from 123 different iPSC lines. Secondly, I characterised the sources of variation 
that have a strong effect on macrophage gene expression level so that they could be controlled 
for more effectively in future genomic studies. Finally, because flow cytometry is often used as a 
quality control step in cellular differentiation assays, I focussed on the factors that are 
responsible for variability in the expression of cell surface markers in IPSC-derived 
macrophages. 
  
In the fourth chapter, I used IPSDMs to study the genetics of gene expression in macrophage 
immune response. We performed RNA-seq on macrophage differentiated from 84 donors in four 
experimental conditions: naive, IFNɣ stimulation (18 hours), Salmonella infection (5 hours) and 
IFNɣ stimulation followed by Salmonella infection. I used this data to answer three main 
questions: How condition-specific are the genetic effects on gene expression in the four 
conditions and what proportion of associations remain undetected when studying the naïve cells 
alone? How does common genetic variation affect other aspects of transcription such as 
alternative promoter usage, alternative splicing and alternative polyadenylation? What are the 
complex traits whose genetic risk variants are most enriched among macrophage eQTLs and 
alternative transcription QTLs? 
 
Finally, in the fifth chapter we used ATAC-seq to measure chromatin accessibility in up to 42 
individuals in the same four experimental conditions used in chapter 4. I then identified 
chromatin accessibility QTLs (caQTLs) and compared them to eQTLs from chapter 4 to explore, 
how condition-specific are genetic effect on chromatin accessibility compared to gene 
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expression. I also studied, how genetic effects propagate from chromatin accessibility to gene 
expression between experimental stimulations. Finally, I tested if caQTLs could be used to fine 
map causal variants underlying eQTLs and GWAS associations.   
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2 Comparison of monocyte-derived and 
iPSC-derived macrophages 
 
Collaboration note 
The work described in this chapter has been published as “Transcriptional profiling of 
macrophages derived from monocytes and iPS cells identifies a conserved response to LPS 
and novel alternative transcription” (Alasoo et al., 2015). I performed the iPSC-derived 
macrophage experiments and analysed the data. Fernando O. Martinez from the University of 
Oxford performed the monocyte-derived macrophage experiments. Subhankar Mukhopadhyay 
and Gordon Dougan were involved in designing and optimising the experiments and interpreting 
the results. RNA-seq library construction and sequencing was done by DNA Pipelines core 
facility at Sanger. I thank Kosuke Yusa and Mariya Chhatriwala for fruitful discussions on 
troubleshooting iPSC culture. 
2.1 Introduction 
Macrophages are key cells associated with innate immunity, pathogen containment and 
modulation of the immune response (Murray and Wynn, 2011; Wynn et al., 2013). Commonly 
used model systems for studying macrophage biology have included macrophage-like leukemic 
cell lines, primary macrophages derived from model organisms and primary human 
macrophages differentiated from blood monocytes. Although these cells have provided 
important insights into macrophage-associated biology, they have some limitations. 
Immortalised cell lines often have accumulated multiple genetic aberrations and can exhibit 
functional defects compared to primary cells such as impaired cytokine production upon 
inflammatory stimulation (Adati et al., 2009; Schildberger et al., 2013), while multiple functional 
differences exist between macrophages from different species (Schroder et al., 2012). 
Additionally, human monocyte derived macrophages (MDMs) can be difficult to obtain in 
sufficient numbers for repeated experimental assays and it is currently challenging to introduce 
targeted mutations into their genomes, limiting their utility in genetic studies. For example, 
introduction of foreign nucleic acid into the cytosol induces a robust antiviral response that may 
make it difficult to interpret experimental data (Muruve et al., 2008). 
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Recently, methods have been developed to differentiate macrophage-like cells from human 
induced pluripotent stem cells (IPSCs) that have the potential to complement current 
approaches and overcome some of their limitations (Karlsson et al., 2008; van Wilgenburg et 
al., 2013). This approach is scalable and large numbers of highly pure iPSC-derived 
macrophages (IPSDMs) can be routinely obtained from any human donor following 
establishment of an iPSC line. IPSDMs also share striking phenotypic and functional similarities 
with primary human macrophages (Karlsson et al., 2008; van Wilgenburg et al., 2013). Since 
human iPSCs are amenable to genetic manipulation, this approach can provide large numbers 
of genetically modified human macrophages (van Wilgenburg et al., 2013). Previous studies 
have successfully used IPSDMs to model rare monogenic defects that severely impact 
macrophage function (Jiang et al., 2012). However, it remains unclear how closely IPSDMs 
resemble primary human monocyte-derived macrophages (MDMs) at the transcriptome level 
and to what extent they can be used as an alternative model for functional assays.  
 
Here, we provide an in-depth comparison of the global transcriptional profiles of naïve and 
lipopolysaccharide (LPS) stimulated IPSDMs with MDMs using RNA-seq. We found that their 
transcriptional profiles were broadly similar in both naïve and LPS-stimulated conditions. 
However, certain chemokine genes as well as genes involved in antigen presentation and tissue 
remodelling were differentially regulated between MDMs and IPSDMs. Additionally, we 
identified novel changes in alternative transcript usage following LPS stimulation suggesting that 
alternative transcription may represent an important component of the macrophage immune 
response. 
2.2 Methods 
2.2.1 Samples 
Human blood for monocyte-derived macrophages was obtained from NHS Blood and 
Transplant, UK and all experiments were performed according to guidelines of the University of 
Oxford ethics review committee. All IPSDMs were differentiated from four iPSC lines: CRL1, 
S7RE, FSPS10C and FSPS11B. CRL1 iPSC line was originally derived from a commercially 
available human fibroblast cell line and has been described before (Vallier et al., 2009). S7RE 
iPSC line was derived as part of an earlier study from our lab (Rouhani et al., 2014). FSPS10C 
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and FSPS11B iPSC lines were derived as part of the Human Induced Pluripotent Stem Cell 
Initiative (Kilpinen et al., 2016). All iPSC work was carried out in accordance to UK research 
ethics committee approvals (REC No. 09/H306/73 & REC No. 09/H0304/77). 
2.2.2 Cell culture and reagents 
IPSCs were grown on Mitomycin C-inactivated mouse embryonic fibroblast (MEF) feeder cells 
in Advanced DMEM F12 (Gibco) supplemented with 20% KnockOut Serum Replacement 
(Gibco, cat no 10828-028), 2mM L-glutamine, 50 IU/ml penicillin, 50 IU/ml streptomycin and 50 
µM 2-mercaptoethanol (Sigma M6250) on 10 cm tissue-culture treated dishes (Corning). The 
medium was supplemented with 4 ng/ml rhFGF basic (R&D) and changed daily (10 ml per dish). 
Prior to passage, the cells were detached from the dish with 1:1 solution of 1 mg/ml collagenase 
and 1mg/ml dispase (both Gibco). Human macrophage colony stimulating factor (M-CSF) 
producing cell line CRL-10154 was obtained from ATCC. The cells were grown in T150 tissue 
culture flasks containing 40 ml of medium (90% alpha minimum essential medium (Sigma), 10% 
FBS, 2mM L-glutamine, 50 IU/ml penicillin, 50 IU/ml streptomycin). On day 9 the supernatant 
was sterile-filtered and stored at -80°C. 
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Figure 2.1. Biological reproducibility of IPSDM differentiation. Two biological replicates of 
FSPS10C-derived IPSDMs differentiated with either supernatant (SUP_1 and SUP_2) or 
recombinant M-CSF (MCSF_1 and MCSF_2). Above diagonal: pairwise scatterplots of 
expressed genes (transcripts per million (TPM) > 1) between all four samples. Below diagonal: 
pairwise Spearman’s correlation of gene expression between all four samples. 
 
IPSCs were differentiated into macrophages following a previously published protocol consisting 
of three steps: i) embryoid body (EB) formation, ii) production of myeloid progenitors from the 
EBs and iii) terminal differentiation of myeloid progenitors into mature macrophages (van 
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Wilgenburg et al., 2013). For EB formation, intact iPSC colonies were separated from MEFs 
using collagenase-dispase solution, transferred to 10 cm low-adherence bacteriological dishes 
(Sterilin) and cultured in 25 ml iPSC medium without rhFGF for 3 days. Mature EBs were 
resuspended in myeloid progenitor differentiation medium (90% X-VIVO 15 (Lonza), 10% FBS, 
2mM L-glutamine, 50 IU/ml penicillin, 50 IU/ml streptomycin and 50 μM 2-mercaptoethanol 
(Sigma M6250), 50 ng/ml hM-CSF (R&D), 25 ng/ml hIL-3 (R&D)) and plated on 10 cm 
gelatinised tissue-culture treated dishes. Medium was changed every 4-7 days. After 3-4 weeks, 
floating progenitor cells were isolated from the adherent EBs, filtered using a 40 µm cell strainer 
(Falcon) and resuspended in macrophage differentiation medium (90 % RPMI 1640, 10% FBS, 
50 IU/ml penicillin and 50 IU/ml streptomycin) supplemented with 20% supernatant from CRL-
10154 cell line. Approximately 7×105 cells in 15 ml of media were plated on a 10 cm tissue-
culture treated dish and cultured for 7 days until final differentiation. We observed that using 
supernatant instead of 100 ng/ml M-CSF as specified in the original protocol (van Wilgenburg et 
al., 2013) did not alter macrophage gene expression profile. The variation between cells 
differentiated with supernatant or M-CSF was comparable to the variation between two 
biological replicates of macrophages differentiated with M-CSF (Figure 2.1). 
 
Human monocytes (90-95% purity) were obtained from healthy donor leukocyte cones 
(corresponding to 450 ml of total blood) by 2-step gradient centrifugation (Martinez, 2012; 
Martinez et al., 2006). The monocyte fraction in this type of preparation is on average 98% 
CD14+, 13% CD16+ by single staining. The isolated monocytes were cultured for 7 days in the 
same macrophage differentiation medium as IPSDMs. The same seeding density and tissue-
culture treated plastic was used as for IPSDMs. Non-adherent contaminating cells were 
removed by vigorous washing before cell lysis at day 7. 
 
On day 7 of macrophage differentiation, medium was replaced with either 10 ml of fresh 
macrophage medium (without M-CSF) or medium supplemented with 2.5 ng/ml LPS (E. coli). 
After 6 hours, cells were lifted from the plate using lidocaine solution (6 mg/ml lidocaine, PBS, 
0.0002% EDTA), counted with haemocytometer (C-Chip) and lysed in 600 µl RLT buffer 
(Qiagen). All cells from a dish were used for lysis and subsequent RNA extraction.  
2.2.3 Flow cytometry 
Flow cytometry was used to characterise the IPSDM cell populations used in the experiments. 
Approximately 1×106 cells were resuspended in flow cytometry buffer (D-PBS, 2% BSA, 0.001% 
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EDTA) supplemented with Human TruStain FcX (Biolegend) and incubated for 45 minutes on 
ice to block the Fc receptors. Next, cells were washed once and resuspended in buffer 
containing one of the antibodies or isotype control. After 1 hour, cells were washed three times 
with flow cytometry buffer and immediately measured on BD LSRFortessa cell analyser. The 
following antibodies (BD) were used (cat no): CD14-Pacific Blue (558121), CD32-FITC 
(552883), CD163-PE (556018), CD4-PE (561844), CD206-APC (550889) and PE isotype 
control (555749). The data were analysed using FlowJo. The raw data are available on figshare 
(doi: 10.6084/m9.figshare.1119735). 
2.2.4 RNA extraction and sequencing 
RNA was extracted with RNeasy Mini Kit (Qiagen) according to the manufacturer’s protocol. 
After extraction, the sample was incubated with Turbo DNase at 37°C for 30 minutes and 
subsequently re-purified using RNeasy clean-up protocol. Standard Illumina unstranded poly-A 
enriched libraries were prepared and then sequenced 5-plex on Illumina HiSeq 2500 generating 
20-50 million 75bp paired-end reads per sample. RNA-seq data from six iPSC samples was 
taken from a previous study (Rouhani et al., 2014). Sample information together with the total 
number of aligned fragments are detailed in Table 2.1.  
 
Table 2.1: General information about the RNA-seq samples. Library size column contains 
the total number of aligned fragments per sample. 
Sample Donor Cell	type Treatment Library	size 
S7_RE15 S7RE IPSC control 83280070 
S7_RE11 S7RE IPSC control 72411619 
S4_SF5 S4SF IPSC control 72167859 
S4_SF3 S4SF IPSC control 72427265 
S5_SF1 S5SF IPSC control 90998616 
S5_SF3 S5SF IPSC control 83746320 
CRL1_ctrl CRL1 IPSDM control 47052432 
S7RE_ctrl S7RE IPSDM control 25322078 
FSPS10C_ctrl FSPS10C IPSDM control 23443481 
FSPS11B_ctrl FSPS11B IPSDM control 19933949 
CRL1_LPS CRL1 IPSDM LPS 33985920 
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S7RE_LPS S7RE IPSDM LPS 24349911 
FSPS10C_LPS FSPS10C IPSDM LPS 24570506 
FSPS11B_LPS FSPS11B IPSDM LPS 24394255 
B1_ctrl B1 MDM control 23381545 
B4_ctrl B4 MDM control 47790764 
B5_ctrl B5 MDM control 26056124 
B2_ctrl B2 MDM control 20901894 
B3_ctrl B3 MDM control 26059134 
B1_LPS B1 MDM LPS 20748290 
B4_LPS B4 MDM LPS 25538994 
B5_LPS B5 MDM LPS 56227352 
B2_LPS B2 MDM LPS 24456569 
B3_LPS B3 MDM LPS 24075743 
 
2.2.5 RNA-seq data analysis  
Differential expression 
Sequencing reads were aligned to GRCh37 reference genome with Ensembl 74 annotations 
using TopHat v2.0.8b (Kim et al., 2013). Reads overlapping gene annotations were counted 
using featureCounts (Liao et al., 2014) and DESeq2 (Love et al., 2014) was used to identify 
differentially expressed genes. Genes with FDR < 0.01 and fold-change > 2 were identified as 
differentially expressed. We used g:Profiler to perform Gene Ontology and pathway enrichment 
analysis (Reimand et al., 2011). For conditional enrichment analysis of the genes differentially 
regulated in LPS response we used all LPS-responsive genes as the background set. All 
analysis was performed on genes classified as expressed in at least one condition (TPM > 2) 
except where noted otherwise. The bedtools (Quinlan and Hall, 2010) suite was used to 
construct BigWig files with genome-wide read coverage. All downstream analysis was carried 
out in R and ggplot2 was used for figures.  
Effect of genetic differences on differential expression analysis 
To estimate the contribution that genetic differences between IPSDMs and MDMs might have 
on the differential expression analysis, I obtained gene level RNA-seq read counts from 
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lymphoblastoid cell lines (LCLs) from 84 British individuals from a previously published study 
(Lappalainen et al., 2013). To mimic our experimental design, I repeatedly (100 times) sampled 
9 individuals from the pool of 84, assigned them randomly into two groups (four and five 
individuals) and used DESeq2 to estimate the number of differentially expressed genes 
between the groups that satisfied the same thresholds that I used in the main analysis (FDR < 
0.01, fold change > 2). 
Alternative transcript usage 
To quantify alternative transcript usage, reads were aligned to Ensembl 74 transcriptome using 
bowtie v1.0.0 (Langmead et al., 2009). Next, I used mmseq and mmdiff to quantify transcript 
expression and identify transcripts whose proportions had significantly changed (Turro et al., 
2011, 2014). For each transcript I estimated the posterior probability of five models (i) no 
difference in isoform proportion (null model), (ii) difference between LPS treatment and control 
(LPS effect), (iii) difference between IPSDMs and MDMs (macrophage type effect), (iv) 
independent treatment and cell type effects (both effects), (v) LPS response different between 
MDMs and IPSDMs (interaction effect). I specified the prior probabilities as (0.6, 0.1, 0.1, 0.1, 
0.1) reflecting the prior belief that most transcripts were not likely to be differentially expressed. 
Transcripts with posterior probability of the null model < 0.05 were considered significantly 
changed. 
 
 43 
 
Figure 2.2. Constructing alternative transcription events from annotated transcripts. (A) 
Hypothetical RNA-seq read coverage over a gene indicating that there is switch from proximal 
to distal promoter between conditions 1 and 2. (B) True transcript annotations generating the 
read coverage observed on panel A. (C) Hypothetical reference transcripts detected to be 
differentially expressed between conditions 1 and 2. Note that the true transcript 2A from which 
the reads were generated was not present in the annotated transcripts. Consequently, different 
transcript 2B was detected to be differentially expressed that also had a skipped exon 4 and 
shorter 3′ UTR. Comparing transcript 1 to transcript 2B gives the wrong impression that exon 4 
and the 3′ UTR are also differentially expressed although their read coverage has not changed 
between the conditions. (D) Three alternative transcription events constructed from transcripts 1 
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and 2B using the reviseAnnotations package. Estimating the differential expression of these 
alternative events separately correctly identifies that only the promoter usage changes between 
conditions. 
 
Next, I used a two-step process to identify the exact alternative transcription events (alternative 
promoter usage, alternative splicing or alternative 3′ end usage) that were responsible for the 
observed changes in transcript proportions. First, to identify all potential alternative transcription 
events in each gene, I compared the transcript whose proportion changed the most between the 
two conditions to the most highly expressed transcript of the gene (Figure 2.2). This analysis 
revealed that for 93% of the genes the two selected transcripts differed from each other in more 
than one location, for example both the promoters and alternative 3′ ends were different 
between the two transcripts. However, visual inspection of the read coverage plots suggested 
that in majority of these cases there was only one change between the two transcripts and the 
other changes were false positives caused by missing or incomplete transcript annotations. To 
identify which one of the changes was responsible for the alternative transcription signal, I 
developed the reviseAnnotations R package (https://github.com/kauralasoo/reviseAnnotations) 
to split the two identified transcripts into individual alternative transcription events (Figure 2.2). 
Next, I reanalysed the RNA-seq data using exactly the same strategy as described above 
(bowtie + mmseq + mmdiff) but substituted Ensembl 74 annotations with the identified 
transcription events. Finally, I required events to change at least 10% in proportion between the 
two conditions to be considered for downstream analysis. This analysis revealed that instead of 
the 93% suggested by the transcript level analysis, only 4% of the genes had more than one 
event whose proportion changed at least 10%, indicating that transcript level analysis leads to a 
large number of false positives. Our event-based approach is similar to the one used by the 
Mixture of Isoforms (MISO) model (Katz et al., 2010).  
Visualising alternative transcript usage 
I developed the wiggleplotr R package (https://github.com/kauralasoo/wiggleplotr) to aid the 
visualisation of RNA-seq read coverage across alternative transcription events. A key feature of 
the software is that it allows introns to be shortened to constant width thus making it easier to 
see differences in read coverage between neighbouring exons in genes with long introns. 
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2.3 Gene expression variation between iPSCs, IPSDMs and 
MDMs 
2.3.1 Global patterns of gene expression 
RNA-seq was used to profile the transcriptomes of MDMs derived from five and IPSDMs 
derived from four different individuals (Methods). Identical preparation, sequencing and 
analytical methodologies were used for all samples. Initially, I used Principal Component 
Analysis (PCA) to generate a genome-wide overview of the similarities and differences between 
naïve and LPS-stimulated IPSDMs and MDMs as well as undifferentiated iPSCs. The first 
principal component (PC1) explained 50% of the variance and clearly separated iPSCs from all 
macrophage samples (Figure 2.3A) illustrating that IPSDMs are transcriptionally much more 
similar to MDMs compared to undifferentiated iPSCs. This was further confirmed by high 
expression of macrophage specific markers and low expression of pluripotency factors in 
IPSDMs (Figure 2.3B). The second PC separated naïve cells from LPS-stimulated cells and 
explained 16% of the variance, while the third PC, explaining 8% of the variance, separated 
IPSDMs from MDMs. The principal component that separated IPSDMs from MDMs (PC3) was 
different from that separating macrophages from iPSCs (PC1). Since principal components are 
orthogonal to one another, this suggests that the differences between MDMs and IPSDMs are 
beyond the simple explanation of incomplete gene activation or silencing compared to iPSCs.  
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Figure 2.3. Gene expression variation between iPSCs, IPSDMs and MDMs. (A) Principal 
Component Analysis of expressed genes (TPM > 2) in iPSCs, IPSDMs and MDMs. (B) 
Heatmap showing the gene expression of selected iPSC-specific transcription factors (TFs), 
macrophage specific TFs, pattern recognition receptors (PRRs) and canonical macrophage cell 
surface markers. Rectangles correspond to measurements from independent biological 
replicates. 
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2.3.2 Differential expression analysis of IPSDMs vs MDMs 
Table 2.2. Selection of enriched Gene Ontology terms and KEGG pathways for different 
groups of differentially expressed genes. 
 
 
Although PCA provides a clear picture of global patterns and sources of transcriptional variation 
across all genes in the genome, important signals at individual genes might be missed. To 
better understand transcriptional changes at the gene level I used a two factor linear model 
implemented in the DESeq2 package (Love et al., 2014). The model included an LPS effect, 
capturing differences between unstimulated and stimulated macrophages and a macrophage 
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type effect capturing differences between MDMs and IPSDMs. Our model also included an 
interaction term that identified genes whose response to LPS differed between MDMs and 
IPSDMs. I defined significantly differentially expressed genes as having a fold-change of >2 
between two conditions using a p-value threshold set to control our false discovery rate (FDR) 
to 0.01.  
 
Using these thresholds, I identified 2977 genes that were differentially expressed between 
unstimulated IPSDMs and MDMs. Among these genes, 2080 were more highly expressed in 
IPSDMs and 897 were more highly expressed in MDMs (Figure 2.4A). Genes that were more 
highly expressed in MDMs such as HLA-B, LYZ, MARCO and HLA-DRB1 (Figure 2.4C), were 
significantly enriched for antigen binding, phagosome and lysosome pathways (Table 2.2). This 
result is consistent with a previous report that MDMs have higher cell surface expression of 
MHC-II compared to IPSDMs (Karlsson et al., 2008; van Wilgenburg et al., 2013). Genes that 
were more highly expressed in IPSDMs, such as MMP2, VEGFC and TGFB2 (Figure 2.4C) 
were significantly enriched for cell adhesion, extracellular matrix, angiogenesis, and multiple 
developmental processes (Table 2).  
 
In the LPS response I identified 2638 genes that were differentially expressed in both MDMs 
and IPSDMs, of which 1525 genes were upregulated while 1113 were downregulated. As might 
be expected, Gene Ontology and KEGG pathway analysis revealed large enrichment for terms 
associated with innate immune and LPS response, NF-κB and TNF signalling (Table 2.2). I also 
identified 569 genes whose response to LPS was significantly different between IPSDMs and 
MDMs. The majority of these genes (365) responded in the same direction in both IPSDMs and 
MDMs, but the magnitude of change was significantly different. The remaining 229 genes 
showed a change in the opposite direction (8.7% of the LPS-responsive genes) (Figure 2.4B). 
This set of 229 were much weaker responders to LPS overall (2.3-fold compared to 4.7-fold). 
Additionally, I could not find convincing pathway or Gene Ontology enrichment signals in either 
gene set (229 and 569 genes) compared to all LPS-responsive genes. Overall, I found that the 
fold change of the genes that responded to LPS was highly correlated between MDMs and 
IPSDMs (r = 0.82, Figure 2.4B) indicating that the LPS response in these two macrophage 
types was broadly conserved. Interestingly, I also found that mean fold change was marginally 
(10%) higher in MDMs (4.95) compared to IPSDMs (4.43). The behaviour of some canonical 
LPS response genes is illustrated in Figure 2.4D. 
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Figure 2.4. Differential expression analysis of IPSDMs vs MDMs. (A) Scatter plot of gene 
expression levels between MDMs and IPSDMs. Genes that are significantly more highly 
expressed in IPSDMs are shown in red and genes that are significantly more highly expressed 
in MDMs are shown in blue. (B) Scatter plot of fold change in response to LPS between MDMs 
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(x-axis) and IPSDMs (y-axis). Only genes with significant LPS or interaction term in the linear 
model are shown. Genes with LPS response fold change in the opposite direction between 
MDMs and IPSDMs are highlighted in purple. (C) Heatmap of genes differentially expressed 
between MDMs and IPSDMs. Representative genes from significantly overrepresented Gene 
Ontology terms (Table 1) include antigen presentation (HLA genes), lysosome formation (LYZ), 
angiogenesis (VEGFC, TGFB2), and extracellular matrix (SERPINE2, MMP2 COL4A5). The 
same genes are also marked in panel A. (D) Heatmap of example genes upregulated in LPS 
response.  
 
Although genes with significantly different response to LPS between MDMs and IPSDMs were 
not enriched for particular Gene Ontology terms or pathways, IL8 and CCL7 mRNAs were more 
strongly upregulated in IPSDMs compared to MDMs (Figure 2.4B). Consequently, I looked at 
the response of all canonical chemokines in an unbiased manner. I observed relatively higher 
induction of further CXC subfamily monocyte and neutrophil attracting chemokines in IPSDMs 
(Figure 2.3). Moreover, five out of seven CXCR2 ligands (Zlotnik and Yoshie, 2012) were more 
strongly induced in IPSDMs (FDR < 0.1, fold-change difference between MDMs and IPSDMs > 
2) which is significantly more than is expected by chance (Fisher’s exact test p = 4.5×10-6) 
(Figure 2.5). These genes were also expressed at substantial levels (TPM > 100), with IL8 
being one of the most highly expressed gene in IPSDMs after LPS stimulation. On the other 
hand, MDMs displayed relatively higher induction of three chemokines involved in attracting B-
cells, T-cells and dendritic cells (CCL18, CCL19, CXCL13) (Figure 2.5). 
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Figure 2.5. Chemokine genes that were particularly upregulated in either IPSDMs or 
MDMs in LPS response. Their annotated receptors and target cell types were taken from the 
literature (Soehnlein and Lindbom, 2010; Zlotnik and Yoshie, 2012). 
2.3.3 Mechanisms underlying differences between MDMs and IPSDMs 
To understand the mechanisms that might underlie the gene expression differences between 
MDMs and IPSDMs, I focussed on three hypotheses: (1) a minority contaminating cell 
population in IPSDM samples that is absent in MDMs, (2) genetic differences between donors 
from which the IPSDMs and MDMs were derived, and (3) incomplete differentiation from iPSCs 
resulting in developmentally immature macrophages that might exhibit some properties of the 
iPSCs. The high purity of our IPSDM samples (92-98%) (Table 2.3) and MDM samples 
(routinely 90-95% pure) suggested that there was no obvious contaminating cell type present 
that did not express the canonical macrophage markers. Furthermore, even the 99% pure 
IPSDM samples retained most of the differential expression with MDMs (Figure 2.6A) 
suggesting contamination is not a major source of IPSDM-MDM differences.  
 
Table 2.3. Purity of iPSC-derived macrophages. We used flow cytometry to estimate the 
percentage of cells expressing five cell surface markers in IPSDMs differentiated from three 
IPSC lines.       
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Marker / Cell line FSPS10C FSPS11B S7RE 
CD14 98.6 90.4 91.2 
CD206 99.5 85.1  
CD4 99.5 92.8 92.9 
CD32 94.8  87.6 
CD163 74.1 92 85.6 
 
Alternatively, IPSDMs could be incompletely differentiated from iPSCs. Under this model, genes 
that are expressed in iPSCs but repressed in mature macrophages would be more highly 
expressed in IPSDMs compared to MDMs. Consistent with this hypothesis, genes that were 
more highly expressed in IPSDMs were often also expressed in iPSCs (Figure 2.4C, Figure 
2.6A). Furthermore, while the majority of the genes that were more highly expressed in MDMs 
had mean expression > 2 TPM in both cell types, a large proportion of the genes that were more 
highly expressed in IPSDMs had mean expression < 1 TPM across both cell types (Figure 
2.6B), suggesting that their expression level in IPSDMs might be too low to be functional. 
Moreover, the promoters of the upregulated genes were highly enriched for repressive 
H3K27me3 histone marks in CD14+ monocytes (The ENCODE Project Consortium, 2012) 
(Figure 2.6C), suggesting that these genes normally become silenced prior to monocyte-
macrophage differentiation in vivo and may not have been completely silenced in IPSDMs.  
 
Finally, it is possible that some of the differences between IPSDMs and MDMs could be 
confounded with genetic differences between the donors. For example, by chance, the different 
individuals from which the IPSDMs and MDMs were derived could be fixed for alternate alleles 
of a cis-regulatory variant that changes the expression of a given gene, which would appear to 
be differentially expressed between the two cell types. However, since all our IPSDM and MDM 
donors were randomly sampled from the same population, strong clustering of IPSDM and 
MDM samples in the PCA analysis (Figure 2.3A) suggests that genetics is not a major source of 
differences between these cell types. To address this quantitatively, I reanalysed an 
independent RNA-seq data from 84 British individuals (Lappalainen et al., 2013). I found only a 
median of three differentially expressed genes between any two random samples of 4 and 5 
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individuals (Figure 2.6D). This suggests that only a small fraction of the differences between 
MDMs and IPSDMs are likely to be due to genetics. 
 
 
Figure 2.6: Mechanisms underlying differential expression between MDMs and IPSDMs. 
(A) Expression levels of genes that were more highly expressed in IPSDMs compared to MDMs 
(TPM > 2). Purple violin plots show the mean expression of these genes in MDMs and orange in 
IPS cells. Red asterisks mark IPSDM samples (FSPS10C) that stained > 99% positive for 
CD14, CD206 and CD4 while S7RE and FSPS11B samples were ~91% positive. (B) MA-plot of 
differentially expressed genes between MDMs and IPSDMs (without TPM cut-off). On the y-axis 
is the DESeq2 estimate of fold-change between MDMs and IPSDMs. Red line denotes the 2 
TPM cut-off used in most analyses. (C) Fraction of gene promoters overlapping H3K27Me3 
peaks in ENCODE CD14+ monocyte samples stratified by the percentile of gene expression 
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level. Up - genes upregulated in IPSDMs; Down - downregulated in IPSDMs; None - not 
differentially expressed between MDMs and IPSDMs. (D) Histogram of the number of 
differentially expressed genes between two groups of randomly selected individuals. 
2.4 Global variation in alternative transcript usage 
Many human genes express multiple transcripts that can differ from each other in terms of 
function, stability or subcellular localisation of the protein product (Carpenter et al., 2014; Wang 
et al., 2008). Considering expression only at a whole gene level can hide some of these 
important differences. Therefore, we sought to quantify how similar were naïve and stimulated 
IPSDMs and MDMs at the individual transcript expression level. Here, we first used mmseq 
(Turro et al., 2011) to estimate the most likely expression level of each annotated transcript that 
would best fit the observed pattern of RNA-seq reads across the gene. Next, we calculated the 
proportion of total expression accounted for by each transcript by dividing transcript expression 
by the overall expression level of the gene, only including genes that were expressed over two 
transcripts per million (TPM) (Wagner et al., 2012) in all experimental conditions (8284 genes). 
Since the proportions of all transcripts of a gene sum to one and most genes express one 
dominant transcript (Gonzàlez-Porta et al., 2013), I used the proportion of the most highly 
expressed transcript as a proxy to capture variation in transcript proportions within a gene. In 
this context and similarly to gene level analysis, the first PC explained 31% of the variance and 
clearly separated IPSCs from macrophages (Figure 2.7A). However, the second PC (11% of 
variance) not only separated unstimulated cells from stimulated cells but also IPSDMs from 
MDMs. One interpretation of this result is that the changes in transcript proportions between 
IPSDMs and MDMs, to some extent, also resemble those induced in the LPS response. Further 
analysis (below) highlighted that much of this variation can be explained by changes in 3′ 
untranslated region (UTR) usage. 
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Figure 2.7. Alternative transcription in IPSDMs and MDMs. (A) PCA of relative transcript 
proportions in iPSCs, IPSDMs and MDMs. Only genes with mean TPM > 2 in all conditions were 
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included. (B) Alternative transcription events detected in LPS response. Each point corresponds 
to an alternative transcription event and shows the absolute change in the proportion of the 
most highly expressed transcript (across all samples) in LPS response in MDMs (x-axis) and 
IPSDMs (y-axis). (C) All detected alternative transcription events were divided into three groups 
based on whether they affected alternative promoter, alternative splicing or alternative 3′ end of 
the transcript. For each event, we plotted its change in proportion in LPS response (x-axis) 
against its change between macrophage types (y-axis). The events are coloured by the most 
parsimonious model of change selected by mmseq: LPS effect (difference between naïve and 
LPS-stimulated cells only); macrophage (MF) type (difference between IPSDMs and MDMs 
only); both (data support both MF type and LPS effects). (D) Number of alternative transcription 
events form panel C grouped by position in the gene (alternative promoter, alternative splicing, 
alternative 3′ end) and most parsimonious model selected by mmseq. (e) Relative expression of 
long alternative 3′ UTRs in genes showing a change between IPSDM and MDMs (MF type), 
between naïve and LPS-stimulated cells (LPS effect) and for genes showing both types of 
change. 
2.4.1 Identification and characterisation of alternative transcription events 
Alternative transcription can manifest in many forms, including alternative promoter usage, 
alternative splicing and alternative 3′ end choice, each likely to be regulated by independent 
biological pathways. Thus, I sought to characterise and quantify how these different classes of 
alternative transcription events were regulated in the LPS response, and between MDMs and 
IPSDMs. Using a linear model implemented in the mmdiff (Turro et al., 2014) package followed 
by a series of downstream filtering steps (Methods) we identified 504 alternative transcription 
events (ATEs) in 485 genes. Out of those, 145 events changed between unstimulated IPSDMs 
and MDMs (macrophage (MF) type effect) while 156 events changed between naive and LPS 
stimulated cells across macrophage types (LPS effect). Further 197 events had different 
baseline expression between macrophage types, but also changed in the same direction after 
LPS stimulation (Both effects). Finally, only 6 events change in the opposite direction after LPS 
stimulation between MDMs and IPSDMs (Figure 2.7B). Next, I focussed on the 359 events that 
changed in the LPS response in at least one macrophage type (156 + 197 events with LPS 
response in the same direction and 6 events with LPS response in the opposite direction). I 
found that the LPS-induced change in the proportion of the most highly expressed transcript 
was highly correlated between MDMs and IPSDMs (Pearson r = 0.83) (Figure 2.7B), further 
confirming that the LPS response in both macrophage types is conserved. 
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Perhaps surprisingly, although the transcriptional response to LPS at the whole gene level is 
relatively well understood, the effect of LPS on transcript usage has remained largely 
unexplored. Therefore, I decided to investigate the types of alternative transcription events 
identified in LPS response as well as between MDMs and IPSDMs (See Methods for details). 
Most protein coding changes in LPS response were generated by alternative promoter usage 
(Figure 2.7C-D). In total, I identified 180 alternative promoter events, 51 of which changed the 
coding sequence by more than 100 bp in LPS response. Strikingly, alternative promoter events 
displayed larger change in proportion than other events so that often the most highly expressed 
transcript of the gene changed between cell types and conditions (Figure 2.7C). Alternative 
promoter usage for three example genes is illustrated on Figure 2.8. 
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Figure 2.8. Examples of alternative promoter usage in LPS response. Each plot shows 
normalised read depth across the gene body in IPSDMs (green) and MDMs (purple) with gene 
structure in the panel beneath each plot. Introns have been compressed relative to exons to 
facilitate visualisation. (A-C) Alternative promoter usage in NCOA7, OSBPL9 and OSBPL1A 
genes. 
 
I also observed widespread alternative 3′ end usage both in the LPS response as well as 
between MDMs and IPSDMs (Figure 2.7C-D). In contrast to alternative promoters, most of the 
3′ end events only changed the length of the 3′ UTR and not the coding sequence (Figure 2.7D). 
Changes in 3′ UTR usage were strongly asymmetric, with longer 3’ UTRs being more highly 
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expressed in IPSDMs relative to MDMs, and in unstimulated cells relative to stimulated cells 
(Figure 2.7E, Figure 2.9A). Notably, I also observed that the decrease in 3′ UTR length 
correlated with the second principal component of relative transcript expression (Figure 2.7A). 
Consistent with this observation, I found that genes with 3′ UTR events were enriched for high 
absolute weights in PC2 (p < 2.2×10-16, chi-square goodness-of-fit test), (Figure 2.9B) indicating 
that part of the transcriptional variation captured by PC2 manifests as changes in 3′ UTR usage. 
I found no convincing pathway or Gene Ontology enrichment signal in genes with alternative 3′ 
UTR events.  
 
 
Figure 2.9. 3′ UTR shortening in LPS response. (A) Examples of 3′ UTR shortening in LPS 
response. The plot shows normalised read depth across the gene body in IPSDMs (green) and 
MDMs (purple) with gene structure in the panel beneath the plot. Introns have been compressed 
relative to exons to facilitate visualisation. (B) All genes were ranked based on their weights in 
PC2 (Figure 2.7A) and the relative ranks of the 162 genes with 3’UTR events are displayed on 
the histogram. The ranks of a randomly sampled set of genes should be uniformly distributed 
whereas genes that contribute strongly to the PC should be enriched for high and low relative 
ranks (corresponding to large positive and negative weights on the PC). 
 
Finally, I detected only a small number of alternative splicing events influencing middle exons, 
most of which occurred between MDMs and IPSDMs rather than in the LPS response (Figure 
2.7C-D). Three of the events with largest changes in proportion affected cassette exons in 
UAP1, CTTN and CLSTN1 genes (Figure 2.10A-C). The inclusion of these exons has previously 
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been shown to be regulated by RNA-binding protein RBFOX2 that was also significantly more 
highly expressed in IPSDMs (Figure 2.10D) (Lambert et al., 2014; Venables et al., 2013). 
 
 
 
Figure 2.10. Alternative splicing between IPSDMs and MDMs. (A-C) Examples of alternative 
splicing between MDMs and IPSDMs. The alternatively spliced exon is marked with the red 
rectangle. (D) Expression of RBFOX2 gene in iPSCs, IPSDMs and MDMs.  
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2.5 Discussion 
In this study, we used high-depth RNA-seq to investigate transcriptional similarities and 
differences between human monocyte and iPSC-derived macrophages. Our principal findings 
are that, relative to differences between MDMs and iPSCs, the transcriptomes of naïve and LPS 
stimulated MDMs and IPSDMs are broadly similar both at the whole gene and individual 
transcript levels. Concurrently with our study, another paper using a different macrophages 
differentiation protocol came to the same broad conclusion (Zhang et al., 2015). Although we 
have only examined steady-state mRNA levels, conservation of transcriptional response to LPS 
implies that the major components of regulatory network that coordinate LPS response on the 
protein level are likely to also be similarly conserved. We did, however, also observe intriguing 
differences in expression in specific sets of genes, including those involved in tissue 
remodelling, antigen presentation and neutrophil recruitment, suggesting that IPSDMs might 
possess some phenotypic differences from MDMs. Our analysis also revealed a rich diversity of 
alternative transcription changes suggesting widespread fine-tuning of regulation in macrophage 
LPS response. 
 
We also looked at the mechanisms that might be underlying the observed differences between 
MDMs and IPSDMs. We were able to rule out genetic differences between MDMs and IPSDMs 
or contamination by some other cell type not expressing macrophage specific cell surface 
markers as a major source of these differences. However, we did find some evidence that 
IPSDMs might be developmentally less mature than MDMs. This was illustrated by the fact that 
IPSDMs expressed residual amounts of genes what were substantially more highly expressed 
in iPSCs and almost completely silenced in MDMs. Furthermore, we found that promoters of 
these genes were usually actively silenced by H3K27Me3 histone modifications in CD14+ 
monocytes suggesting that this silencing might be incomplete in IPSDMs. 
 
Alternatively, IPSDMs might share some features with tissue resident macrophages that are 
developmentally and phenotypically distinct from MDMs (Gautier et al., 2012; Ginhoux et al., 
2010; Gosselin et al., 2014; Lavin et al., 2014). In support of that, higher expression of tissue 
remodelling and neutrophil recruitment genes has previously been associated with tissue and 
tumour associated macrophages (Cailhier et al., 2005; Mantovani et al., 2013; Schmieder et al., 
2012; Soehnlein and Lindbom, 2010). On the other hand, higher expression of antigen 
presentation genes in MDMs is consistent with the specialised role of monocyte-derived cells in 
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immune regulation and antigen presentation (Gundra et al., 2014; Jakubzick et al., 2013; 
Soehnlein and Lindbom, 2010). This is consistent with a previous study suggesting a shared 
developmental pathway between IPSDMs and foetal macrophages (Klimchenko et al., 2011). 
Nevertheless, it is likely that the exact characteristics of IPSDMs can be shaped by the addition 
of cytokines and other factors during differentiation and this could be an important area for 
further exploration. 
 
In addition to showing that LPS response was broadly conserved between MDMs and IPSDMs 
both on gene and transcript level, we also identified hundreds of individual alternative 
transcription events, highlighting an important, but potentially overlooked, regulatory mechanism 
in innate immune response. A small number of the events have known functional 
consequences. For example, the LPS-induced short isoform of the NCOA7 (Figure 2.8A) gene 
is known to be regulated by Interferon β-1b and it is suggested to protect against inflammation-
mediated oxidative stress (Yu et al., 2014) whereas the long isoform is a constitutively 
expressed coactivator of oestrogen receptor (Shao et al., 2002). Similarly, the two isoforms of 
the OSBPL1A gene (Figure 2.8C) have distinct intracellular localisation and function (Johansson 
et al., 2003) while the LPS-induced short transcript of the OSBPL9 gene (Figure 2.8B) codes for 
an inhibitory isoform of the protein (Ngo and Ridgway, 2009). Thus, alternative promoter usage 
has the potential to significantly alter gene function in LPS response and these changes can be 
missed in gene level analysis. 
 
Widespread shortening of 3′ UTRs has previously been observed in proliferating cells and 
cancer as well as activated T-cells and monocytes (Mayr and Bartel, 2009; Sandberg et al., 
2008). The functional consequences of 3′ UTR shortening are unclear, but extended 3′ UTRs 
are often enriched for binding sites for miRNAs or RNA-binding proteins that can regulate 
mRNA stability and translation efficiency (Gupta et al., 2014; Sandberg et al., 2008). The role of 
miRNAs in fine-tuning immune response is well established (O’Neill et al., 2011). Furthermore, 
interactions between alternative 3′ UTRs and miRNAs have recently been implicated in the brain 
(Miura et al., 2013; Wehrspaun et al., 2014). Therefore, it might be interesting to explore how 3′ 
UTR shortening affects miRNA-dependent regulation in LPS response. 
 
In summary, we have performed an in depth comparison of an iPSC-derived immune cell with 
its primary counterpart. Our study suggests that iPSC-derived macrophages are potentially 
valuable alternative models for the study of innate immune stimuli in a genetically manipulable, 
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stable cell culture system. The ability to readily derive and store iPSCs potentially enables in-
depth future studies of the innate immune response in both healthy and diseased individuals. A 
key advantage of this model will be the ability to study the impact of human genetic variation, 
both natural and engineered, in innate immunity. 
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3 Large-scale differentiation of 
macrophages from human iPSCs 
 
Collaboration note 
The macrophage differentiation work in this chapter was performed in collaboration with Julia 
Rodrigues who was a research assistant in Daniel Gaffney’s lab at the time. I designed the 
experiments, performed Salmonella infection and IFNɣ stimulation assays, took care of sample 
logistics and performed all of the data analysis. Julia was mainly responsible for tissue culture 
required for macrophage differentiation and preparing cells for stimulation experiments. Julia 
also prepared and stained the cells for flow cytometry experiments. Subhankar Mukhopadhyay 
and Gordon Dougan provided valuable feedback in designing and optimising Salmonella 
infection and IFNɣ stimulation conditions. RNA-seq library construction and sequencing was 
done by DNA Pipelines core facility at Sanger. 
3.1 Introduction 
Human induced pluripotent cells (iPSCs) can be derived from almost any individual with many 
differentiation protocols available for different cell lineages, including macrophages (van 
Wilgenburg et al., 2013), neurons (Rigamonti et al., 2016) and cardiomyocytes (Kempf et al., 
2015). However, typical published differentiation protocols have been developed and used on a 
few iPSC lines. Hence, the expected range of normal variability between iPSC lines regarding 
many aspects of these protocols including success rate, duration of differentiation, yield, and 
purity of the differentiated cells is generally not well understood. If iPSCs are to be used for 
studying the functions of common genetic variation in differentiated cell types, differentiation 
protocols need to be robust enough to facilitate large-scale studies in tens or hundreds of lines. 
However, for most differentiation protocols systematic studies of critical iPSC differentiation 
parameters are not available. 
 
The factors that influences iPSC differentiation success and yield are not well understood. In 
one of the largest studies to date, (Koyanagi-Aoi et al., 2013) performed neural differentiation 
from 10 human embryonic stem cell lines (ESCs) and 40 human iPSC lines. They observed that 
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7/40 iPSC lines showed aberrant gene expression profiles that correlated with defects in neural 
differentiation. A smaller study looking at five human ESC lines and 12 iPSC lines observed that 
iPSCs showed higher variability in their potency to differentiate into neurons compared to ESCs, 
but was unable uncover a specific cause (Hu et al., 2010). A study of 28 iPSC lines found that 
variations in hepatic differentiation could largely be attributed to differences between donors 
(Kajiwara et al., 2012) and other work has found that the method used to form embryoid bodies 
can have a large effect on differentiation propensity (Paull et al., 2015). Finally, a study in 
mouse iPSCs showed that the cell type of origin might influence differentiation propensity in 
early passage iPSCs, but these effects disappeared after 10-16 passages (Polo et al., 2010). 
Thus, there are many factors influencing differentiation success and their relative importance is 
likely to vary between protocols.  
 
Additionally, when we differentiate iPSCs into a cell type of interest, we typically have a specific 
phenotype of interest, such as difference in gene expression level between two conditions, that 
we want to measure. Ideal experimental design should control for all other sources of variability 
in differentiation to maximise the chance of detecting the signal of interest. However, controlling 
all potential sources of variability is often impractical or even unfeasible. Hence, there is great 
interest in knowing which sources of variability have a strong effect on the phenotype (and 
should be controlled for) and which are so weak that they can be ignored. Variance component 
analysis is an effective approach to understand the relative contribution of both technical and 
biological factors on a phenotype of interest such as gene expression levels (’t Hoen et al., 
2013; Rouhani et al., 2014). For example, two recent studies have used this approach to 
highlight the importance of genetic differences between donors as a major factor underlying 
gene expression variation in human iPSCs (Kilpinen et al., 2016; Rouhani et al., 2014). 
 
We performed 138 macrophage differentiation attempts from 123 IPSC lines selected randomly 
from the HipSci project (Kilpinen et al., 2016), making it one of the largest directed differentiation 
study from human iPSCs. However, some of the differentiated lines did not produce enough 
macrophages to perform all of the experimental assays or the cells were not pure enough to be 
used in stimulation experiments. In total, we sequenced the RNA from 84 of these lines in four 
experimental conditions. We focussed on three questions: (i) how reliable and reproducible was 
the macrophage differentiation protocol (ii) which sources of variation had a strong effect on 
macrophage gene expression levels (iii) because flow cytometry is often used as a quality 
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control step in cellular differentiation assays, what factors are responsible for variability in the 
expression of cell surface markers in iPSC-derived macrophages. 
 
We were able to successfully differentiate macrophages from 101/123 iPSC cell lines, with an 
overall success rate of 82%. Combining gene expression data with extensive sample metadata, 
we were able to estimate the relative proportion of gene expression variance explained by 
different experimental factors. Our results highlight the importance of maintaining high purity 
and constant cell density of the differentiated cells. We also showed that using live bacteria can 
lead to larger stimulation-specific batch effects than using well-defined molecular stimuli such as 
IFNɣ. Finally, we have shown that expression of CD14 and CD16 cell surface markers can be 
highly variable between genetically distinct cell lines and in the case of CD14, most of this 
variation can be attributed to a genetic variant upstream of the CD14 gene. This highlights the 
importance of accounting for genetic differences when comparing primary and iPSC-derived 
cells from different individuals. 
3.2 Methods 
3.2.1 Cell culture and reagents 
Donors and cell lines 
Human induced pluripotent stem cells (iPSCs) from 123 healthy donors (72 females and 51 
males) were obtained from the HipSci project (Kilpinen et al., 2016). Of these lines, 57 were 
initially grown in feeder-dependent medium and 66 were grown in feeder-free E8 medium.  
Feeder-free iPSC culture 
Feeder-free iPSCs were grown on tissue culture treated plates coated with vitronectin (VTN-N) 
(Gibco, cat. no. A14700) in Essential 8 (E8) medium (Gibco). The cells were dissociated from 
the plates using Gentle Cell Dissociation Buffer (Stemcell Technologies, cat. no. 07174) and 
passaged every 3-5 days. Prior to macrophage differentiation, the feeder-free iPSCs were first 
transferred to feeder-dependent media and propagated for at least two passages. This step was 
necessary because multiple attempts to differentiate macrophage directly from feeder-free 
iPSCs with our protocol failed. 
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Feeder-dependent iPSC culture   
Feeder-dependent iPSCs were grown on irradiated CF-1 mouse embryonic fibroblast (MEF) 
feeder cells (AMS Biotechnology) in Advanced DMEM-F12 (Gibco) supplemented with 20% 
KnockOut Serum Replacement (KSR) (Gibco), 2mM L-glutamine (Sigma), 50 IU/ml penicillin 
(Sigma), 50 IU/ml Streptomycin (Sigma) and 50µM β-Mercaptoethanol (Sigma M6250). The 
media was supplemented with 4 ng/ml recombinant human fibroblast growth factor (rhFGF) 
basic (R&D, 233-FB-025) to maintain pluripotency and was changed daily. MEFs were seeded 
on 0.1% gelatine-coated tissue-culture treated plates (Corning 6-well or 10 cm plates) 24 hours 
prior to passaging iPSCs at a cell density of 2 million cells per 6-well or 10-cm plate in 
Advanced DMEM-F12 supplemented with 10% FBS (Labtech), 2mM L-glutamine (Sigma), 
50IU/ml Penicillin & 50IU/ml Streptomycin (Sigma). Prior to passaging or embryoid body 
formation, iPSCs were dissociated from the plates using 1:1 mixture of collagenase (1 mg/ml) 
and dispase (1 mg/ml) (both Gibco). 
Macrophage differentiation 
iPSCs were differentiated into macrophages using a previously published protocol (van 
Wilgenburg et al., 2013) involving 3 stages: i) embryoid body (EB) formation, ii) generation of 
monocyte-like myeloid progenitors from the EBs and iii) terminal differentiation of the 
progenitors into macrophages. For EB formation, iPSC colonies were treated with 1:1 mixture of 
collagenase (1 mg/ml) and dispase (1 mg/ml) and intact colonies were transferred to low-
adherence plates (Sterilin). The colonies were cultured in feeder-dependent iPSC medium 
without rhFGF for 3 days. On day 3, the EBs were harvested and transferred to gelatinised 
tissue-culture treated 10 cm plates in serum-free haematopoietic medium (Lonza X-VIVO 15), 
supplemented with 2 mM L-glutamine (Sigma), 50 IU/ml penicillin, 50 IU/ml streptomycin 
(Sigma), 50 µM β-Mercaptoethanol (Sigma M6250), 50 ng/ml macrophage colony stimulating 
factor (M-CSF) (R&D) and 25 ng/ml interleukin-3 (IL-3) (R&D). EBs were maintained in these 
plates with media changes every 3-5 days for 4-6 weeks until the progenitor cells appeared in 
the supernatant. Progenitor cells were harvested from the supernatant, filtered through a 40µm 
cell strainer (BD 352340), centrifuged at 1200 rpm for 5 minutes, counted, and plated in RPMI 
1640 (Gibco) supplemented with 10% FBS (Labtech), 2mM L-glutamine (Sigma) and 100 ng/ml 
hM-CSF (R&D) at a cell density of 150,000 cells per 6-well plate or 1,000,000 cells per 10 cm 
plate and differentiated for another 7 days. 
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3.2.2 Macrophage stimulation assays 
After harvesting, macrophage progenitors were seeded on 6-well plates at 150,000 cells/well. 
Two wells were used per condition to ensure sufficient amount of RNA. On day 6 of 
macrophage differentiation, medium was changed for all wells with half of the wells receiving 
macrophage differentiation media (with M-CSF) and half of the cells receiving macrophage 
differentiation media supplemented with 20 ng/ml IFNɣ (R&D) and M-CSF. After 18 hours, cells 
from two wells of the naive and IFNɣ conditions were harvested for RNA extraction. The 
remaining two wells from each condition were additionally infected with Salmonella 
Typhimurium SL1344 (hereafter ‘SL1344’) for 5 hours. For RNA extraction, cells were washed 
once with PBS and lysed in 300 μl of RLT buffer (Qiagen) per one well of a 6-well plate. Lysates 
from two wells were immediately pooled and stored at -80°C. RNA was extracted using RNA 
Mini Kit (Qiagen) following manufacturer’s instructions and eluted in 35 µl nuclease-free water. 
RNA concentration was measured using NanoDrop and RNA integrity was measured on Agilent 
2100 Bioanalyzer using RNA 6000 Nano total RNA kit. 
 
Two days before infection, Salmonella Typhimurium SL1344 culture was inoculated in 10 ml low 
salt LB broth and incubated overnight in a shaking incubator (200 rpm) at 37°C. Next morning, 
the culture was diluted 1:100 into 10 ml of fresh LB broth and incubated again in a shaking 
incubator. In the afternoon the culture was diluted once more 1:100 into 45 ml of LB broth and 
kept overnight in a static incubator. In the morning before infection, the culture was centrifuged 
at 4000 rpm for 10 minutes, washed once with 4°C PBS and re-suspended in 30 ml of PBS. 
Subsequently, optical density at 600 nm was measured and Salmonella was diluted in 
macrophage differentiation media (without M-CSF) at multiplicity of infection (MOI) 10 assuming 
300,000 cells per well. To infect the cells, old media was removed and replaced with 1 ml of 
media containing Salmonella for 45 minutes. Subsequently, the cells were washed twice with 
PBS and replaced in fresh medium with 50 ng/ml gentamicin (Sigma) to kill extracellular 
bacteria. After 45 minutes, the medium was changed once again to fresh medium containing 10 
ng/ml gentamicin. 
3.2.3 RNA sequencing 
All of the RNA-seq libraries were constructed using poly-A selection. The first 120 RNA-seq 
libraries from 30 donors were constructed manually using the Illumina TruSeq stranded library 
preparation kit. The TruSeq libraries were quantified using Bioanalyzer and manually pooled for 
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sequencing. For the remaining 216 samples, we used an automated library construction 
protocol that was based on the KAPA stranded mRNA-seq kit. The KAPA libraries were 
quantified using Quant-iT plate reader and pooled automatically using the Beckman Coulter NX-
8. The first 16 samples were sequenced on Illumina HiSeq 2500 using V3 chemistry and 
multiplexed at 4 samples/lane. All of the other samples were sequenced on Illumina HiSeq 2000 
using V4 chemistry and multiplexed at 6 samples/lane.  
RNA-seq pre-processing and quality control 
I aligned RNA-seq data to the GRCh38 reference genome and Ensembl 79 transcript 
annotations using STAR v2.4.0j (Dobin et al., 2013). I then used VerifyBamID v1.1.2 (Jun et al., 
2012) to detect and correct any potential sample swaps and cross-contamination between 
donors. I did not detect any cross-contamination, but I did identify one sample swap between 
two donors. I used featureCounts v1.5.0 (Liao et al., 2014) to count the number of uniquely 
mapping fragments overlapping GENCODE (Harrow et al., 2012) basic annotation from 
Ensembl 79. I excluded short RNAs and pseudogenes from the analysis leaving 35,033 unique 
genes of which 19,796 were protein coding. I only used 15,797 genes with mean expression in 
at least one of the conditions greater than 0.5 transcripts per million (TPM) (Wagner et al., 2012) 
in all downstream analyses. I also quantile-normalised the data and corrected for sample-
specific GC content bias using the conditional quantile normalisation (cqn) (Hansen et al., 2012) 
R package as recommended previously (Ellis et al., 2013). To detect hidden confounders in 
gene expression, I applied PEER (Stegle et al., 2012) on each condition separately allowing for 
at most 10 hidden factors. I found that the first 3-5 factors explained the most variation in the 
data and the others remained close to zero. 
Variance component analysis 
I used a linear mixed model implemented in the lme4 (Bates et al., 2015) package to estimate 
the proportion of variance explained by various biological and technical factors in the expression 
levels of 15,797 genes across 336 samples. The 14 factors that I included in the model are 
listed below. Continuous variables were binned into a small number of categories as described. 
1. Salmonella - Salmonella infection status (yes or no) (binary) 
2. IFNɣ - IFNɣ stimulation status (yes or no) (binary) 
3. IFNɣ:Salmonella - interaction term between Salmonella and IFNɣ stimulations (binary) 
4. Line - the iPSC cell line from which the macrophages were derived. All lines used in the 
analysis were from 84 unique donors. This component should capture genetic 
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differences between donors, but can also capture line and differentiation specific effects. 
(84 categories) 
5. Cell density - I used mean RNA concentration across the four conditions as proxy of the 
total number of cells on a plate, because counting the cells prior to lysis and RNA 
extraction was not feasible. (categorical: 0-100 ng/ul, 100-200 ng/ul, 200-300 ng/ul, 300-
500 ng/ul) 
6. Library type - type of the RNA library construction method used (manual or automatic) 
(binary) 
7. Sex - sex of the donor (binary) 
8. Purity - purity of the differentiated macrophages as quantified by flow cytometry. This is 
a noisy measurement, because RNA-seq and flow cytometry were not performed from 
the same plate of cells and they were often performed on different days (up to 2 weeks 
apart) due to logistical reasons (categorical: 90-95%, 95-97.5%, 97.5-100%).  
9. Chemistry - chemistry of the Illumina RNA-seq protocol (V3 or V4). 
10. Stimulation date - date of the stimulation assays and cell lysis (categorical: 32 levels)  
11. Library pool - RNA-seq library construction batch (categorical: 10 levels) 
12. RNA extraction - RNA extraction batch (categorical: 31 levels) 
13. Differentiation duration - Number of days from the start of the differentiation until cell 
lysis (5 categories: 20-30 days, 31-40 days, 41-50 days, 51-60 days, 61+ days). 
14. Passage - passage of the IPSC line at the start of the differentiation (4 categories: 0-25, 
26-35, 36-45, 46-60)  
 
First, I analysed all 15,797 expressed genes from all of the 336 samples across the four 
conditions together using a single linear mixed model with all of the 14 factors included as 
random effects. The following model was fit to each gene independently, using lme4:  
 
expression ~ (1|Salmonella) + (1|IFNɣ) + (1|IFNɣ:Salmonella) + (1| Line) +  
(1| Cell_density) + (1| Library_type) + (1| Stimulation_date) +  
(1| Sex) + (1| Chemistry) + (1| Purity) + (1| Passage) +  
(1| Diff_duration) + (1| Library_pool) + (1| RNA_extraction) 
 
To better understand the relative contribution of weaker technical factors and how their effects 
might vary between conditions, I also performed variance component analysis in each condition 
separately by only including the ten technical factors in the model as random effects: 
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expression ~ (1| Cell_density) + (1| Library_type) + (1| Stimulation_date) +  
(1| Sex) + (1| Chemistry) + (1| Purity) + (1| Passage) +  
(1| Diff_duration) + (1| Library_pool) + (1| RNA_extraction) 
 
Next, I used the VarCorr function from the lme4 package to calculate the amount of variance 
attributed to each of the factors. I then estimated the proportion of variance explained by each 
factor by dividing the variance attributed to each factor by the total variance of the gene. As a 
result, for each factor I obtained a distribution of the proportion of variance explained estimates 
across 15,797 genes.  
3.2.4 Flow cytometry 
Measuring macrophage cell surface marker expression using flow cytometry 
We used flow cytometry to measure the cell surface expression of three canonical macrophage 
markers: CD14, CD16 (FCGR3A/FCGR3B) and CD206 (MRC1). Macrophages were cultured in 
10 cm tissue-culture treated plates and detached from the plates by incubation in 6 mg/ml 
lidocaine-PBS solution (Sigma L5647) for 30 minutes followed by gentle scraping. From each 
cell line we harvested between 300,000-500,000 cells. Detached cells were washed in media, 
centrifuged at 1200 rpm for 5 minutes and resuspended in flow cytometry buffer (2% BSA, 
0.001% EDTA in D-PBS) and split into two wells of a 96-well plate. Nonspecific antibody binding 
sites were blocked by incubating cells with Human TruStain FcX (Biolegend) for 45 minutes and 
washing with flow cytometry buffer. Half of the cells were stained for 1 hour with the PE-isotype 
control (BD 555749) antibody. The other half of the cells were co-stained for 1 hour with 
following three antibodies: CD14-Pacific Blue (BD 558121), CD16-PE (BD 555407), CD206-
APC (BD 550889). After staining, the cells were washed three times. Resuspended cells were 
filtered through cell strainer cap tubes (BD 352235) and measured on the BD LSRFortessa Cell 
Analyzer. 
Flow cytometry data analysis 
I used the flow cytometry data for two purposes: to estimate the proportion of cells expressing 
macrophage surface markers CD14, CD16 and CD206 and to quantify the relative intensity of 
these markers compared to unstained cells. I imported the raw FCS files into R using the 
OpenCyto (Finak et al., 2014) package. First, I logicle-transformed (Herzenberg et al., 2006) the 
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intensity values for all three channels in both stained and isotype control samples using the 
estimateLogicle function. I then performed two automated gating steps to exclude debris and 
identify the main cell population using the mindensity (max = 150,000) and flowCust (K=2, 
target=c(1e5,5e4), level=0.9) functions. For pure macrophage samples the distribution of 
intensity values for all three cell surface markers looked bimodal with stained and unstained 
cells in two separate peaks (Figure 3.1). Samples with moderate contamination had an 
additional low intensity peak both in stained and unstained cells (Figure 3.1) corresponding to 
the contaminating cells. Since all of the peaks were approximately normally distributed, I 
decided to model the data for each mark as a mixture of Gaussian distributions and used the 
mclust (Fraley and Raftery, 1999) R package to estimate the optimal number of components (2 
or 3) as well as the mean and standard deviation of each component. I used the Bayesian 
Information Criterion to choose between two or three components. I then compared the mean of 
the highest intensity peak (μstained) to the mean of the second highest intensity peak (μunstained) to 
estimate the relative fluorescent intensity of each cell surface marker (Figure 3.1). I also 
measured sample purity by estimating the proportion of cells whose intensity was greater than 
the threshold t = μstained - 3×σstained (Figure 3.1), where σstained is the standard deviation of the 
stained population. 
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Figure 3.1: Quantifying cell purity and relative fluorescent intensity of macrophage 
CD206, CD16 and CD14 markers from the flow cytometry data. The rows correspond to 
three different iPSC lines and the columns represent three macrophage markers. X-axis shows 
the logicle-transformed absolute intensity values from the flow cytometer and values on the y-
axis correspond the density of the cells with that intensity value. Red designates cells stained 
with antibodies against the three markers, blue indicates cells stained with isotype control 
(unstained). Marker relative fluorescent intensity is defined as the difference in mean intensity 
between the stained and unstained cell populations (middle panel). Purity is measure by 
estimating the proportion of stained cells (red) whose intensity is greater than the purity 
threshold (purple) t = μstained - 3×σstained. 
Variance component analysis and QTL mapping 
I used linear mixed model implemented in lme4 (Bates et al., 2015) package in R to 
characterise the observed variation in the relative fluorescent intensity measurements of the 
three macrophage markers. For each marker, I estimated the proportion of variance explained 
by differences between the iPSC lines (hereafter ‘line effect’) as well as the batch effect 
represented by the date when the cells were harvested, stained and measured on the flow 
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cytometer (‘date effect’). I used the following lme4 model specification: intensity ~ (1|date) 
+ (1|line).  
 
I used FastQTL (Ongen et al., 2016) to test for association between relative fluorescent intensity 
and common genetic variants (minor allele frequency > 0.05, IMP2 > 0.7) in the +/- 200kb 
region around the corresponding genes: CD14, FCGR3A and FCGR3B for CD16, and MRC1 for 
CD206. I used measurements from 95 unique lines (donors) for QTL mapping. If a particular line 
had multiple measurements, then I picked one randomly. After permutation testing (n=10,000), I 
identified significant cis QTLs for CD14 and CD16 markers. Subsequently, I redid the variance 
component analysis for each marker and included the lead QTL variants into the model: 
‘intensity ~ (1|date) + (1|line) + (1|rs2569177) + (1|rs4657019)’. 
3.3 Large-scale differentiation of macrophages for genomics 
assays 
We aimed to develop a robust and standardised differentiation pipeline that would allow us to 
produce at least 3 million macrophages from each donor for four different experimental assays: 
(1) Flow cytometry (this chapter), Salmonella RNA-seq (Chapter 4), Salmonella ATAC-seq 
(Chapter 5) and acLDL RNA-seq (not described here). We relied on a previously published 
macrophage differentiation protocol (van Wilgenburg et al., 2013) that I compared to monocyte-
derived macrophages in Chapter 2. The timeline of the differentiation protocol is illustrated in 
Figure 3.2 and the full details of the protocol are given in the Methods. Briefly, the main steps of 
the differentiation are (1) expansion of iPSCs in feeder-dependent medium (median 19 days), 
(2) embryoid body (EB) formation (3 days), (3) differentiating EBs into macrophage progenitors 
(median 27 days) and (4) harvesting and final differentiation of progenitors into macrophage (7 
days). One attractive feature of this system is that differentiated EBs can be kept in culture for 
prolonged period of time and progenitors can be harvested in every 4-5 days making it possible 
to perform additional assays on the cells without increasing the amount of tissue culture needed 
for the initial steps of the differentiation (van Wilgenburg et al., 2013).  
 
Although other protocols exist that can be used to differentiate macrophages in a shorter period 
of time (Zhang et al., 2015), a major advantage of our protocol is that the bulk of the 
differentiation and maintenance is performed in single medium containing only two cytokines 
(interleukin-3 (IL-3) and macrophage colony stimulating factor (M-CSF)) and the exact timing 
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between medium changes can be varied without significantly influencing differentiation success. 
This property made the protocol scalable to differentiating many iPSC lines in parallel without a 
large increase in complexity, because all of the dishes receive the same media and medium 
changes could be conveniently scheduled.   
 
 
Figure 3.2: Timeline of macrophage differentiation from iPSCs. The protocol starts with the 
expansion of IPSCs followed by embryoid body formation. The bulk of the differentiation is 
performed in X-VIVO 15 media supplemented with IL-3 and M-CSF cytokines. The 
differentiation takes usually 4-5 weeks (median 27 days) until macrophages progenitors appear. 
During this time the medium has to be changed in every 4-5 days. Once the macrophage 
progenitors appear, they are harvested at every medium change and differentiated in the 
presence of M-CSF for another 7 days until the cells are ready for experimental assays. 
 
We differentiated macrophages from batches of multiple iPSC lines in parallel. In addition to 
logistical convenience, this approach enabled us to estimate and control for batch-to-batch 
variation in gene expression and differentiation success measurements. 
3.3.1 Variability in success rate 
We performed 138 macrophage differentiation attempts from 123 different HipSci iPSC lines.  
We were able to successfully differentiate macrophages from 101/123 (82%) of the iPSC lines. 
Here successful differentiation is defined as obtaining at least some proportion of cells that 
exhibited characteristic spindle-like macrophage morphology. For 97/101 lines, we further 
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confirmed the expression of CD14, CD16 and CD206 macrophage cell surface markers with 
flow cytometry.  
 
To understand what was responsible for the failed differentiation, we tried to re-differentiate 8 
iPSC lines that had failed on the first attempt. Surprisingly, 7/8 failed also at the second attempt. 
This was over 6 times higher than the global 18% failure rate observed across all lines (Fisher’s 
exact test p = 0.002), suggesting that there might be a line specific bias against macrophage 
differentiation. However, six of these lines (all of which failed) were all re-differentiated in the 
same month (January 2015), meaning that this observation might have also arisen from a 
shared batch effect. We note though, that 3/4 lines cultured concurrently with the 6 failed lines 
differentiated successfully into macrophages. Hence, this suggests that there might be a line-
specific (or donor-specific) bias against macrophage differentiation but further experiments on 
more iPSC lines are needed to confirm this. 
3.3.2 Variability in the duration of the differentiation 
Throughout our experiments we observed considerable variation in the time from initial iPSC 
culture to the production of mature macrophages. This variation was influenced by a variety of 
experimental factors, most importantly whether the differentiation was started from live or frozen 
cells. Initially, we received live cells in feeder dependent media from Wellcome Trust Sanger 
Institute core facilities. These live cell cultures required only a single passage before EB 
formation could be initiated (Figure 3.3A). Subsequently, however, for operational reasons we 
switched to cryopreserved cells cultured either on feeder-dependent or feeder-free E8 medium. 
Since our attempts to differentiate macrophages directly from feeder-free iPSCs were not 
successful, we had to transfer feeder-free cells to feeder-dependent medium for at least two 
passages. This added approximately 7-10 days to the time required for initial iPSC culture and 
expansion. However, the total time needed for iPSC expansion was comparable for feeder-free 
and feeder-dependent cryopreserved cells, because thawing feeder-dependent iPSCs generally 
took much longer than thawing feeder-free iPSCs (Figure 3.3A). We did not observe any 
discrepancy in the differentiation success rate between IPSCs initially grown either on feeder-
dependent or feeder-free media. 
 
The median time from the start of the differentiation (3 days after EB formation) until the 
appearance of first macrophage progenitors was 27 days (Figure 3.3B), and 96% of the lines 
that successfully differentiated into macrophages did so within 40 days. Thus, for this protocol, a 
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40-day threshold provided a useful guideline for deciding when a differentiation attempt had 
failed and should be aborted. Final macrophage differentiation added another 7 days to the 
protocol and for logistical reasons we were not always able to perform the stimulation assays on 
the first batch of cells that we harvested. This increased the median time from differentiation 
start to cell lysis to 38 days (Figure 3.3C). We recorded this information for each cell line to 
assess retrospectively if the time spent in culture had an effect on the macrophage 
transcriptome. 
 
 
Figure 3.3: Variation in the duration of macrophage differentiation. (A) Duration of iPSC 
culture prior to the start of the differentiation. The two panels correspond to iPSC lines that were 
initially either on feeder-dependent medium or feeder-free medium. The colour represents 
whether the cell lines were received as live culture or cryopreserved stock. (B) Number of days 
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from the start of the differentiation until the harvest of first macrophages. Red line corresponds 
to the median of the distribution (27 days). (C) Histogram of the number of days from the start of 
the differentiation until the Salmonella infection experiment and cell lysis (median 38 days). (D) 
Histogram of the number of passages iPSCs had been propagated prior to the start of the 
differentiation. 
3.3.3 Variability in cell numbers 
Although we differentiated all lines in the same number of tissue culture plates, we observed an 
order of magnitude variation between lines in the mean number of macrophage progenitors 
produced per harvest (min 3×105, median 3×106, max 15×106) (Figure 3.4A). Most of the 
variation was likely caused by differences in the size and number of EBs per line, which was 
challenging to control during differentiations. Our approach to deal with this variation was to use 
more than minimally required cells for EB formation, thus ensuring that even differentiation with 
lower yield would produce enough cells for all of the planned experimental assays.  
 
For the final macrophage differentiation, we always seeded 150,000 progenitors into a single 
well of a 6-well plate. However, due to variation in the fraction of adherent cells and their 
proliferation rate between iPSC lines, we observed substantial variation in the numbers of cells 
on the plate at the time of the stimulation assays. Since this variation was hard to control for 
experimentally (macrophages are strongly adherent cell type making them difficult to replate), 
we decided to measure the mean RNA concentration for each line as a proxy of the cell count 
(Figure 3.4B). 
3.3.4 Variability in macrophage purity 
Finally, we examined the purity of the differentiated macrophages. Despite not using cell sorting 
or other methods to experimentally enrich for macrophages, we found that 88% of the 
differentiations produced macrophages that were >90% pure based on the cell surface 
expression of CD14, CD16 and CD206 markers (Figure 3.4C). Although we did not use flow 
cytometry to directly select samples for RNA sequencing (flow cytometry was often performed 
after RNA had been collected), we found that only 4/84 of the selected samples had purity 
below 90% (Figure 3.4C).  
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Figure 3.4: Distributions of some the key experimental variables the could influence the 
transcriptomes of differentiated macrophages. (A) Histogram of the mean number of cells 
obtained per harvest for all of the iPSC lines that successfully differentiated into macrophages. 
Red line corresponds to the median (3.16 million). (B) Histogram of the mean RNA 
concentration values for all of the cell lines across four experimental conditions. (C) 
Differentiated cells were stained with antibodies for CD14, CD16 and CD206 and the proportion 
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of cells staining positive for each of the three marks was estimated. The mean of the three 
marks was used as the purity score for each cell line. The figure shows the histogram of the 
purity scores across iPSC lines. Samples represented in green were used for RNA-seq 
experiments. 
3.4 Variability in gene expression data 
While many aspects of the differentiation might be variable between iPSCs lines, not all of them 
will have a significant effect on downstream macrophage gene expression levels. Thus, I 
decided to use variance component analysis to estimate the relative contribution of various 
biological and technical factors on macrophage gene expression levels.  
3.4.1 Technical variability between RNA-seq samples 
In addition to biological variability in the differentiation protocol described above, macrophage 
gene expression levels could also be influenced by technical variability in the way RNA samples 
were processed. The potential sources of variability that we identified were RNA extraction 
batch, RNA integrity, library construction batch, method of library construction used (manual or 
automatic) and sequencing chemistry used.  
 
 
Figure 3.5: Distribution of RNA integrity (RIN) values for a subset of the RNA-seq 
samples.  
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Fortunately, I observed very little variation in RNA integrity between samples and for the vast 
majority of the samples the RNA integrity number (RIN) was greater than 9 out of 10 (Figure 
3.5). However, I did observe some differences between automatic and manual library 
construction methods. First, the variability in total read coverage between samples was greatly 
reduced when the automatic protocol was used (Figure 3.6A). I also found that the automated 
protocol had lower GC content bias than the manual protocol which showed slight preference 
for low GC content fragments over high GC content fragments (Figure 3.6B).  
 
Figure 3.6: Comparison of manual and automated RNA-seq library construction 
protocols. (A) Histogram of total library size distribution for samples prepared either with 
manual or automatic protocol. (B) Mean GC content bias for the two library construction 
protocols. GC content bias was estimated from the raw read counts using the cqn (Hansen et 
al., 2012) package in R. 
3.4.2 Variance component analysis of the RNA-seq data 
Variance component analysis is a powerful approach to estimate the relative importance of 
various known experimental factors in an unbalanced experimental design (Rouhani et al. 2014; 
Kilpinen et al. 2016). When applied to our dataset, variance component analysis revealed that 
most of the variance in gene expression was explained by the three experimental stimuli: 
Salmonella infection (32.9%), IFNɣ stimulation (15.5%) and interaction between the two (11.4%) 
(Figure 3.7), highlighting the plasticity of the macrophage transcriptome in response to strong 
immunological stimuli. The second largest amount of variance explained (7.7%) was attributed 
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to differences between cell lines (hereafter ‘line effect’) while all of technical factors explained 
significantly less variance  
 
 
Figure 3.7: Variance component analysis of all four conditions in a joint model. We used a 
linear mixed model to estimate the proportion of variance explained by 14 different factors in the 
expression levels of 15,797 expressed genes (see Methods). For each factor on the x-axis, the 
violin plot shows the distribution of variance explained by that factor across all expressed genes. 
Factors are ordered by the mean variance explained across all genes. 
 
To see how the relative contribution of the weaker technical factors varied between conditions, I 
performed variance component analysis in each of the four conditions separately. Now that the 
differences between stimulations were controlled for, most of variance was explained by RNA-
seq library type (automatic vs manual), cell density, sex and purity of the macrophage 
population (Figure 3.8A) and the estimates for most of the factors were similar in all four 
conditions. The large contribution of library type is likely to be at least partially explained by 
differences between GC bias reported above (Figure 3.6B). The date when macrophages were 
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stimulated with IFNɣ and infected with Salmonella (‘stimulation date’) explained almost double 
the variance in Salmonella and IFNɣ + Salmonella conditions than in naive and IFNɣ conditions 
(Figure 3.8B). This is probably because live Salmonella culture was prepared fresh for each day 
of infections whereas IFNɣ originated from single-use frozen aliquots. Indeed, both of the 
Salmonella conditions had an excess of highly variable genes compared to naive and IFNɣ 
conditions (Figure 3.8C), indicating that Salmonella batch introduced additional variability into 
the data. Finally, the passage number of the iPSCs prior to differentiation (Figure 3.3D) and the 
total duration of the differentiation (Figure 3.3C) (after accounting for differences in purity) 
explained less than 3% of the variance, suggesting that controlling for these factors during 
differentiation is less important. 
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Figure 3.8: Variance component analysis of each of the four conditions separately. (A) 
Variance explained by ten technical factors in each of the four conditions. Points correspond to 
mean across all genes and horizontal lines represent standard deviation. Note that the lines are 
not true confidence intervals, because variance explained cannot be negative. (B) Proportion of 
variance explained by the date when the macrophages were stimulated with IFNɣ and infected 
with Salmonella (‘stimulation date’ effect). The violin plots show the distributions of the variance 
explained estimates across all genes in four experimental conditions. (C) Distribution of 
coefficient of variation (standard deviation / mean) for 10,000 most highly expressed genes in 
each condition.  
3.4.3 Detecting hidden sources of variation 
A complementary approach to dissect sources of variability in a large gene expression dataset 
are latent variable models (Leek and Storey, 2007; Stegle et al., 2010). Latent variable models 
are especially useful when the relevant covariates are not known beforehand or when they have 
not been measured accurately (Parts et al., 2011; Stegle et al., 2010). I applied PEER (Stegle et 
al., 2010) to the RNA-seq data from each condition to detect hidden sources of variation that 
affect many genes at the same time. I then calculated the proportion of variance explained by 
each hidden factor in each of the four experimental conditions (Figure 3.9). Note that PEER 
does not report residual variance and as a result these estimates are not directly comparable to 
the estimates from variance component analysis above. I found that in the naive cells 90% of 
the variance captured by PEER was explained by the first factor. Although macrophage purity 
and cell density (mean RNA concentration) were both correlated with the first factor (Figure 
3.10A-B), in a joint linear model these two known covariates could explain only 42% of the 
variance captured by the first factor. This illustrates that PEER is able to capture additional 
variability beyond what can be explained by known covariates.  
 
The second PEER factor explained an additional 3.1% of the variance and was correlated with 
the RNA-seq library type (Figure 3.10C) (r = 0.79, p < 2.2×10-16). However, as shown on Figure 
3.6B, one of the differences between automatic and manual RNA-seq protocol was difference in 
GC bias. The quantile normalised gene expression values that we used as input to PEER were 
already corrected for sample-specific differences in GC bias. Therefore, the amount of variance 
explained by the second PEER factor might be higher in uncorrected samples.  
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I noticed that in stimulated conditions factors 2-5 explained much more variance than they did in 
the naive condition (Figure 3.9). This was especially prominent after Salmonella infection where 
~40% of variance was explained by factors 2-5 (7.5% in naive). One possible interpretation is 
that stimulating cells introduces additional independent sources of variability (‘batch effects’) 
that are then captured by PEER as additional factors. This is consistent with the excess of 
highly variable genes observed after Salmonella infection (Figure 3.8C) and more variance 
explained by stimulation date (Figure 3.8B) reported above.  
 
 
Figure 3.9: Proportion of variance explained by the first 10 PEER factors in each 
experimental condition. PEER was run on each condition separately, which mean that the 
factor names do not necessarily correspond to the same sources of variation in each condition.  
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Figure 3.10: Correlation between first two PEER factors and experimental variables. (A) 
Correlation between mean purity and PEER factor 1 (B) Correlation between RNA 
concentration and PEER factor 1 (C) Correlation between RNA-seq library construction protocol 
(automatic vs manual) and PEER factor 2. 
 
3.4.4 Reproducibility of differentiation 
To assess how reproducible gene expression profiles were between differentiations, I analysed 
RNA-seq data from multiple independent differentiations from three different donors (three 
differentiations from donor ffdj and two from donors fpdl and ougl). We performed the same 
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stimulation experiments and RNA-seq on all of the samples. Although the differentiations were 
performed over the course of 10 months, I found that in the naive condition the samples clearly 
clustered together by donor (Figure 3.11), indicating that donor specific effects on gene 
expression are reproducible between differentiations. The clustering was not as clear in the 
stimulated conditions, possibly because of stronger batch effects induced by stimulation. For the 
ffdj donor we know that two of the differentiations were from the same iPSC line (samples 
fpdj_A and fpdj_A_2) whereas the third (nibo_A) was from a different line. For ougl and fpdl 
donors we unfortunately do not know if the two differentiations were from the same line or 
different lines, because we received these lines twice due to accidental sample swaps upstream 
and we only discovered the duplicate samples after matching genotypes in the RNA-seq data to 
the VCF file. 
 
 
Figure 3.11: Gene expression reproducibility between independent differentiations. The 
heat map shows the Spearman correlation of gene expression profiles from 7 independent 
differentiations from 3 different donors. 
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3.5 Variability in cell surface marker expression 
In addition to gene expression data, we also wanted to understand what is responsible for the 
variance in the cell surface expression of macrophage markers. Specifically, we wanted to know 
if, on average, the fluorescent intensity measurements of the same line on different days were 
more similar to each other than the measurements of different lines on the same day.  
 
We measured cell surface expression of CD14, CD16 and CD206 macrophage markers in 97 
different cell lines. This included 19 cell lines where duplicate measurements were obtained on 
different days. We processed and measured a median of four cell lines in a single batch on the 
same day. This allowed me to use a linear mixed model to estimate the relative proportion of 
variance explained by cell line and date of the assay (batch) for each of the three markers. I 
found that 62% of the variance in CD14 surface expression and 52% of the variance in CD16 
surface expression was explained by the line effect and almost no variance was attributed to the 
date of the assay (Figure 3.12A). On the other hand, 64% of the variation in CD206 
measurement was explained by the date of the assay and there was almost no line effect, 
suggesting that this antibody might have been more susceptible to technical variation. Between 
25-50% of the variance remained unexplained for all three marks. 
 
Next, I tested whether there was a genetic basis for the observed variation in the surface 
expression of CD14, CD16 and CD206 by performing QTL mapping for each of the three 
markers in +/- 200kb cis window around the corresponding genes (CD14, FCGR3A and 
FCGR3B for CD16, and MRC1 for CD206). I detected a very strong association between CD14 
surface expression and rs2569177 variant (MAF = 0.24) located 19 kb upstream of the CD14 
gene (permutation FDR = 2.7×10-11) (Figure 3.12B). I also detected a weak association between 
CD16 expression and rs4657019 variant (MAF = 0.28) located 120 kb upstream of the FCGR3A 
gene (permutation FDR = 0.047) (Figure 3.12C). There was no significant QTL for CD206 
consistent with only a small fraction of the variance being attributed to differences between 
lines. I redid the variance component analysis with the two CD14 and CD16 QTL SNPs included 
in the model. I found that the CD14 QTL explained most of the variation in CD14 intensity that 
was previously attributed to line effect (3.12D). On the other hand, the CD16 QTL explained 
only ~⅓ of the CD16 line effect, suggesting that there might be additional cis or trans QTLs for 
this protein that we were unable to detect because of our small sample size (Figure 3.12D).  
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Figure 3.12: Variance of macrophage cell surface marker expression. (A) Variance of cell 
surface expression of CD14, CD16 and CD206 partitioned into three components: (1) iPSC line 
from which the macrophages were differentiated; (2) date of the flow cytometry assay; (3) 
residual variation. (B) Fluorescent intensity of CD14 cell surface expression stratified by the 
genotype of the lead QTL variant (FDR < 2.7×10-11). (C) Fluorescent intensity of CD16 cell 
surface expression stratified by the genotype of the lead QTL variant (FDR < 0.048). (D) 
Variance partitioning after including CD14 and CD16 lead QTL variants into the model. 
3.6 Discussion 
In this chapter, we performed 138 macrophages differentiation attempts from 123 unique iPSC 
lines and we were able to successfully differentiate 101 (82%) of them. This makes our study 
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one of the largest long term directed differentiations of human iPSCs into another cell type. 
Extensive documentation of the differentiation attempts allowed us to characterise the extent of 
normal variation in multiple aspects of the differentiation protocol such as success rate, 
duration, yield and purity of the resulting macrophage population. We have shown that this 
differentiation protocol is highly reproducible at the level of gene expression, works on most 
iPSC lines and can be scaled to differentiate large numbers of cells in parallel. 
 
An important open question is what underlies variability in iPSCs differentiation potential; are 
these genetic differences between donors, differences between clonal iPSC lines from the same 
donor or technical batch effects between independent differentiation attempts. Our experimental 
design of differentiating only one line per donor was optimised for detecting the maximal number 
of gene expression QTLs. As a result, we were not able to distinguish between donor and line 
effects. However, our observation that repeated differentiations are much more likely to fail for 
lines that failed the first differentiation than for lines that succeeded the first differentiation does 
suggest that there are some differences between iPSC lines (either genetic or epigenetic) that 
influence differentiation success.   
 
We also collected RNA-seq data from most of the differentiated lines in four experimental 
conditions. Combining gene expression data with extensive metadata from the differentiations in 
a linear mixed model allowed us to identify important factors contributing to gene expression 
variation in iPSC-derived macrophages. In particular, we highlighted the importance of 
controlling for cell density and cell purity when performing genomics assays on iPSC-derived 
cells. The large effect of macrophage purity was unexpected, because the majority of the 
samples were already over 95% pure and we had discarded all samples that were less than 
90% pure prior to RNA sequencing. On visual inspection the contaminating cells seemed larger 
than macrophages, and thus could have contributed relatively more RNA to the pool. We also 
observed that the date of stimulation explained double the variance in conditions where live 
Salmonella was used to infect cells compared to naive and IFNɣ conditions, highlighting an 
important trade-off between physiologically more accurate live infections and inherently less 
variable stimulations with well-defined molecular signals (such as IFNɣ and LPS). 
 
Finally, we showed that variation in the intensity of expression of commonly used macrophage 
markers CD14 and CD16 on the cell surface is driven by common genetic variants. This was 
especially pronounced for CD14, where we identified a common genetic variant 19 kb upstream 
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of the gene that could explain almost all of the line-to-line variation in CD14 expression. Thus, it 
is important to take into account natural genetic variation when comparing the expression of cell 
type specific markers between primary cells, iPSC-derived cells and embryonic stem cell-
derived cells. This is especially important because these different cell types can rarely be 
obtained from genetically matched donors. For example, CD14 has previously been highlighted 
as variably methylated gene in human ESCs and variably expressed in differentiated 
macrophages (Bock et al., 2011). The authors attributed this variability to defective methylation 
in some ESCs that interfered with macrophage differentiation. However, our results suggest that 
much of this variability is caused by segregation of a common genetic polymorphism. Flow 
cytometry on cell surface markers is also commonly used to quantify the relative abundance of 
different cell types in a tissue (such as blood). It is therefore important to take the natural 
variation in the expression of these markers into account when designing the experiments and 
setting threshold values so as not to mistake differences in cell surface expression of marker 
gene as differences of cell type proportion. 
 
An important area for future work will be to optimise the differentiation protocol to work directly 
on feeder-free iPSCs without transferring them to feeder cells. This has the potential to greatly 
reduce the time and work needed for iPSC expansion prior to differentiation which currently 
takes ~20 days. With newer RNA-seq and chromatin assay requiring fewer cells, there is also 
potential to miniaturise the differentiation protocol making it feasible to differentiate hundreds of 
IPSCs in parallel. Here, alternative embryoid body formation protocols can be trialled (e.g. 
AggreWell plates (van Wilgenburg et al., 2013)) that have the potential to reduce variability in 
macrophage yield between differentiations. 
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4 Genetics of gene expression in 
macrophage immune response 
 
Collaboration note 
The macrophage differentiation work in this chapter was performed in collaboration with Julia 
Rodrigues who was a research assistant in Daniel Gaffney’s lab at the time. I designed the 
experiments, performed Salmonella infection and IFNɣ stimulation assays, took care of sample 
logistics and performed all of the data analysis. Julia was mainly responsible for tissue culture 
required for macrophage differentiation and preparing cells for stimulation experiments. 
Subhankar Mukhopadhyay and Gordon Dougan provided valuable feedback in designing and 
optimising Salmonella infection and IFNɣ stimulation conditions. 
4.1 Introduction 
Genetic differences between individuals can have a major impact on how immune cells respond 
to environmental stimuli, such as the amount of cytokines they produce after infection (Li et al., 
2016a). A number of studies have looked at the impact of genetic variation on cellular 
responses to different (immunological) environmental stimuli via the regulation of gene 
expression. Most studies have used either primary monocytes purified from peripheral blood 
(Fairfax et al., 2014; Kim et al., 2014) or monocyte-derived dendritic cells (Barreiro et al., 2012; 
Lee et al., 2014). While powerful, one limitation of primary cells is that the amount of material 
that can be obtained from a single individual is limited. This in turn limits both the number of 
assays that can be performed on cells from a single individual as well as the number of stimuli 
that can be studied. This is especially important because for any given cell type there can be 
tens of different relevant stimuli or combinations of stimuli, each one potentially revealing a 
different set regulatory variants that are otherwise hidden in the unstimulated state.  
 
A major advantage of cell lines is that the number of cells is essentially unlimited meaning 
different phenotypes can be collected from the same set of individuals over time. In this respect, 
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human lymphoblastoid cell lines (LCLs) have been very powerful. For example, over the years 
LCLs from the Yoruban population have been profiled on many different levels including RNA 
sequencing (Pickrell et al., 2010), ribosome profiling (Battle et al., 2015), proteomics (Battle et 
al., 2015), DNase-seq (Degner et al., 2012) and ChIP-seq (Grubert et al., 2015; McVicker et al., 
2013) and in multiple cases integrating old data sets with new ones has provided new biological 
insight (Li et al., 2016c). However, since LCLs are immortalised by infection with Epstein-Barr 
virus they are not a suitable model to study the response to different immunological stimuli.  
 
A promising approach to overcome the limitations of LCLs are human induced pluripotent stem 
cells (iPSC) that have recently been derived from large collection of unrelated individuals 
(Kilpinen et al., 2016). In Chapter 3, we showed that iPSCs can be reliably differentiated into 
macrophages on a scale necessary for QTL mapping studies. The aim of this chapter is to first 
characterise how well iPSC-derived macrophage are able to recapitulate known aspects of 
macrophage response to Salmonella infection and IFNɣ stimulation. Subsequently, I want to 
identify common genetic variant that influence gene expression and mRNA processing 
(promoters, splicing, poly-adenylation) in each of the four conditions and assess how condition 
specific they are. 
 
We obtained RNA-seq data from 84 iPSC-derived macrophage lines in four immunological 
conditions: (1) naive, (2) 18-hour IFNɣ stimulation, (3) 5-hour Salmonella infection (4) 18-hour 
IFNɣ stimulation followed by 5-hour Salmonella infection. We chose these stimuli, because they 
are known to activate distinct downstream signalling pathways. Lipopolysaccharide (LPS) and 
other components on the surface of Salmonella cell wall are recognised by macrophage Toll-like 
receptors (TLRs) that lead to activation of NF-kB and AP-1 signalling pathways (Takeuchi and 
Akira, 2010). TLR4 activation by LPS also leads to specific activation of the interferon response 
factor 3 (IRF) transcription factor and downstream antiviral response genes (Doyle et al., 2002). 
IFNɣ, on the other hand, is specifically recognised by the IFNɣ receptor that leads to 
phosphorylation and activation of the STAT1 transcription factor (Platanias, 2005). Moreover, 
pre-stimulating macrophages with IFNɣ prior to bacterial infection leads to enhanced microbial 
killing and stronger activation of inflammatory response by Toll-like receptors (TLRs) (Hu and 
Ivashkiv, 2009; Qiao et al., 2013; Su et al., 2015). There are at least two potential mechanisms 
that could be responsible for the enhanced response: (1) IFNɣ pre-stimulation can prime certain 
enhancers so that they can now be bound by Salmonella-activated TFs (Qiao et al., 2013), (2) 
IFNɣ priming can change the pool of active TFs available in the cell, this can facilitate new types 
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of collaborative binding between Salmonella-activated TFs and IFNɣ-activated TFs similarly to 
PU.1 binding to latent enhancers in mouse macrophages activated by IFNɣ stimulation (Ostuni 
et al., 2013).  
 
With 84 samples, we were also highly powered to detect differential expression between the 
four conditions. By comparing the differentially expressed genes to the literature, I was able to 
show that iPSC-derived macrophages predominantly activated expected genes and pathways in 
response to the three stimuli, indicating that they are a suitable model to study human 
macrophage immune response. The main aim of the chapter was to uncover genetic variants 
that regulate gene expression on gene and transcript level. I used two complementary models 
to identify gene expression quantitative trait loci (eQTLs) and assess their condition specificity. I 
also developed a novel approach to pre-process transcript annotations prior to transcript ratio 
QTL (trQTL) mapping that increased interpretability of trQTLs and allowed me to detect more 
independent trQTLs per gene than established methods. I identified thousands of eQTLs and 
trQTLs across conditions and estimated that ~25% of them were condition specific. 
Consequently, a large proportion of the condition-specific QTLs were ‘hidden’ in the naive state, 
highlighting the importance of studying many different stimuli to uncover potential QTLs 
underlying disease associations. Although I was able to detect similar numbers of eQTLs and 
trQTLs across conditions, I found that eQTLs and trQTLs for the same genes were largely 
independent from each other, indicating that ignoring transcript-level variation can miss many 
genetic effects. Finally, I uncovered considerable heterogeneity in the QTLs discovered by 
different computational approaches. This was especially true for trQTLs because alternative 
transcripts are still poorly annotated. I was able to show that both macrophage eQTLs and 
trQTLs were enriched for GWAS hits for Alzheimer’s disease, lipid traits and multiple 
autoimmune disorders. Together, these results highlight that iPSC-derived macrophages are a 
promising cell culture-based system to study condition-specific regulatory variation. 
4.2 Methods 
4.2.1 Gene expression analysis 
Full details of the macrophage differentiation protocol, stimulation assays, RNA-seq 
experimental procedures, read alignment and gene expression quantification are presented in 
Chapter 3. I used the quantile normalised gene expression values from the cqn (Hansen et al., 
 96 
2012) package for clustering, eQTL mapping with linear models as well as for visualisation. For 
count-based methods such as DESeq2 (Love et al., 2014) and RASQUAL (Kumasaka et al., 
2016) I used the raw read count data directly.  
Differential expression analysis 
I included 15,797 genes whose mean expression in at least one of the conditions was greater 
than 0.5 transcripts per million (TPM) into our differential expression analysis. For each gene, I 
used likelihood ratio test (test = “LRT”) implemented in DESeq2 (Love et al., 2014) v1.10.0 to 
test if a model that allowed different mean expression in each condition was a better fit to the 
data than a null model assuming the same mean expression across conditions. I used 1% 
Benjamini-Hochberg FDR threshold to identify differentially expressed genes. I further filtered 
the genes by requiring them to be at least 2-fold differentially expressed between the naive 
condition and one of the stimulated conditions resulting in 8758 differentially expressed genes. 
 
To identify differentially expressed genes with specific expression patterns, I calculated mean 
quantile-normalised expression level in each condition and standardised the mean expression 
values across conditions to have zero mean and unit variance. I then used c-means fuzzy 
clustering implemented in MFuzz v.2.28 (Kumar and E Futschik, 2007) package with 
parameters ‘c = 9, m = 1.5, iter = 1000’ to assign the genes into 9 clusters. The number of 
clusters was chosen iteratively by trialling different numbers and observing which ones led to 
stable clustering results from independent runs. I ranked the genes in each cluster by their fold 
change and used g:Profiler (Reimand et al., 2016) R packages to identify pathways and Gene 
Ontology (GO) categories enriched in each cluster. 
Detecting hidden confounders with PEER 
To detect hidden confounders in gene expression, I applied PEER (Stegle et al., 2012) on each 
condition separately allowing for at most 10 hidden factors. As discussed in Chapter 3, I found 
that the first 3-5 factors explained the most variation in the data and the others remained close 
to zero. 
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4.2.2 Gene expression QTL mapping 
Preparing genotype data 
I obtained imputed genotypes for all of the samples from the HipSci project (Kilpinen et al., 
2016). I used CrossMap (Zhao et al., 2014) v0.1.8 to convert variant coordinates from GRCh37 
reference genome to GRCh38. Subsequently, I filtered the VCF file with bcftools v.1.2 
(http://samtools.github.io/bcftools/) to contain only bi-allelic variants (both SNPs and indels) with 
IMP2 score > 0.4 and minor allele frequency (MAF) > 0.05 in our 84 samples. This VCF file was 
used for all subsequent analyses. The genotype data for 52 managed access lines is available 
from the European Genome-phenome Archive (EGA) (EGAD00010000773), the data for the 
remaining 34 open access lines is deposited in the European Nucleotide Archive (ENA) 
(PRJEB11749). The VCF file was imported into R using the SNPRelate (Zheng et al., 2012) R 
package.  
Detecting eQTLs using linear model 
I used linear regression implemented in the fastQTL (Ongen et al., 2016) software to map cis 
eQTLs in each experimental condition. I used the “--permute 100 10000” option to obtain 
permutation p-values for each gene. The size of the cis windows was set to +/-500 kb around 
the gene. I used sex and the first six PEER factors as covariates in the model. I picked single 
most significantly associated variant for each gene and used Benjamini-Hochberg correction to 
identify genes with at least one significant eQTL at 10% FDR level (‘eGenes’).  
Quantifying allele-specific expression 
I used ASEReadCounter (Castel et al., 2015) from the Genome Analysis ToolKit (GATK) to 
count the number of allele-specific fragments overlapping each variant. I used the following 
flags with ASEReadCounter: ‘-U ALLOW_N_CIGAR_READS -dt NONE --minMappingQuality 10 
-rf MateSameStrand’. I removed indels from the VCF file prior to quantifying allele-specific 
expression because they are not supported by the RASQUAL model.  
Detecting QTLs using RASQUAL 
I wrote a collection of python scripts and a rasqualTools R package to simplify running 
RASQUAL on large number of samples and work with large RASQUAL output files. This 
software is available on GitHub (https://github.com/kauralasoo/rasqual). I used the 
vcfAddASE.py script to add allele-specific counts calculated in the previous step into the VCF 
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file. I ran RASQUAL (Kumasaka et al., 2016) independently for each experimental condition 
using sex and first two PEER factors as covariates. In contrast to standard linear model, 
covariates seemed to have only a minor effect on the number of eQTLs detected by RASQUAL. 
I only included variants that were either in the gene body or within 500 kb upstream or 
downstream of the gene. I specified ‘--imputation-quality > 0.7’. As a result, variants with 
imputation quality of < 0.7 were used as feature SNPs in allele-specific analysis but were not 
considered as possible causal variants. I also used RASQUAL’s GC correction option to correct 
for sample-specific GC bias in the gene-level read count data. To correct for multiple testing, I 
picked one minimal p-value per gene, used eigenMT (Davis et al., 2016) to estimate the number 
of independent tests performed in the cis-region of each gene and then performed Bonferroni 
correction to obtain the corrected p-value. I further performed Benjamini-Hochberg FDR 
correction on the Bonferroni-corrected p-values to account for multiple testing between features 
and defined associations with FDR < 0.1 as significant. 
Comparing RASQUAL and FastQTL results 
To compare RASQUAL and FastQTL, I focussed on genes that were not filtered out by 
RASQUAL because of zero read count. Since performing thousands of genome-wide 
permutations was not feasible for RASQUAL, I only computed nominal p-values for the lead 
eQTL variant for each gene from both methods. I estimated the number of independent variants 
in the cis region of each gene with eigenMT (Davis et al., 2016) and then performed Bonferroni 
correction on gene level using the eigenMT estimates. Subsequently, I used Benjamini-
Hochberg FDR correction to account for the number of genes tested and identified the genes 
that had a significant eQTL at 10% FDR. The eigenMT based FDR threshold was more 
conservative than permutation-based FDR normally used for FastQTL as reported in the 
eigenMT paper (Davis et al., 2016).  
Detecting condition-specific QTLs with a linear model 
In each condition, I first identified all features (genes or intron clusters) and corresponding lead 
variants that displayed significant association at 10% FDR level. These were identified either 
using RASQUAL (gene expression) or linear regression (intron excision ratios). For each 
feature, I then only kept independent lead variants (R2 < 0.8). Finally, I used all independent 
pairs of features and corresponding lead variants to test if the QTL effect size was significantly 
different between conditions. This was equivalent to testing the significance of the interaction 
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term between condition and lead QTL variant for each feature. Specifically, I used ANOVA to 
compare two models for each gene-lead SNP pair: 
H0: expression ~ genotype + condition + covariates 
H1: expression ~ genotype + condition + genotype:condition + covariates 
I calculated the p-value of rejecting H0 and performed Benjamini-Hochberg FDR correction to 
identify condition-specific QTLs that were significant at 10% FDR level. For both gene 
expression and alternative transcription analysis, I used the same normalised data sets and 
covariates that were used for QTL mapping in each condition separately. 
Filtering and clustering QTLs based on effect size 
I extracted the RASQUAL eQTL effect size estimates π for each gene-variant pair in each 
condition and converted them to log2 fold changes between the two homozygotes using the 
formula log2FC = -log2(π/(1-π)). For an eQTL to be considered condition specific I required the 
difference in log2FC between naive and any one of the stimulated conditions to be greater than 
0.32 (~1.25 fold). I used k-means clustering to identify groups of eQTLs that had similar 
condition-specific patterns. For each eQTL, I divided the log2FC values in each condition by the 
maximal log2FC value observed across conditions. This scaling was necessary to make eQTLs 
with different absolute effect size comparable to each other for the k-means algorithm. 
4.2.3 Alternative transcription analysis 
I used three complementary approaches to quantify transcript expression in our samples. First, I 
quantified the expression levels of all known Ensembl transcripts. Secondly, I constructed 
alternative transcription events from known transcript annotations and quantified their relative 
expression. Finally, I used an annotation-free approach to quantify the rates of intron excision. 
All of these quantification approaches were subsequently used to identify transcript ratio QTLs 
(trQTLs). 
Quantifying the expression of annotated alternative transcripts 
I downloaded the Ensembl 85 gene annotations in FASTA format from the Ensembl website. I 
then used Salmon (Patro et al., 2016) v0.7.2 to quantify the expression levels of 178,136 
transcripts from 39,037 genes. I specified the following options: ‘--useVBOpt --seqBias --gcBias 
--libType ISR’. The ‘--seqBias’ option quantified the extent of sample specific fragment bias for 
each gene and adjusted the normalised transcript expression levels accordingly. Similarly, ‘--
gcBias’ option quantified the extent of sample specific GC content bias and corrected the 
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normalised transcript expression levels accordingly. I expected the ‘--gcBias’ option to be 
important given the difference in GC content bias between automatic and manual library 
construction methods that I identified in Chapter 3. 
Constructing alternative transcription events from known annotations 
In the second approach, I modified the reviseAnnotations 
(https://github.com/kauralasoo/reviseAnnotations) code introduced in Chapter 2 to construct 
alternative transcription events from known annotated transcripts. I downloaded the Ensembl 85 
transcript coordinates as well as transcript metadata using the biomaRt (Durinck et al., 2005) R 
package. I focussed the analysis on 71,991 protein coding and lincRNA transcripts from 16,762 
genes, only including genes that had at least two annotated transcripts. I also extracted 
transcript tags from the Ensembl 85 GTF file downloaded from the Ensembl website. 
Importantly, the tags contained information if the 3′ or 5′ end of the coding sequence (CDS) was 
incomplete for any given transcript. In total, I found that the coding sequence was incomplete for 
20,966/65,140 (32%) of the protein coding transcripts. The truncated transcripts of the IRF5 
gene are illustrated on Figure 4.1A. To overcome potential bias caused by incomplete transcript 
annotations, I first decided to extend the truncated transcripts by using exons from transcript 
with the furthermost 3′ or 5′ end (depending on which end of the transcript was incomplete). The 
extended transcripts of the IRF5 gene are illustrated on Figure 4.1B. 
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Figure 4.1: Extending truncated transcripts of the IRF5 gene. (A) Protein coding transcripts 
of the IRF5 gene from the Ensembl 85 gene set. The transcripts with annotated incomplete 3′ 
ends are marked with red asterisks. (B) Truncated transcripts have been extended using the 
exons from the transcript with the furthermost 3′ end (ENST00000249375). Transcript 
annotations have been plotted using wiggleplotr (https://github.com/kauralasoo/wiggleplotr) R 
package and introns have been rescaled to constant length to facilitate visualisation. 
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In Chapter 2 I observed that different types of alternative transcription are often regulated 
independently, but this complexity is not well represented by current transcript annotation. After 
extending the truncated transcripts, I modified the reviseAnnotations 
(https://github.com/kauralasoo/reviseAnnotations) code to split the full transcripts into alternative 
transcription events. Briefly, I first identified the set of exons that were shared by all transcripts 
of the gene. Then I went through all of the individual transcripts of the gene and identified all the 
exons of the transcript that were either upstream, between or downstream of the shared exons. 
Finally, I appended the transcript-specific exons to the shared exons to construct alternative 
transcription events corresponding to alternative promoters, alternative middle exons and 
alternative transcript ends. With this approach I was able to identify seven different alternative 
promoters, one alternative middle exon and four alternative transcript ends from the original 11 
different transcripts of the IRF5 gene (Figure 4.2). If there were no shared exons between all of 
the transcripts of the gene, I first split the transcripts into multiple groups of overlapping 
transcripts and then constructed alternative events in each group separately. The approach 
described here is best suited for disentangling changes in alternative promoters from changes in 
alternative transcript ends. Due to high complexity in transcript annotations, the alternative 
promoter and alternative transcript end events identified with this approach can still contain 
alternative middle exons (Figure 4.2).  
 
I used the rtracklayer (Lawrence et al., 2009) package to export the alternative transcript 
annotations in GFF format and used to gffread tool from cufflinks v2.2.1 (Trapnell et al., 2010) to 
extract the alternative event sequences from the GRCh38 reference genome sequence. Finally, 
I quantified the expression of each alternative transcription event with Salmon using identical 
parameters that I used for full transcript analysis. I used separate Salmon index for the three 
different types of events (alternative promoters, middle exons and transcript ends) to avoid any 
bias caused by shared exons common to all of these events. 
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Figure 4.2: Alternative transcription events constructed from the 11 annotated transcripts 
(Figure 4.1B) of the IRF5 gene. Exons shared by all alternative events are highlighted in green 
and exons specific to some events are shown in blue. 
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Quantifying rates of intron retention 
I used LeafCutter (Li et al., 2016b) to identify 38,725 clusters of intron excision events 
corresponding to a total of 142,030 alternatively excised introns. In each sample, I counted the 
number of reads supporting each intron excision event in a cluster as well as the total number of 
reads in a cluster.  
4.2.4 Transcript ratio QTL mapping 
Data normalisation 
All three quantification approach described above (Ensembl 85, reviseAnnotations, and 
LeafCutter) allowed me to calculate the relative expression of a single event (transcript, 
transcription event or intron) relative to all other events in the same cluster (gene, part of a gene 
or intron cluster). In the case of transcripts, this can be interpreted as the proportion of the total 
expression of the gene that can be attributed to a single transcript. For transcripts and 
transcription events I used the Salmon TPM estimates to calculate the relative expression 
values. For intron excision events identified by LeafCutter I used the raw read counts 
overlapping exon junctions.  
 
In some samples the relative expression of an event was not defined because the total 
expression of the group was zero. In those cases, I replaced the missing relative expression 
values with the mean value from all present samples. Finally, I quantile normalized the relative 
expression levels for each event across samples to a standard normal distribution. While 
conservative, this approach was efficient against two types of artefacts in intron excision ratios: 
(i) excess of values very close to 0 and 1 and (ii) excess of outlier excision ratios caused by very 
low estimated expression level for some events. 
Detecting transcript ratio QTLs 
I applied FastQTL to the quantile normalised transcript ratios from the three quantification 
approaches described above. I used the first six principal components of the phenotype matrix 
as covariates for the transcript ratio QTL (trQTL) mapping. I limited the cis region to +/- 100kb 
around the group of transcripts and obtained permutation p-values for each transcript. For each 
group, I took the p-value of the most significantly associated transcript and used Bonferroni 
correction to correct for the number of transcripts in a group. This approach was conservative as 
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the alternative events in a group are not independent from each other. Finally, I used Benjamin-
Hochberg FDR correction on the Bonferroni-corrected p-values to identify all trQTLs at 10% 
FDR level. 
4.2.5 Overlap analysis with the NHGRI-EBI GWAS catalogue 
I downloaded the latest version of the NHGRI-EBI GWAS catalogue v1.0.1 from the EBI website 
on 2 March 2016 (Welter et al., 2014). I only retained studies that were conducted in European 
populations and where the sample size exceeded 1,000. For each trait, I performed LD pruning 
to only keep independent associations (R2 < 0.8). After filtering, the catalogue contained 10,727 
independent associations for 807 different traits. I considered an QTL to overlap a GWAS hit if 
the distance between the lead QTL variant and the GWAS hit was less than 1 Mb and R2 
between the variants was greater than 0.8. 
4.2.6 QTL replicability between conditions 
For the Storey’s π1 analysis (Nica et al., 2011), I identified eGenes at 10% FDR in one 
condition, took their permutation-based lead variant p-values in the other condition and used the 
qvalue (Dabney et al., 2010) package to estimate the proportion of non-null p-values. For the 
lead variant concordance analysis, I identified eGenes together with their lead variants at 1% 
FDR in one condition, extracted their lead variants in the other condition and counted how often 
R2 between the two lead variants of the same gene was > 0.8. 
4.3 Quantifying gene expression and alternative transcription 
We collected a total of 336 RNA-seq samples from macrophages differentiated from 84 iPSC 
lines in four experimental conditions. After quantifying gene expression levels (See Methods), I 
used Principal Component Analysis (PCA) to assess the quality of the data. PCA revealed four 
distinct clusters with the first principal component (PC1) explaining 44% of the variance and 
roughly corresponding to Salmonella infection status and PC2 (explaining 15% of the variance) 
roughly corresponding to IFNɣ stimulation (Figure 4.3). PC5 that was most strongly correlated 
with the RNA-seq library construction method (manual or automatic) explained only 1.6% of the 
variance in the data. 
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Figure 4.3. Principal component analysis of normalised and standardised gene 
expression data. 
 
In addition to gene level analysis, I also quantified the relative expression of individual 
transcripts from the Ensembl 85 reference annotations and used the ratio between the transcript 
expression and total gene expression as the phenotype of interest. However, as highlighted in 
Chapter 2, reference annotations are still incomplete and often miss many transcripts expressed 
by the cells. To overcome this limitations, I used a modified version of the reviseAnnotations tool 
that I developed in Chapter 2 to split reference transcripts into individual alternative transcription 
events and subsequently quantified the relative expression of each event. I also used 
LeafCutter (Li et al., 2016b) to identify and quantify the relative excision ratios of 50,538 
alternative introns. These three complementary quantification approaches are referred to as 
Ensembl 85, reviseAnnotations, and LeafCutter in the following text. More details on each of 
these approaches is given in the Methods section. 
 
In the LeafCutter data, the first two PCs only explained ~9% of the variance, indicating that 
there was less structure in the intron excision measurements (Figure 4.4A) compare to the gene 
expression levels. Moreover, while PC1 (explaining 5% of the variance) still corresponded to 
Salmonella infection, the second PC was now strongly correlated with the method of RNA 
library preparation (manual vs automatic) (Figure 4.4A). Finally, PC3 (2% variance explained) 
corresponded to IFNɣ stimulation (Figure 4.4B). In Chapter 3 I showed that there was a 
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difference in GC-content bias between manual and automatic RNA-seq library construction 
protocols. This suggests that intron excision ratios that are based on a small number of reads 
from a short region are more susceptible to GC-content bias than gene expression 
measurements that are aggregated over a longer region. 
 
Figure 4.4: Principal component analysis of normalised intron excision ratios. (A) PC1 
plotted against PC2. (B) PC1 plotted against PC3. Protocol - type of RNA-seq library 
construction protocol used, either manual or automatic. 
 
4.3.1 Differential expression analysis reveals expected pathways 
First, I wanted to verify that our iPSC-derived macrophages are a suitable model to study 
genetics of gene expression in immune response. Fortunately, macrophage response to IFNɣ 
and bacterial stimuli (such as LPS) have been extensively studied and most of the pathways 
involved in the response have been identified. I therefore sought to verify that the expected 
pathways are also activated in iPSC-derived macrophages after corresponding stimuli. 
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Figure 4.5: Differential gene expression between the four experimental conditions. (A) 
Heatmap of 8758 differentially expressed genes clustered into nine distinct patterns of 
expression. (B) A selection of Gene Ontology (GO) terms specifically enriched in each cluster. 
Only enrichments with p < 1×10-8 are shown in the figure. ‘IFNɣ response’ was the only GO term 
with enrichment p-value < 1×10-8 in more than one cluster. 
 
I identified 8758 genes that were > 2-fold differentially expressed across all four conditions and 
clustered them into nine distinct expression patterns (Figure 4.5A). I then used g:Profiler 
(Reimand et al., 2016) to perform pathway and Gene Ontology enrichment analysis on these 
clusters. Cluster 1 (genes strongly upregulated by Salmonella or IFNɣ + Salmonella) was 
enriched for TNF and NF-κB signalling pathways (IL1B, TRAF1) as well as pathways involved in 
cell death and apoptosis (Figure 4.5B). This agrees with the observation that we recovered less 
total RNA from Salmonella and especially IFNɣ + Salmonella conditions (Figure 4.6), which 
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would also result from greater cell death following Salmonella infection. Cluster 2 (upregulated 
by Salmonella) was enriched for genes involved in locomotion. Cluster 3 consisted of genes that 
responded to Salmonella infection only after the cells had been pre-treated with IFNɣ. This 
cluster was enriched for type I interferon genes (IFNA1/8, IFNL2/3, IFNW1) and JAK-STAT 
signalling, but also contained other important inflammatory genes such as NOD2 and IL12A. 
Moreover, the synergistic activation of IL12A in response to IFNɣ and LPS is well established in 
monocyte-derived macrophages (Qiao et al., 2013). Cluster 4 contained genes that were 
upregulated similarly by IFNɣ and Salmonella and it was strongly enriched for type I interferon 
response and IRF1 target genes (CXCL8, IRF1, ATF3, STAT2, IDO1/2). This is consistent with 
the production of IFNβ and activation of IFNβ signalling downstream of TLR4 activation 
(Ivashkiv and Donlin, 2014). Genes in cluster 5 were only upregulated by IFNɣ and they were 
strongly enriched for antigen processing and presentation and MHC class II protein complex 
(CIITA). Again, the role of IFNɣ in activating antigen presentation genes is well established 
(Schroder et al., 2004). 
 
 
Figure 4.6: Relative amount of RNA obtained from each condition across 84 macrophage 
lines. I quantified the total amount of RNA obtained from each sample. For all four samples 
from a single line (corresponding to four conditions) I then subtracted the mean RNA amount 
across conditions and divided by standard deviation to obtain relative RNA amount. 
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Genes downregulated in the stimulated conditions also clustered into four distinct groups 
(Figure 4.5). Here, cluster 6 (downregulated by IFNɣ) were strongly enriched for cell cycle 
genes. This is consistent with multiple reports that stimulation with IFNɣ induces cell cycle arrest 
in macrophages (Schroder et al., 2004; Xaus et al., 1999). Finally, clusters 7,8 and 9 (all 
downregulated by Salmonella) was strongly enriched for ncRNA processing, ribosome 
biogenesis and tRNA processing, perhaps representing repression of translation as a general 
stress response. 
4.4 Genetics of gene expression 
4.4.1 Gene expression QTL mapping 
Table 4.1: Number of eQTLs detected in +/-500kb window around each gene using either 
linear model (FastQTL) or allele-specific model (RASQUAL). 
condition FastQTL RASQUAL % difference 
Naive 1932 2590 34 
IFNɣ 1985 2478 25 
Salmonella 1518 1882 24 
Both 1449 1869 29 
 
I used two alternative approaches to map eQTLs in each of the four conditions. First, I used 
standard linear model implemented in the FastQTL (Ongen et al., 2016) software. Secondly, I 
also used a novel RASQUAL (Kumasaka et al., 2016) method that combines both allele-specific 
and between-individual signal to increase the power of detecting eQTLs and also improves fine 
mapping causal variants. I decided to use both models for two reasons: (1) I wanted to take 
advantage of the allele-specific information to increase eQTL detection power (2) gene-level 
permutation p-values and summary statistics from the linear model can be directly used in eQTL 
replication and colocalisation analyses whereas this is not as straightforward for the RASQUAL 
output. I found that at the same 10% FDR level RASQUAL was able to detect on average 28% 
more genes with significant eQTLs (Table 4.1). The increase in power was also evident on the 
quantile-quantile (Q-Q) plot (Figure 4.7). 
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Figure 4.7: Quantile-quantile plots for the p-values of eQTLs detected either with 
RASQUAL or FastQTL. Solid lines represent the expected distribution of p-values under the 
null model. 
4.4.2 Transcript ratio QTL mapping 
I also used FastQTL in combination with the three quantification methods described above to 
map transcript ratio QTLs (trQTLs) in a +/-100 kb cis-window around the feature in all four 
conditions. I use smaller cis-window for trQTLs compared to eQTLs (+/-500kb), because trQTLs 
are known to be strongly enriched near the exon boundaries (Li et al., 2016c). Using either raw 
reference transcripts (Salmon + Ensembl 85) or transcription events constructed from them 
(Salmon + reviseAnnotatons), I detected between 1,500 and 2,500 trQTLs per condition (Table 
4.2). Ensembl 85 results contained slightly more unique genes while reviseAnnotatons was able 
to identify multiple independent trQTLs for a subset of genes as illustrated by the IRF5 example 
below. Finally, LeafCutter detected approximately 45% less trQTLs than the annotation-based 
methods.  
 
Table 4.2: Number of transcript ratio QTLs detected by different quantification methods 
at 10% FDR. Only variants within +/- 100kb of the transcript were included in the analysis. 
Condition LeafCutter Salmon + 
Ensembl 85 
Salmon + 
reviseAnnotations 
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Naive 1953 2201 2429 
IFNɣ 1756 2095 2314 
Salmonella 1496 1743 1858 
Both 1304 1481 1547 
 
4.4.3 Concordance of QTLs detected by different methods 
Comparing different QTL mapping approaches just by the numbers of QTLs found is not very 
informative, because it completely ignores the identity of the QTLs detected. Looking at simple 
overlaps between lead QTL variants can also be misleading, because the lead SNPs can be 
randomly different between the methods and still tag the same causal variant in high LD. To 
overcome this limitation, I decided to test if the lead variants for the same sets of genes (or 
transcripts) were concordant with each other for two different QTL mapping approaches. 
Specifically, I took all lead variants at 1% FDR from one method and compared them to the lead 
variants of the same genes (or transcripts) from a different method (even if below the 1% 
threshold). I then calculated the fraction of lead variant pairs that were in high LD (R2 > 0.8) with 
each other. Note that this approach is likely to underestimate the true extent of QTL sharing 
between methods in cases where there are multiple independent QTLs per gene. 
 
First, I found that 60% of the eQTL lead variants detected by FastQTL were also found by 
RASQUAL whereas only 40% of the RASQUAL QTLs were detected by FastQTL (Figure 4.8). 
This is consistent with the smaller number of eQTLs detected by the linear model (Table 4.1). I 
found similar level of lead variant sharing (~60%) between trQTLs detected using 
reviseAnnotations and Ensembl 85 annotations whereas sharing between reviseAnnotations 
and LeafCutter trQTLs was considerably lower (30-40%). This suggests that LeafCutter might 
be more efficient in capturing unannotated alternative exons that are not present in reference 
annotations. Finally, there was only moderate (20-30%) lead variant sharing between FastQTL 
eQTLs and reviseAnnotations trQTLs and this decreased to 10-12% when comparing to 
LeafCutter. This suggests that eQTLs and trQTLs are to a large extent independent from each 
other. 
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Figure 4.8: Concordance of lead QTL variants detected by different methods. In the gene 
expression (eQTL) comparison (left panel) I used FastQTL and RASQUAL lead variants from 
+/-500kb cis-window. For the eQTL and trQTL comparison (rightmost panel) I reran FastQTL 
eQTL mapping in a 100kb around the gene to ensure that the lead variants were comparable to 
the trQTLs. 
4.4.4 Condition specificity of eQTLs and trQTLs 
Next, I used two different approaches to estimate the proportion of condition specific eQTLs and 
caQTLs. First, I used Storey’s π1 statistic to estimate the sharing of QTLs between conditions. 
Briefly, I identified eGenes at 10% FDR in each condition and then looked their minimal p-
values in the other three conditions and estimated the fraction of those that were true positives. I 
found that the fraction of shared eGenes varied between 0.75 and 0.90 with the lowest sharing 
observed between naive and IFNɣ + Salmonella conditions (Figure 4.9). This is somewhat 
higher than the 53-80% sharing observed between different tissues (Nica et al., 2011; The 
GTEx Consortium, 2015), but much lower than the sharing of eQTLs in the same tissue across 
twin pairs (Nica et al., 2011).  
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Figure 4.9: Replicability of eGenes between conditions. The heatmap shows the pairwise 
Storey’s π1 statistic for eQTLs detected between conditions. 
 
However, this type of replicability analysis has several limitations. First, it considers only the p-
value of one lead variant per gene and ignores patterns of linkage disequilibrium. Consequently, 
if the gene has two unlinked highly condition-specific eQTLs then this would be considered a 
successful replication even though both of the variants have condition-specific effects. 
Secondly, calculating the π1 statistic requires that the null p-values are uniformly distributed. 
This assumption is not satisfied by the Bonferroni corrected p-values from RASQUAL or trQTL 
analyses where most p-values are strongly skewed towards 1. As a result, π1 statistic cannot be 
used on those datasets. 
 
To overcome these limitations, I decided to use the same lead variant concordance analysis 
described above to compare QTLs from different conditions. I found that ~55% of the eQTL lead 
variants and ~65 trQTL lead variants were shared between conditions, suggesting that trQTLs 
are slightly less likely to be condition specific than eQTLs (Figure 4.10).  
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Figure 4.10: Concordance of QTL lead variants between pairs of conditions detected by 
different QTL mapping methods. Each dot represents one pairwise comparison between 
conditions (such as IFNɣ vs naive). I mapped eQTLs with FastQTL in both +/- 500kb and +/- 
100kb cis-windows to match the 100 kb window used for transcript ratio QTLs. 
Identifying condition-specific eQTLs 
Although the π1 and lead variant concordance analyses are useful to estimate the global level of 
eQTL replicability between conditions, they do not identify specific variants and analyse their 
effect sizes. To identify individual condition-specific eQTL and their target genes, I compiled all 
independent (R2 < 0.8) lead SNP-gene pairs from RASQUAL across conditions and used 
standard ANOVA model to test for interactions between genotype and condition (See methods). 
A Q-Q plot revealed that the p-values of the interaction test were well calibrated (Figure 4.11A). 
I found that 1,172/5,782 (20%) lead eQTL variants corresponding to 996/3,905 (26%) eGenes 
had significantly different effect sizes between conditions.  
 
Although statistically significant, sometimes the effect size differences were relatively small. As 
a measure of the effect size of an eQTL I used the log2 fold change (log2FC) between reference 
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and alternative alleles estimated by RASQUAL. For an eQTL to be considered condition specific 
I required the difference in log2FC between naive and any one of the stimulated conditions to be 
greater than 0.32 (~1.25 fold). In our dataset, 741/996 condition-specific eQTLs passed this 
threshold out of which 496 appeared after stimulation (i.e. log2FC was less than <= 0.59 (~1.5-
fold) in the naive condition, Figure 4.11C) and 245 disappeared after stimulation (log2FC was 
greater than 0.59 (~1.5-fold) in the naive condition, Figure 4.11B). Finally, I used k-means 
clustering of the relative effect sizes to assign eQTLs into different activity patterns (Figure 
4.11B-C). I observed that slightly more eQTLs appeared after Salmonella infection (clusters 2,3 
and 4, n = 260) than after IFNɣ stimulation (clusters 5,6, n = 156). Furthermore, 83 eQTLs only 
appeared after both of the stimuli were present (cluster 1), highlighting the importance of 
studying combinations of stimuli. 
 
Figure 4.11: Condition-specific eQTLs clustered by their effect size. (A) Quantile-quantile 
plot of the expected and observed p-values for the interaction test (B) Effect size heatmap of the 
seven clusters of eQTLs that disappeared after stimulation. (C) Effect size heatmap of the six 
clusters of eQTLs that appeared after stimulation. For each gene, the relative effect size was 
calculated by dividing the eQTL effect size in each condition by the maximal absolute effect size 
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across conditions. This ensured that the eQTLs with different absolute effect sizes were visually 
comparable on the heatmap. 
4.5 Case study: genetics of IRF5 transcription 
To illustrate the power of using complementary approaches for gene expression and transcript 
ratio QTL mapping, I focussed on the IRF5 gene. Using total read counts and the standard 
linear model (FastQTL), I was not able to detect any significant eQTLs for this gene. Transcript 
level analysis with Ensembl 85 annotations, however, identified a very strong trQTL 
(rs10954213, p < 2.9×10-32, MAF = 0.46) that on a closer inspection turned out to regulate 3′ 
UTR usage (Figure 4.12). The association between the rs10954213 variant and 3′ UTR usage 
of the IRF5 gene has been previously reported by multiple studies (Cunninghame Graham et 
al., 2007; Yoon et al., 2012; Zhernakova et al., 2013) and the lead variant is likely to be the 
causal one because it changes the canonical polyadenylation signal from AATAAA to AATGAA.   
 
Using alternative transcription events from reviseAnnotations not only detected the 3′ UTR QTL 
(Figure 4.12), but also identified an additional trQTL regulating alternative promoter usage 
(rs3778754, p < 4.7×10-16, MAF = 0.33) independently of the 3′ UTR usage (MAF = 0.43) 
(Figure 4.13). A key advantage of reviseAnnotations was that it was able to correctly identify 
that one of the trQTLs regulated 3′ UTR usage while the other one regulated alternative 
promoters, thus greatly improving the interpretability of the detected trQTLs. Although the 
promoter QTL was also detected by LeafCutter (p < 3×10-17) the 3′ UTR QTL was not, because 
alternative polyadenylation will not result in detectable changes in exon-exon junction reads. 
The lead promoter QTL variant (rs3778754) is also in high LD (R2 = 0.84) with a GWAS lead 
SNP rs4728142 for Systemic lupus erythematosus and Ulcerative colitis. Moreover, a recent 
fine mapping analysis of the GWAS locus identified rs3757387 as the most likely causal variant 
which is in even higher LD with the promoter QTL (R2 = 0.93) (Kottyan et al., 2015).  
 
Finally, RASQUAL detected a third trQTL for the same gene (rs199508964, p < 4.9×10-33, MAF 
=0.48) that seems to influence the excision of an alternative intron in the fifth coding exon of the 
gene (Figure 4.14). Although the lead variant directly overlaps the splice site of the retained 
intron, it is a 33 bp deletion that is also in moderate LD with the 3′ UTR QTL variant (R2 = 0.58). 
Therefore, some care is in order when interpreting this variant. This trQTL was missed by 
LeafCutter, because it does not detect intron retention events. 
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Figure 4.12: Example of a trQTL for the IRF5 gene that influences the proximal 
polyadenylation site usage. (A) Manhattan plot of the associated variants around the IRF5 
gene in the naive condition. The lead variant rs10954213 disrupts the proximal polyadenylation 
site motif. (B) RNA-seq read coverage stratified by the lead variant genotype. The panel below 
the coverage plot shows the union of IRF5 exons (top row) together with transcription events 
constructed by reviseAnnotations (other rows). The alternative 3′ UTR is highlighted by the 
dashed box. 
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Figure 4.13: Alternative promoter QTL for the IRF5 gene. (A) Manhattan plot of the 
associated variants upstream of the IRF5 promoter in the naive condition. (B) RNA-seq read 
coverage across the IRF5 gene stratified by the genotype of the lead promoter QTL variant 
(rs3778754). The panel below the coverage plot shows the union of IRF5 exons (top row) 
followed by alternative promoter annotations constructed by reviseAnnotations. 
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Figure 4.14: Intron excision QTL in the IRF5 gene. (A) Manhattan plot of eQTL p-values from 
RASQUAL in the naive condition. (B) Read coverage across the IRF5 gene stratified by the 
genotype of the lead QTL variant (rs199508964). The alternatively excised intron is highlighted 
by the dashed box.  
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4.6 Overlap with GWAS hits 
An important motivation for studying the genetics of gene expression is to identify molecular 
QTLs that enable GWAS hits to be linked to their target genes and thereby provide a 
mechanistic hypothesis that could potentially explain the GWAS association. I have performed a 
naive overlap analysis (R2 > 0.8) between all independent GWAS associations from the NHGRI-
EBI GWAS catalogue and all eQTLs and trQTLs identified from the macrophage RNA-seq data. 
As a result, the probability that any individual overlap represents a shared causal mechanism is 
likely to be low. However, looking at the overlaps in aggregate can inform us about the traits and 
diseases for which iPSC-derived macrophages might be a relevant cell type. 
 
First, I assessed how many potential GWAS overlaps are missed when looking at eQTLs and 
trQTLs only in the naive condition. I found using eQTLs and trQTLs from all four conditions as 
opposed to just from the unstimulated cells identified at least twice as many overlapping GWAS 
associations (Figure 4.15). Furthermore, the GWAS overlaps with eQTLs and trQTLs were 
largely independent from each other as illustrated by the fact that joint analysis with all QTLs 
identify 40% more overlaps. It is important to stress that most of these overlaps are likely to be 
spurious and careful colocalisation analyses are needed to dissect individual loci.  
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Figure 4.15: Number of RASQUAL eQTLs and Salmon trQTLs overlapping GWAS hits. 
‘Naive’ represents QTLs from the unstimulated condition only while ‘all’ stands for all 
independent (R2 < 0.8) QTLs across conditions. Lead QTL and GWAS variants were considered 
to be overlapping if the distance between the variants was less than 1 Mb and R2 between the 
variants was > 0.8. 
 
Secondly, I counted the number of overlaps for each trait in the GWAS catalogue and ranked 
the traits by fraction of associations that overlapped a macrophage QTL. I found that top 20 
traits with the largest fraction of associations overlapping macrophage QTLs contained 
Alzheimer’s disease, multiple autoimmune disorders and multiple lipid traits, suggesting that 
iPSC-derived macrophages might be a relevant cell type for studying the genetic mechanisms 
underlying these traits. As a negative control, height ranked 56th with only 10% of its 
associations overlapping macrophage eQTLs and trQTLs and most cancers had even smaller 
overlap. 
 
Table 4.3: List of top 20 traits with largest overlap between GWAS hits and macrophage 
eQTLs/trQTLs. Only traits with more than 15 independent associations were included. 
Autoimmune traits are highlighted in red, lipid traits in green and blood traits in blue. 
 Trait Overlap size Trait size Fraction 
1 Ankylosing spondylitis 5 17 0.29 
2 Primary biliary cirrhosis 8 28 0.29 
3 Testicular germ cell tumor 5 21 0.24 
4 Alzheimer's disease (late onset) 8 36 0.22 
5 Metabolic traits 8 36 0.22 
6 Fibrinogen 5 25 0.2 
7 White blood cell count 4 20 0.2 
8 Inflammatory bowel disease 21 111 0.19 
9 Menopause (age at onset) 6 32 0.19 
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10 Idiopathic membranous nephropathy 3 16 0.19 
11 Platelet count 10 58 0.17 
12 HDL cholesterol 15 90 0.17 
13 C-reactive protein levels 3 18 0.17 
14 Triglycerides 10 61 0.16 
15 Liver enzyme levels (gamma-glutamyl 
transferase) 
4 25 0.16 
16 Homocysteine levels 3 19 0.16 
17 Crohn's disease 17 109 0.16 
18 LDL cholesterol 11 71 0.15 
19 Multiple sclerosis 19 123 0.15 
20 Cholesterol, total 12 78 0.15 
 
4.7 Discussion 
In this chapter I have shown that iPSC-derived macrophages are able to well recapitulate known 
aspects of macrophage biology in immune response. In particular, I have shown that their gene 
expression response to Salmonella infection and IFNɣ stimulation matches what is known from 
the literature. I have also shown iPSC-derived macrophages are a robust cell culture based 
system that can be used to map condition-specific genetic effects on both gene and transcript 
expression level. 
 
We detected around 2,000 gene expression and transcript ratio QTLs in each experimental 
condition and found that ~25% of the QTLs were condition specific. This also included 495 
eQTLs that were completely hidden in the unstimulated cells and only appeared after 
stimulation. Many potential overlaps with disease hits were also only detected in the condition-
specific samples. Together these results highlight that the effect of some genetic variants on 
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gene expression manifests most clearly in specific environmental conditions. Hence, to 
construct a comprehensive catalogue of regulatory variation we need to profile gene expression 
in a large number of conditions. IPSC-derived cells provided an excellent opportunity for this, 
because they can be reliably obtained in large numbers from the same set of individuals. 
 
The three independent transcript ratio QTLs regulating alternative promoter usage, alternative 
intron retention and alternative 3′ UTR usage of the IRF5 gene highlight that different parts of 
the same transcript can be regulated by independent genetic mechanisms. This can be a 
challenge for transcript ratio QTL mapping, because all possible combinations of promoters, 
exons and 3′ ends are usually not represented by the set of annotated transcripts. Furthermore, 
up to 30% of the human protein coding transcripts annotations are incomplete and miss either 
their 3′ or 5′ ends. As a result, methods that focus on individual alternative transcription events 
such as MISO (Katz et al., 2010), DEXSeq (Anders et al., 2012) and LeafCutter (Li et al., 
2016b) have proven to be very successful. The first contribution of my reviseAnnotations 
approach is that it extends truncated transcripts with known exons of the gene. It then splits 
known transcripts into alternative 5′ ends, middle sections and 3′ ends. It is therefore a hybrid 
approach between full transcript and exon level analyses, that is still able to take advantage of 
the read coverage patterns over multiple exons (such as alternative promoters skipping multiple 
first exons) and at the same time identify independent effects on different parts of the gene.   
I found that eQTLs and LeafCutter trQTLs were largely independent from each other, thus 
confirming an earlier observation in LCLs (Li et al., 2016c). I also mapped trQTLs on 
transcription event level (Salmon + reviseAnnotations) and found that these QTLs were also 
largely independent from eQTLs, although to a lesser degree. Although LeafCutter and Salmon 
detected similar numbers of trQTLs, I found that only 30-40% of the lead variants were shared. 
One reason for this discrepancy is that the two approaches capture different transcription 
events. LeafCutter is able to detect QTLs for alternative exons that have not been annotated. 
Salmon, on the other hand, is able to detect QTLs for annotated alternative 3’ and 5’ ends that 
do not involve splicing (i.e. alternative polyadenylation) and are therefore missed by LeafCutter. 
Salmon might also be more powerful for lowly expressed genes and weaker effects, because it 
is not limited to exon-exon junction reads and is able to correct for fragment length and GC-
content bias during quantification. 
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5 Genetics of chromatin accessibility in 
macrophage immune response 
 
Collaboration note 
The work in this chapter was performed in collaboration with Julia Rodrigues who was a 
research assistant in Daniel Gaffney’s lab at the time. I designed the experiments, performed 
Salmonella infection and IFNɣ stimulation assays, took care of sample logistics and performed 
all of the data analysis. Julia prepared the cells for experiments and performed the experimental 
side of the ATAC-seq protocol. We shared macrophage differentiation tissue culture 
responsibilities. 
5.1 Introduction 
A major limitation of gene expression quantitative trait loci (eQTL) mapping studies is that due to 
linkage disequilibrium we are usually unable to identify causal variant(s). Although genetic 
variation can influence a gene expression through a variety of transcriptional and post-
transcriptional mechanisms, a large fraction of local eQTLs act by modulating the activity of 
regulatory elements (promoters and enhancers) and, subsequently, the rate of transcription of 
the gene. For example, an early study that measured chromatin accessibility and gene 
expression in the same population of lymphoblastoid cell lines (LCLs) estimated that as many 
as 55% of eQTLs were also chromatin accessibility QTLs (caQTLs) (Degner et al., 2012). 
Furthermore, caQTLs are strongly enriched in a relatively small accessible region, thus 
narrowing down the set of likely causal variants. However, no study thus far has mapped both 
eQTLs and caQTLs in multiple conditions to study how genetic effects on chromatin level 
propagate down to gene expression level in the context of stimulation.  
 
Since the original caQTL experiment (Degner et al., 2012), other studies have followed looking 
at the genetics of histone modifications and transcription factor binding (Ding et al., 2014; 
Grubert et al., 2015; Waszak et al., 2015). However, due to the large cell numbers required by 
chromatin assays, all of these studies have been conducted in LCLs. Therefore, although the 
cell type and condition specificity of eQTLs is well established (Fairfax et al., 2012, 2014), how 
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these effects manifest on the chromatin level and how they propagate down to gene expression 
is mostly unknown. The development of ATAC-seq (assay for transpose accessible chromatin) 
has made it possible to measure chromatin accessibility in much smaller number of cells, thus 
greatly increasing the number of cell types and conditions that can be profiled  
 
This chapter has two main aims. First, I wanted to estimate how well iPSC-derived 
macrophages (IPSDMs) recapitulate known aspects of macrophage immune response on the 
chromatin level. Secondly, I aimed to understand how condition-specific are genetic effects on 
the chromatin level and how these effects propagate to changes in gene expression. To study 
these two questions, we used ATAC-seq to measure chromatin accessibility of IPSDMs in the 
same four experimental conditions (naive, IFNɣ, Salmonella and IFNɣ + Salmonella) that were 
used for eQTL mapping Chapter 4 in 31-42 individuals.  
 
As highlighted in Chapter 4, the signalling pathways and transcription factors (TFs) activated by 
IFNɣ and Salmonella have been well characterised. Briefly, the activated TFs together with the 
DNA motifs that they recognise are illustrated on Figure 5.1. ChIP-seq experiments in both 
human and mouse macrophages have shown that thousands of regulatory elements change 
their activity in response to these and other stimuli (Kaikkonen et al., 2013; Ostuni et al., 2013; 
Qiao et al., 2013; Schmidt et al., 2016). Furthermore, while most of the enhancers that became 
active after stimulation are already primed in the naive state, a subset of them are created de 
novo after the simulation (Kaikkonen et al., 2013; Ostuni et al., 2013).  
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Figure 5.1: Main signalling pathways activated in macrophages after Salmonella infection 
and IFNɣ stimulation. Macrophages recognise LPS on the Salmonella cell wall via the TLR4 
receptor that leads to the downstream activation of the nuclear factor kappa B (NF-κB) and 
activator protein 1 (AP-1) (Takeuchi and Akira, 2010) as well as the interferon response factor 3 
(IRF3) (Doyle et al., 2002) TFs. IFNɣ, on the other hand, activates signal transducer and 
activator of transcription 1 (STAT1) and IRF1 TFs. Finally, IRF3 can also activate the IFNβ 
signalling pathway that culminates with the activation of STAT1-STAT2-IRF9 complex. While 
AP-1, NF-κB and STAT1 all recognise distinct DNA motifs (illustrated by the sequence logos 
under the TF names), IRF3, STAT1-STAT2-IRF9 and IRF1 recognise similar interferon-specific 
response element (ISRE) motif. 
 
By using motif enrichment analysis and comparing IPSDM ATAC-seq signal to published ChIP-
seq experiments, I was able to show that IPSDMs are able to recapitulate many known aspects 
of chromatin dynamics in macrophage immune response. Secondly, I identified caQTLs for 
4,000-10,000 ATAC-seq peaks depending on the condition and showed that approximately 25% 
of the caQTLs were condition specific. I also identify a small number of ‘multi-peak’ caQTLs 
where a single putative causal variant influenced chromatin accessibility of multiple independent 
peaks. I showed that some single-peak caQTLs can become multi-peak caQTLs after 
stimulation, thus highlighting hierarchical relationships between regulatory elements. Finally, I 
showed that for approximately 50% of stimulation-specific eQTLs the corresponding caQTL was 
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visible already in the naive state, suggesting that a proportion of caQTLs correspond to primed 
enhancers that are waiting for an appropriate environmental signal before regulating gene 
expression. 
5.2 Methods 
The experimental protocols for cell culture and stimulation experiments are described in Chapter 
3. This section focusses on methods that were specific to the chromatin accessibility part of the 
study. 
5.2.1 ATAC-seq 
Experimental procedures 
Approximately 150,000 cells were seeded into 1 well of a 6-well plate and treated identically to 
the RNA-seq samples. After stimulation, cells were washed once with ice-cold D-PBS and 
incubated for 12 minutes on ice in 500 µl sucrose buffer (10 mM Tris-Cl pH 7.5, 3 mM CaCl2, 
2mM MgCl2, 0.32 M sucrose). After 12 minutes, 25 µl of 10% Triton-X-100 (FC = 0.5%) was 
added and the cells were incubated for another 6 minutes to release the nuclei. Cells were 
centrifuged at 300 rpm for 8 minutes at 4°C and the supernatant was discarded. Tagmentation 
was performed with Illumina Nextera DNA Sample Preparation Kit as specified in the original 
ATAC-seq protocol (Buenrostro et al., 2013). Finally, size selection was performed using 
agarose gel and SPRI beads (Kumasaka et al., 2016). Five samples were pooled per lane and 
75 bp paired end reads were sequenced on Illumina HiSeq 2000 using the V4 chemistry.  
Read alignment 
Illumina Nextera sequencing adapters were trimmed using skewer v0.1.127 (Jiang et al., 2014) 
in paired end mode. Trimmed reads were aligned to GRCh38 human reference genome using 
bwa mem v0.7.12 (Li, 2013) (Li, 2013). Reads mapping to the mitochondrial genome and 
alternative contigs were excluded from all downstream analysis. Picard 1.134 MarkDuplicates 
was used to remove duplicate fragments. I used verifyBamID (Jun et al., 2012) 1.1.2 to detect 
and correct potential sample swaps between individuals. Fragment coverage BigWig files were 
constructed using bedtools v2.17.0 (Quinlan and Hall, 2010).  
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Peak calling  
I used MACS2 (Zhang et al., 2008b) v2.1.0 with ‘--nomodel --shift -25 --extsize 50 -q 0.01’ to 
identify open chromatin regions (peaks) that were enriched for transposase integration sites 
compared to the background at 1% FDR level. With these parameters I detected between 
31,658 and 208,330 peaks per sample. I constructed consensus peak sets in each condition 
separately by pooling all of the peak calls from all of the samples. For each peak, I counted the 
number samples in which that peak was identified and calculated the union of all peaks that 
were detected in at least 3 samples. Finally, I pooled the consensus peaks from all four 
conditions to obtain the final set of 296,220 unique peaks that were used for all downstream 
analyses. I used featureCounts (Liao et al., 2014) v.1.5.0 to count fragments overlapping 
consensus peak annotations and ASEReadCounter (Castel et al., 2015) from Genome Analysis 
Toolkit (GATK) to quantify allele-specific chromatin accessibility.  
Sample quality control 
I used the following criteria to assess the quality of ATAC-seq samples: 
● Assigned fragment count - the total number of paired end fragments assigned to peaks 
by featureCounts. 
● Mitochondrial fraction - fraction of total fragments aligned to the mitochondrial genome. 
● Assigned fraction - fraction of non-mitochondrial reads assigned to consensus peaks. A 
measure of signal-to-noise ratio. 
● Duplicated fraction - fraction of fragments that were marked as duplicates by Picard 
MarkDuplicates. 
● Peak count - number of peaks called by MACS2. 
● Length ratio - # of short fragments (< 150 nt) / # long fragments (>= 150 nt). This 
measures if the read length distribution has characteristic ATAC-seq profile with clearly 
visible mono-nucleosomal and di-nucleosomal peaks. 
I used these criteria to exclude 5 samples prior to performing caQTL mapping. One sample was 
excluded because of very low assigned fraction (~10%) and peak count, two more were 
excluded because of extremely large length ratio (>7) and an uncharacteristic ATAC-seq profile. 
The final two samples were excluded because they appeared to be outliers in the principal 
component analysis. 
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Differentially accessible regions 
I used limma voom v3.26.3 (Law et al., 2014) to identify 63,430 peaks that were more than 4-
fold differentially accessible (FDR < 0.01) between naive and any one of the stimulated 
conditions. I noticed that limma voom was sensitive to lower quality samples. Therefore, I only 
used high quality samples from 16 donors (64 samples) for the differential accessibility analysis. 
Subsequently, I quantile-normalised the peak accessibility data using cqn (Hansen et al., 2012), 
calculated the mean accessibility of each peak in each condition and used Mfuzz v.2.28 (Kumar 
and E Futschik, 2007) to cluster the peaks into seven distinct activity patterns. For principal 
component analysis (PCA) I normalised the peak fragment counts data using transcripts per 
million (TPM) (Wagner et al., 2012) approach. 
Motif enrichment 
I downloaded the CIS-BP (Weirauch et al., 2014) human TF motif database from the MEME 
website and used FIMO (Grant et al., 2011) to identify the occurrences of all TF motifs within the 
ATAC consensus peaks with FIMO threshold p-value < 1e-5. I also performed the same motif 
scan for 2 kb promoter sequences upstream of 21,350 human genes (downloaded from the 
PWMEnrich (Stojnic and Diez, 2015) R package) and used this as the background set. I used 
Fisher’s exact test to identify motifs that occurred significantly more often in macrophage open 
chromatin regions compared to the background promoter sequences. Because the CIS-BP 
database contains many redundant motifs, I manually selected 21 representative motifs for 
downstream analysis corresponding to the major TFs important in macrophage biology: AP-1, 
IRF-family, ETS-family (PU.1, ELF1, FLI1), NF-κB, CEBPα, CEBPβ, ATF4, CTCF, STAT1, 
MAFB, MEF2A and USF1. I also used Fisher’s exact test to identify motifs that were specifically 
enriched in each cluster of differentially accessible peaks compared to the background of all 
macrophage ATAC peaks. 
5.2.2 ChIP-seq data analysis 
The public ChIP-seq datasets used in this study are summarised in section ‘Summary of public 
ChIP-seq datasets used in the analyses’. Single-end datasets (Pham et al and Qiao et al) were 
aligned to the GRCh38 human reference genome using bwa aln v0.7.12 with default 
parameters. Paired-end datasets (Reschen et al, Schmidt et al and Wong et al) were aligned to 
the GRCh38 reference genome using bwa mem v0.7.12 with the -M flag set. Only properly 
paired reads were used for downstream analysis. Duplicate reads were removed with Picard 
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v1.134 MarkDuplicates with the ‘REMOVE_DUPLICATES=true’ parameter set. I used bedtools 
v2.17.0 (Quinlan and Hall, 2010) to construct genome wide read (single-end) or fragment 
(paired-end) coverage tracks in BigWig format. I called peaks using MACS2 v2.1.0 with ‘-q 0.01’ 
option. 
Summary of public ChIP-seq datasets used in the analyses 
[Pham et al] (Pham et al., 2012, 2013) 
Purification: Gradient centrifugation (85% pure monocytes) 
Culture conditions: Purified monocytes were differentiated into macrophages in RPMI 1640 
medium (Biochrom) supplemented with 2% human pooled AB-group serum on Teflon foils for 
up to 7 days. Macrophages usually > 95% pure. 
Stimulations: Naive only 
Accession: GSE31621, GSE43098 
PMID: 22550342, 23658224 
ChIP-seq antibodies: CTCF, PU.1, C/EBPβ, H3K4me1, H3K27ac, H2AZ. 
Sequencing: 36 bp single-end reads on Illumina GA I/II. 
Replicates: 1 
[Qiao et al] (Qiao et al., 2013) 
Purification: Gradient centrifugation followed by positive selection with anti-CD14 beads 
(Miltenyi Biotec) (>97% pure) 
Culture conditions:  Monocytes were cultured in RPMI 1640 (Invitrogen) supplemented with 
10% defined FBS (HyClone) and 10 ng/mL M-CSF (Peprotech) (days unknown). 
Stimulations: Cells were treated with or without IFN-g (100U/ml) for 24 hours, and then 
stimulated with LPS (50 ng/ml) for 3 hours (STAT1, H3K27Ac) or 6 hours (IRF1). (Naive, IFNɣ, 
LPS, IFNɣ + LPS) 
Accession: GSE43036 
PMID: 24012417 
ChIP-seq antibodies: STAT1, H3K27ac, IRF1 
Sequencing: 50 bp single-end reads on Illumina HiSeq 2000 
Replicates: Up to 2 per condition 
[Reschen et al] (Reschen et al., 2015) 
Purification: Gradient centrifugation followed by positive selection with anti-CD14 beads 
(Miltenyi Biotec) (>95% pure) 
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Culture conditions: Cells were maintained in RPMI 1640 medium with 10% FCF, 4 mM L-
glutamine, 50 units/ml penicillin and 50 μg/ml streptomycin (Sigma, St Louis, MO), 
supplemented with 50 ng/ml M-CSF (eBioscience, San Diego, CA) for 7 days. 
Stimulations: Naive and oxLDL (50 μg/ml, 48h) 
Accession: GSE54975 
PMID: 25835000 
ChIP-seq antibodies: C/EBPβ, H3K27ac, FAIRE-seq 
Sequencing: 50 bp paired-end reads on HiSeq 2000/2500. 
Replicates: 2-4 
[Schmidt et al] (Schmidt et al., 2016) 
Purification: Gradient centrifugation followed by positive selection with anti-CD14 beads 
(Miltenyi Biotec) 
Culture conditions: Monocytes were cultured for 72h with GM-CSF (500 U/ml) in RPMI 1640 
medium containing 10% FCS.  
Stimulations: Naive, IFNɣ (200 U/ml, 72h), TPP (TNF (800 U/ml), PGE2 (1µg/ml) and 
Pam3CSK4 (1µg/ml), 72h), IL-4 (500 U/ml, 72h). 
Accession: GSE66594 
PMID: 26729620 
ChIP-seq antibodies: PU.1, H3K27me3, H3K27ac, H3K4me1 
Sequencing: 75 bp single-end on Illumina HiSeq 1000 
[Wong et al] (Wong et al., 2014) 
Purification: Gradient centrifugation followed by positive selection with anti-CD14 beads 
(Miltenyi Biotec) 
Culture conditions: Experiments were done on monocytes. 
Stimulations: Naive and IFNɣ (10 ng/mL, 24 h) 
Accession: E-MTAB-2424 
PMID: 25366989 
ChIP-seq antibodies: CIITA, RFX5 
Sequencing: 51 bp paired-end reads on HiSeq 
Detecting regions with differential H3K27Ac signal 
I performed differential histone acetylation analysis on the Qiao et al (Qiao et al., 2013) dataset 
to compare it to our ATAC-seq data. As H3K27Ac peaks are generally broader than ATAC-seq 
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peaks, I used MACS2 to call both broad and narrow peaks. Within each condition I only kept 
broad and narrow peaks that were detected at the 1% FDR threshold in both biological 
replicates. By visualising the data in a genome browser, I observed that at the 1% FDR 
threshold MACS2 called an excess of broad peaks compared to the narrow peaks so I further 
removed broad peaks that did not overlap any narrow peaks in the same condition. I then 
defined the union of broad peaks identified in each condition as the consensus set of peaks. I 
used featureCounts (Liao et al., 2014) to count the number of reads overlapping the consensus 
peaks in each sample. Finally, I used limma voom (Law et al., 2014) to identify peaks that 
showed at least 2-fold differential histone acetylation between naive and one of the stimulated 
states at 10% FDR. I used less stringent fold change and FDR thresholds for the histone 
acetylation data compared to the ATAC-seq data, because the broad histone peaks were less 
dynamic than the narrow ATAC peaks and because the histone dataset had only two biological 
replicates. 
Peak overlap analysis 
I used a permutation-based approach implemented in the Genomic Association Test (GAT) 
(Heger et al., 2013) software to test if the overlap between two sets of genomic annotations 
(such as ATAC-seq peaks and H3K27Ac peaks) was larger than expected by chance.  
5.2.3 Chromatin accessibility QTL mapping 
I used identical methodology to map eQTLs and caQTLs and assess their condition specificity. 
The full details of the pipeline are described in Chapter 4. Briefly, this involved mapping caQTLs 
using linear and allele-specific models, assessing replicability of caQTLs between conditions 
and using a linear model to identify peaks that show significant interactions between genotype 
and condition (condition-specific caQTLs). This section describes the areas where caQTL 
mapping differed from eQTL mapping. The size of the cis window for the caQTL mapping was 
+/- 50kb around the peak. 
Filtering condition-specific caQTLs by effect size 
I extracted the RASQUAL caQTL effect size estimates π for each peak-variant pair in each 
conditions and converted them into log2 fold changes between the two homozygotes using the 
formula log2FC = -log2(π/(1-π)). I then filtered the significant condition-specific caQTLs by 
requiring the maximal absolute log2FC across conditions |log2FCmax| to be > 0.59 (corresponding 
to 1.5-fold difference between the homozygotes), the minimal absolute log2FC across conditions 
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|log2FCmin| to be < 0.59 and the absolute difference between the two |log2FCmax - log2FCmin| to be 
>0.59. 
QTL replicability between conditions 
For the Storey’s π1 analysis (Nica et al., 2011), I identified caQTL peaks at 10% FDR in one 
condition, took their permutation-based lead variant p-values in the other condition and used the 
qvalue (Dabney et al., 2010) package to estimate the proportion of non-null p-values. For the 
lead variant concordance analysis, I identified caQTL peaks together with their lead variants at 
1% FDR in one condition, extracted their lead variants in the other condition and counted how 
often R2 between the two lead variants of the same caQTL peak was > 0.8. 
Motif disruption analysis 
I limited motif disruption analysis to caQTL peaks that did not contain associated indels and had 
<= 3 overlapping SNPs in them. For each SNP-peak pair I focussed on the sequence +/- 25 bp 
from the SNP. I constructed both reference and alternative versions of the sequence and used 
TFBSTools (Tan and Lenhard, 2016) to calculate the relative binding scores for both alleles 
(expressed as percentage from 0-100%). I considered the variant to be motif disrupting if the 
difference in relative binding score between the two alleles was > 3 percentage points. I also 
required the relative binding score for at least one of the alleles to be >= 85% of the theoretical 
maximum. This filter was necessary to exclude potential motif disruption events in very weak 
motif matches that are not likely to correspond to binding in vivo and is similar to the default 
recommended by TFBSTools. I used the hypergeometric test to identify motifs that were 
significantly more often disrupted in one of the six condition-specific caQTL clusters compared 
to all caQTLs.  
Identifying condition-specific dependent peaks 
To identify condition-specific dependent peaks, I tested if the effect size of the caQTL changed 
differently for master and dependent peaks between two pairs of conditions. This was 
equivalent to testing the significance of a three-way interactions between genotype, peak 
(master or dependent) and condition. I implemented this as the comparison of two standard 
linear models in R: 
 
H0: y ~ peak + condition + peak*condition + genotype*peak + genotype*condition + covariates 
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H1: y ~ peak + condition + peak*condition + genotype*peak + genotype*condition + 
genotype*condition*peak + covariates 
 
Similarly to condition-specific caQTL analysis, I used the first three principal components 
calculated separately for each condition as covariates in the model. I used the log2FC from 
RASQUAL as the measure of caQTL effect size. To identify true condition-specific dependent 
peaks, I further filtered the results by requiring the absolute log2FC of the master peak to be > 
0.59 (1.5-fold) in the naive condition and the change in the log2FC for the dependent peak 
between the naive and stimulated condition to be > 0.59.  
5.3 Quantifying chromatin accessibility 
First, I tested whether the chromatin accessibility profile in IPSDMs was similar to that of 
primary macrophages. After multiple pre-processing steps (see Methods for details), I identified 
a total of 296,220 consensus ATAC-seq peaks in IPSDMs across four experimental conditions 
and quantified their accessibility. Principal component analysis (PCA) of the data revealed four 
distinct clusters corresponding to the four experimental conditions (Figure 5.2A).  
 
To identify the transcription factors (TFs) that drive chromatin accessibility at these macrophage 
peaks I compared them to 21,350 human promoter sequences. I found that accessible 
chromatin regions in macrophages were enriched for binding motifs of multiple TFs that play 
important roles in macrophage function. The two most enriched motifs belonged to the AP-1 and 
PU.1 TFs (Figure 5.2B) whose collaborative interactions are well known to establish 
macrophage specific enhancers (Heinz et al., 2010). Other motifs enriched in the ATAC-seq 
peaks belonged to multiple TFs recognising the interferon-specific response element (ISRE) 
motif (IRF2, STAT2, IRF8, IRF1) as well as the CEBPα and CEBPβ TFs.  
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Figure 5.2: Summary of chromatin accessibility data. (A) PCA of macrophage chromatin 
accessibility data in four conditions. Axis labels indicate the percentage of variance explained by 
the first two principal components. (B) A selection of 21 representative TF motifs that are 
enriched in macrophage ATAC peaks relative to 21,350 human promoter sequences. 
5.3.1 Differential chromatin accessibility between conditions 
Many condition specific TFs are likely to regulate gene expression by altering chromatin 
accessibility. I next attempted to identify which TFs regulate chromatin accessibility in response 
to the three different stimuli in our study. I identified 63,430 peaks that were more than 4-fold 
differentially accessible (FDR < 0.01) between naive and any one of the stimulated conditions. I 
clustered the differential peaks into seven distinct activity patterns (Figure 5.3A) and to aid 
interpretation, I further grouped the seven clusters into four major groups. I used post hoc 
grouping of the clusters instead of clustering directly into four clusters because specifying a 
smaller number of clusters did not identify all of the four main patterns (See Figure 5.3A). I then 
used Fisher’s exact test to identify TF motifs from the CIS-BP database that were enriched in 
each group of differentially accessible peaks relative to all macrophage ATAC peaks (Figure 
5.3B).  
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Figure 5.3: Dynamics of chromatin accessibility between conditions. (A) The 63,350 
differentially accessible open chromatin regions were clustered into seven distinct patterns 
using c-means clustering implemented in the MFuzz packages. The clusters have been grouped 
into four groups according to whether their accessibility increased after Salmonella infection 
(clusters 1 and 2), IFNɣ stimulation (clusters 4 and 5), synergistically after both stimuli (cluster 
3) or decreases after stimulation (clusters 6 and 7). (B) Enrichment of transcription factor motifs 
in each of the four groups.  
 
Clusters 1 and 2, both of which became more accessible after Salmonella infection, were 
specifically enriched for NF-κB and AP-1 motifs, the two main TFs activated downstream of 
TLR4 signalling (Takeuchi and Akira, 2010). Cluster 3, which became accessible only after both 
of the stimuli were present, was enriched for the IRF (ISRE) and NF-κB motifs, suggesting 
possible collaborative interactions between IFNɣ-induced IRF1 and TLR4-activated NF-κB TFs 
that have been previously reported (Negishi et al., 2006). However, the motif analysis that I 
have performed does not distinguish between IRF1 and other IRF factors, because all IRF 
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factors have similar sequence preferences. In contrast, clusters 4 and 5 were activated by IFNɣ 
and were enriched for IRF and STAT1 motifs, consistent with the activation of STAT1 and IRF1 
downstream of IFNɣ signalling (Schroder et al., 2004).  
 
Finally, clusters 6-7, where accessibility decreased in response to all of the stimuli, were 
enriched for MEF2 and MAFB motifs. Interestingly, MafB binding has recently been shown to 
suppress self-renewal–associated macrophage enhancers in mouse and knocking out MafB 
together with c-Maf is sufficient to generate immortalised macrophages (Aziz et al., 2009; 
Soucie et al., 2016). This is further supported by our observation in Chapter 4 that genes 
downregulated by IFNɣ were strongly enriched for cell cycle and DNA replication pathways 
(Figure 4.5) and consistent with multiple reports that stimulation with IFNɣ induces cell cycle 
arrest in macrophages (Schroder et al., 2004; Xaus et al., 1999) 
5.3.2 Overlap with ChIP-seq signals 
Motif enrichment at differentially accessible peaks showed that iPSDMs activated the same set 
of TFs after stimulation that we would expect from primary monocyte-derived macrophages. 
However, it is not clear from motif enrichment alone if these TFs bind to the same genomic loci 
in both cell types. Unfortunately, there was no ATAC-seq data available from monocyte-derived 
macrophages (MDMs) from the same conditions to perform a direct comparison. Therefore, we 
resorted to comparing iPSDM ATAC peaks to multiple publicly available primary MDM ChIP-seq 
datasets.  
 
First, I focussed on the (Qiao et al., 2013) study that had measured histone 3 lysine 27 
acetylation (H3K27ac) with ChIP-seq in MDMs in very similar conditions to ours (naive, 3h LPS, 
24h IFNɣ and 24h IFNɣ + 3h LPS). I identify 11,735 differentially acetylated ChIP-seq peaks 
(FDR < 0.1, fold-change > 2) and clustered them into six clusters using MFuzz (See Methods for 
details) (Figure 5.4A). Since H3K27Ac peaks are generally much longer than ATAC-seq peaks 
(median lengths 3369 and 231 bp, respectively), I used permutation-based approach 
implemented in the Genomic Association Tester (GAT) (Heger et al., 2013) software to test if 
the overlap between different clusters of peaks was larger than expected. I found strong overlap 
between respective groups of peaks in IPSDM ATAC-seq and MDM H3K27Ac data, suggesting 
that overlapping regulatory elements become active in both cell types after similar experimental 
treatments (Figure 5.4B). 
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Figure 5.4: Concordance of chromatin changes between IPSDMs and MDMs. (A) 
Clustering of differential H3K27Ac peaks from (Qiao et al., 2013) study. The six clusters 
identified by MFuzz have been grouped into four groups based on whether the H3k27ac signal 
increases after LPS stimulation, IFNɣ stimulation, Both of the stimuli or decreases after 
stimulation. (B) Log2 fold enrichment of overlap between differential peak groups identified in 
our IPSDM ATAC-seq data and MDM H3K27ac data. The log2 fold enrichments of overlap were 
calculated using GAT (Heger et al., 2013). 
 
I noticed that the gene expression level of the master regulator of MHC class II complex CIITA 
together with its downstream targets (MHC class II genes) was specifically upregulated after 
IFNɣ stimulation (Figure 5.5A, Figure 4.5). I therefore hypothesised that some of the ATAC 
peaks that appear after IFNɣ stimulation should correspond to CIITA binding events. 
Fortunately, (Wong et al., 2014) had performed ChIP-seq for CIITA and RFX5 TFs (two 
members of the same complex) in primary human monocytes before and after IFNɣ stimulation. 
After reanalysing their data, I identified peaks that were detected in both biological replicates 
and used GAT to test which ATAC peak clusters were enriched in the ChIP-seq peaks. I found 
that only ATAC peaks activated by IFNɣ were enriched for the CIITA and RFX5 ChIP-seq peaks 
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(Figure 5.5B), suggesting that IPSDMs use the same set of regulatory elements to upregulate 
MHC class II expression in response to IFNɣ as do primary monocytes. 
 
 
 
Figure 5.5: Regulation of MHC class II expression in IPSDMs. (A) Expression level of CIITA 
gene in IPSDMs in the four conditions. (B) Enrichment of monocyte RFX5 and CIITA ChIP-seq 
peaks (Wong et al., 2014) in IPSDM ATAC-seq peak clusters from Figure 5.3A. 
5.4 Genetics of chromatin accessibility 
Table 5.1: Number of caQTL peaks identified by the linear (FastQTL) and allele-specific 
(RASQUAL) models in a 50kb cis-window around the 296,220 peaks. Identical multiple 
testing correction approach was used for both FastQTL and RASQUAL results, i.e. for each 
peak, eigenMT (Davis et al., 2016) was used to correct for the number of independent tests 
performed in the cis-window and Benjamini-Hochberg FDR was used to correct for multiple 
independent peaks being tested. 
condition Sample size FastQTL RASQUAL 
Naive 42 10735 10147 
IFNɣ 41 10810 10192 
 141 
Salmonella 31 5267 5493 
Both 31 3782 4337 
 
I used the same approaches to find chromatin accessibility QTLs (caQTLs) and assess their 
condition specificity that I used in Chapter 4 for eQTLs. Briefly, I used a standard linear model 
implemented in FastQTL (Ongen et al., 2016) software and the allele-specific model 
implemented in RASQUAL (Kumasaka et al., 2016) package to find caQTLs in a +/- 50kb 
window around each peak. I used both methods, because even though RASQUAL increases 
power to detect QTLs and fine map causal variants (Kumasaka et al., 2016), the summary 
statistics from the linear model can be directly used in replication and colocalisation analyses. 
Throughout this chapter, I will use caQTL variants to refer to the variants that are associated 
with chromatin accessibility at one or more open chromatin regions and I will use caQTL peaks 
to refer to the ATAC peaks that have at one or more independent significantly associated 
variants. Although RASQUAL and FastQTL identified similar number of caQTLs peaks at the 
10% FDR level (Table 5.1), quantile-quantile (Q-Q) plots revealed that caQTLs from RASQUAL 
generally had much smaller p-values than caQTLs from the linear model (Figure 5.6), 
Consequently, using a stricter FDR threshold (such as 1%) resulted in more caQTLs detected 
with RASQUAL than with the linear model.  
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Figure 5.6: Q-Q plots of caQTLs identified by RASQUAL and FastQTL in each of the four 
conditions. On each plot, the solid line corresponds to the expected distribution of p-values 
under the null model of no association. The FastQTL and RASQUAL p-values have been 
corrected for the number of independent variants tested using eigenMT. 
5.4.1 Fine mapping putative causal variants 
Chromatin accessibility QTL variants have previously been observed to be strongly enriched 
either within the peak itself or within other nearby peaks (Degner et al., 2012; Kumasaka et al., 
2016). This suggests that, unlike expression QTLs, the causal variants that underlie caQTLs are 
often likely to be found in a relatively small genomic region. Furthermore, recent evidence 
indicates that local caQTLs can influence chromatin accessibility by at least two conceptually 
distinct mechanisms (Deplancke et al., 2016). Most commonly, the causal variant is located 
within the accessible region and directly disrupts the binding of a sequence-specific factor. We 
refer to these caQTLs as ‘master’ caQTLs (Figure 5.7). However, sometimes a single causal 
variant in master caQTL peak can be associated with the accessibility of additional regions often 
many kilobases away from the master region forming so called ‘dependent’ caQTLs (Kumasaka 
et al., 2016) (Figure 5.7). The mechanisms that lead to the formation of dependent peaks have 
not yet been elucidated, but similar hierarchical relationships between regulatory elements have 
recently also been observed in the regulation of the WAP gene in mouse mammary tissue (Shin 
et al., 2016). Thus, discovering these associations between peaks can provide important insight 
into how multiple regulatory elements interact to regulate the expression of their target genes.  
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Figure 5.7: Heuristic approach to identify master and dependent caQTLs and their 
putative causal variants. Peak 5 is a master caQTL peak, because all of the variants in its 
credible set (green squares) overlap only peak 5 and no other caQTL region. Peak 1 and 2 are 
uncertain caQTLs, because the credible sets of peak 1 and peak 2 contain variants that overlap 
both peak. Peaks 3 and 4 are dependent caQTLs, because none of the variants in their credible 
set overlap the target peak, but they overlap some other peak (peaks 1 and 2 for peak 3 and 
peak 5 for peak 4). 
 
I developed a heuristic approach to identify putative master and dependent caQTL peaks. 
Across the four conditions, I identified 13,872 caQTL peaks at 10% FDR. For each caQTL peak 
I first defined the credible set of causal variants as the set containing the lead SNP and all 
variants with R2 > 0.8 with this SNP. In 88% of the cases (12,179 peaks) at least one variant in 
the credible set overlapped at least one consensus ATAC peak. The remaining 12% could be 
either false positive caQTLs or overlap open chromatin regions that were not detected by our 
peak calling approach. Furthermore, for 10,339/12,179 (85%) caQTL regions at least one 
variant in the credible set overlapped the region itself, confirming previous observations that 
caQTLs are highly local (Degner et al., 2012) (see regions 1, 2 and 5 on Figure 5.7). 
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However, observing that a variant in the credible set overlaps the corresponding caQTL peak 
does not necessarily mean that we have identified the true causal variant. In addition to many 
technical limitations (discussed below), an important biological limitation is that, because of high 
LD between variants, the same credible set can often overlap multiple caQTL peaks (see 
regions 1 and 2 on Figure 5.7 for illustration). In such cases it can be difficult to distinguish if 
there are two linked causal variants in two independent peaks or if there is only one causal 
variant in one of the peaks that influences the accessibility of both peaks. Thus, to identify 
putative master caQTLs I further required that the credible set variants overlapped strictly only 
one caQTL peak. As a result, I was able to identify 7,903 putative master caQTL peaks 
containing 11,854 putative causal variants. Furthermore, 69% of peaks contained only one 
putative causal variant and 95% of the regions contained <= 3 putative causal variants (Figure 
5.8) highlighting the power of caQTLs in fine mapping causal variants. 
  
Figure 5.8. Histogram of the number of associated variants overlapping 7,903 putative 
master caQTL peaks.  
 
Next, to identify dependent peaks, I focussed on the 1,840 caQTL peaks whose credible sets 
did not overlap the region itself. I found that for 753/1,840 peaks the credible set overlapped one 
of the putative master caQTL peaks identified above. This suggests that ~10% of the putative 
master caQTLs regions also have a dependent caQTL. However, this is likely to be an 
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underestimate, because dependent caQTLs generally have smaller effects than master caQTLs 
and we are less powered to detect them with our small sample size. 
 
This approach has multiple limitations. First, it uses a fixed significance threshold (10% FDR) to 
identify open chromatin regions that do or do not have a caQTLs. This means that weaker 
dependent peaks will remain undetected. Secondly, some potential causal variants overlapping 
caQTL peaks might be missed, because region boundaries are defined by MACS2 peak calls 
that might themselves be inaccurate. 
5.4.2 Assessing condition-specificity of caQTLs 
I used two complementary approaches characterise the replicability of caQTLs between 
conditions. First, I used Storey’s π1 statistic (Nica et al., 2011) to estimate the fraction of caQTL 
peaks that were shared between each pair of conditions irrespective of their corresponding lead 
variants. I found that, similarly to eQTLs analysed in Chapter 3, the fraction of shared caQTL 
peaks varied between 0.75 and 0.90 with the lowest sharing observed between naive and IFNɣ 
+ Salmonella conditions (Figure 5.9A). Secondly, I tested how often the lead caQTL variants 
were concordant (R2 > 0.8) between two pairs of conditions (see Methods). I found that 75-80% 
of the lead caQTL variants were concordant between conditions which was considerably higher 
than 50-60% observed for eQTLs (Figure 5.9B). One possible reason for this discrepancy 
between the π1 and lead variant concordance analyses could be that genes might have more 
independent QTLs between conditions than ATAC peaks. 
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Figure 5.9: Replicability of eQTLs and caQTLs between conditions. (A) Feature-level 
replicability between conditions using the Storey’s π1 statistic. The π1 statistic was calculated 
based on the FastQTL permutation p-values. (B) Pairwise concordance of the lead eQTL and 
caQTL variants for each feature. Each point corresponds to one pairwise comparison between 
two conditions. Concordance was calculated for both RASQUAL and FastQTL lead variants. 
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To identify individual peaks that have condition-specific caQTLs, I compiled all independent (R2 
< 0.8) variant-peak pairs across conditions and used two-way ANOVA to test for interactions 
between genotype and condition. Using sex and first three principal components of the dataset 
as covariates, I found that 4,947/16,924 (28%) caQTLs had significant interactions. After filtering 
out interactions with small effects, I identified 1,990 highly condition-specific caQTLs of which 
1,113 appeared after stimulation (log2FCnaive < 1) and 887 disappeared after stimulation 
(log2FCnaive > 1).  
 
I then clustered the condition-specific caQTLs based on their relative log2FC across conditions. 
For the caQTLs that appeared after stimulation, I identified six distinct clusters of peaks (Figure 
5.10A). I then tested if the likely causal variants for the condition-specific caQTLs were enriched 
for disrupting specific TF binding motifs compared to all caQTLs (Figure 5.10B). For this 
analysis I focussed only on the unique master peaks identified in Section 5.1 that had 1 to 3 
likely causal variants overlapping the peak. I found that Salmonella-specific clusters 2 and 3 
were enriched for disrupting NF-κB and AP-1 motifs whereas IFNɣ-specific clusters 5 and 6 
were enriched for disrupting the ISRE motif. Furthermore, all condition-specific caQTLs were 
depleted for disrupting PU.1 binding motif (Figure 5.10B). This analysis suggests that condition-
specific caQTLs are at least partly driven by variants that disrupt the binding sites of condition-
specific TFs that are not active in the naive state. However, despite observing these motif 
enrichments, only ~15% condition specific caQTL could be explained by a motif disruption event 
at the thresholds that I used. Interestingly, I observed that almost all condition-specific caQTL 
peaks on Figure 5.10A were completely inaccessible in the naive condition and became most 
accessible in the condition with the largest caQTL effect size (Figure 5.11B). On the other hand, 
we observed no such relationship in the gene expression data where the genes with condition-
specific eQTLs were on average equally highly expressed in all four conditions (Figure 5.11A).  
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Figure 5.10: Identifying condition-specific caQTLs. (A) Condition-specific caQTLs clustered 
by their relative effect size. (B) Enrichment of TF motif disruptions in each cluster of caQTLs. 
The six cluster were grouped into four groups based on the caQTL activity pattern.  
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Figure 5.11: Relationship between QTL condition-specificity and mean gene expression 
or chromatin accessibility in each of the four conditions. (A) The distribution of mean gene 
expression values in each condition for the genes with conditions specific eQTLs from Figure 
4.11C in Chapter 4. The numbered panels correspond to the same eQTL clusters that are 
shown on Figure 4.11C. (B) Mean chromatin accessibility of the ATAC-seq peaks from Figure 
5.10A that had condition-specific caQTLs. The numbered panels correspond to the same 
caQTL clusters that are shown on Figure 5.10A. 
5.4.3 Condition-specific dependent peaks 
I noticed that some multi-peak caQTLs exhibited an interesting behaviour where the master 
caQTL peak was present in all conditions, but the dependent caQTL peak appeared or 
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disappeared in subset of the conditions (See Figure 5.12 for examples). To identify these cases 
systematically, I tested if the effect size of the caQTL changed differently for the master and 
dependent peak between conditions. This was equivalent to testing the significance of three-
way interactions between genotype, peak (master or dependent) and condition (see Methods for 
details). After filtering by effect size, I identified 58 significant condition-specific dependent 
peaks. On the read coverage level 25/58 dependent peaks looked convincing, suggesting that 
the simple interaction test might have inflated false positive rate. The number of condition-
specific dependent peaks that I identified is small, but with 31-42 samples we are clearly 
underpowered to detect most of these interactions. 
 
 
Figure 5.12: Two examples of condition-specific dependent peaks. (A) Dependent peak 
appears after Salmonella infection. (B) Dependent peak disappears after Salmonella infection. 
5.5 Linking chromatin accessibility to the transcriptome 
In addition to understanding the how sequence variation influences chromatin accessibility, 
combining caQTLs with eQTLs can also be used to link regulatory elements to their target 
genes.  
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5.5.1 Linking caQTLs to eQTLs 
Knowing that a variant is an eQTL should increase our prior belief that the same variant might 
also be a chromatin accessibility QTL. However, modelling this formally can be challenging. I 
therefore decided to use two heuristic approaches with different levels of stringency. In the more 
stringent approach, I took lists of genome-wide significant eQTL genes and caQTL peaks (at 
10% FDR) together with their lead variants and searched for instances where the two lead 
variants were in strong linkage disequilibrium (R2 > 0.8). I did this either condition-by-condition 
or across conditions. I was able to find a corresponding caQTL for ~20% of the eQTLs. 
However, this approach strongly underestimated the true extent of overlap between eQTLs and 
caQTLs, because both our eQTL and caQTL mapping studies were underpowered. As an 
alternative approach, I focussed only on eQTL lead variants and tested in 100kb window around 
the lead variant for any associated ATAC peaks. I then used Bonferroni correction to account for 
multiple peaks tested per gene and used Benjamini-Hochberg FDR correction to account for 
multiple tested genes. With this approach I was able to identify corresponding caQTL for ~50% 
of the eQTLs.  
 
Next, to understand how genetic effects propagate from chromatin to gene expression, I 
focussed on eQTLs that appeared after stimulation and that had a corresponding caQTL. One 
possible model is that chromatin accessibility largely mirrors gene expression and genetic 
effects become visible on both levels in the same condition. Alternatively, genetic effects on 
chromatin level might appear before they influence gene expression. To investigate these two 
hypotheses, I next examined the relative effect sizes of condition-specific eQTLs and 
corresponding caQTLs. I found that for approximately 50% of the eQTLs that appeared after 
IFNɣ stimulation or Salmonella infection the corresponding caQTL was already present before 
stimulation in naive cells (Figure 5.13). This is consistent with our previous observation that lead 
caQTL variants are more often concordant between conditions than lead eQTL variants (Figure 
5.9B). 
 152 
 
Figure 5.13: Comparison of effect sizes between condition-specific eQTLs and their 
corresponding caQTLs. (A) IFNɣ-specific eQTLs and their corresponding caQTLs. (B) 
Salmonella-specific eQTLs and their corresponding caQTLs. 
 
A specific example is illustrated on Figure 5.14. The E1 peak is a master caQTL peak with a 
constitutive caQTL. The E1 peak has ten associated variants that are in almost perfect LD with 
each other (Figure 5.14A). However, only two of the ten variants overlap the E1 peak and only 
one of them (rs7594476) is located in the middle of a predicted PU.1 TF binding site 
(M6119_1.02 motif from in CIS-BP (Weirauch et al., 2014)). The alternative C allele has 9% 
lower relative binding affinity (87% vs 78%) that is consistent with reduced chromatin 
accessibility at the C allele. Furthermore, the same E1 peak has strong PU.1 ChIP-seq signal in 
a previously published macrophage dataset (Figure 5.14C) (Schmidt et al., 2016) suggesting 
that rs7594476 is the likely causal variant that alters chromatin accessibility at the E1 peak by 
disrupting a PU.1 binding site. The same variant is also associated with accessibility of 15 other 
ATAC peaks in the 200kb region, including the E2-E5 peaks shown Figure 5.14B. Interestingly, 
E2 is a condition specific dependent peak that appears after IFNɣ stimulation. 
 
Finally, rs7594476 is also associated with the expression level of SPOPL and NXPH2 genes 
whose promoters are 200kb upstream and 90kb downstream from the peak, respectively. 
Colocalisation analysis revealed that the two eQTLs and the E1 caQTL are strongly colocalised 
(posterior probability = 0.98), suggesting that they are driven by the same causal variant. 
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Intriguingly, similarly to the E2 dependent peak, the eQTLs for SPOPL and NXPH2 genes 
become visible only after IFNɣ stimulation. 
 
 
Figure 5.14: Example of a single QTL that influences chromatin accessibility at multiple 
peaks and the expression of two genes. (A) Manhattan plot of variants associated with the 
accessibility of the master caQTL peak E1. Only two of the associated variants overlap the E1 
peak, and only rs7594476 is predicted to disrupt a PU.1 TF binding motif (M6119_1.02 in CIS-
BP (Weirauch et al., 2014)). (B) Normalised ATAC-seq fragment coverage before and after 
IFNɣ stimulation stratified by the genotype at the rs7594476 SNP. Arrows correspond to links 
between the master peak E1 and dependent peaks E2-E5. (C) PU.1 ChIP-seq read coverage 
from (Schmidt et al., 2016). (D) Box plots of normalised SPOPL gene expression before and 
after IFNɣ stimulation. The boxplots are stratified by the genotype at rs7594476 SNP. (E) Box 
 154 
plots of normalised SPOPL gene expression before and after IFNɣ stimulation. The boxplots are 
stratified by the genotype at rs7594476 SNP. 
5.5.2 Using caQTLs to fine map causal variants for GWAS hits 
In the previous section I showed that for ~70% of caQTLs at least one of the variants in the 
credible set overlapped the peak itself. This suggests that if there is an eQTL that is colocalised 
with a caQTL then the caQTL signal can be used to fine map causal variants for the eQTL.  
PTK2B eQTL colocalises with a GWAS hit for Alzheimer’s disease 
Preliminary analysis with the NHGRI-EBI GWAS catalogue highlighted that lead eQTL SNP 
rs2322599 for PTK2B gene in the naive condition was in high LD (R2 = 0.98) with rs28834970, a 
GWAS hit for Alzheimer’s disease (Lambert et al., 2013). To see if both of these associations 
could be driven by the same causal variant, I downloaded Alzheimer’s disease GWAS summary 
statistics from the International Genomics of Alzheimer's Project (IGAP) website (Lambert et 
al., 2013). I then used the coloc (Giambartolomei et al., 2014) software on a 250kb window 
around the GWAS lead SNP and found strong evidence of statistical colocalisation 
(posterior probability > 0.98). I also found that there was a caQTL in the same region that 
colocalised both with the GWAS hit as well as the eQTL (Figure 5.15A). Furthermore, the 
lead caQTL SNP rs28834970 was the only associated variant lying within the caQTL peak 
(Figure 5.15B), suggesting this is the most likely causal variant. The lead variant 
rs28834970 is T/C polymorphism and the alternative C allele is predicted to increase the 
relative binding score of the CEBPβ TF motif (M2268_1.02 in CIS-BP (Weirauch et al., 2014)) 
from 0.86 to 0.97 (Figure 5.15B). This is consistent with the increased chromatin accessibility at 
the C allele as well as increased expression of the PTK2B gene (Figure 5.15C). Furthermore, 
the variant also overlaps experimental CEBPβ ChIP-seq peak in primary human macrophages 
(Reschen et al., 2015) (Figure 5.15B). Together, this evidence suggests that rs28834970 is the 
likely causal variant for Alzheimer’s disease risk that influences PTK2B expression by disrupting 
CEBPβ motif in an enhancer in the first intron of the gene. While the possible link between the 
rs28834970 Alzheimer’s GWAS hit and PTK2B eQTL in monocytes has been highlighted before 
(Chan et al., 2015; Karch et al., 2016), we have been able to use statistical colocalisation 
together with caQTL data to pinpoint a single most likely causal variant and provide a plausible 
mechanism. 
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Figure 5.15: Dissecting the Alzheimer’s disease causal variant at the PTK2B locus. (A) 
Manhattan plots for the Alzheimer’s GWAS hit (top panel), colocalised caQTL (second panel) 
and colocalised eQTL for PTK2B gene (third panel). The bottom two tracks show all ATAC-seq 
peaks in the region as well was exons of the PTK2B gene. (B) ATAC-seq fragment coverage 
plot stratified by the rs28834970 genotype. (C) RNA-seq read coverage plot at the PTK2B gene 
stratified by the rs28834970 genotype. 
5.6 Discussion 
We have shown that, similarly to gene expression, (Chapters 2 and 4), the chromatin 
accessibility dynamics of IPSDMs also closely resemble that of primary macrophages. Evidence 
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for this comes from the motif enrichment analysis where constitutive and condition-specific 
macrophage ATAC peaks were enriched for expected macrophage-specific TF motifs such as 
PU.1, AP-1, NF-κB, STAT1 and ISRE motif representing multiple IRF factors. Secondly, overlap 
analysis with multiple public ChIP-seq datasets confirmed that overlapping regions changed 
their activity in IFNɣ and LPS response. Future studies where IPSDMs and MDMs are 
measured in the same experiment are needed to reliable detect any differential chromatin 
accessibility between the two cell types and identify TFs responsible for those differences. 
 
Despite our modest sample size of 31-42 individuals, we identified thousands of caQTLs in each 
of the four conditions. We found that caQTL lead variants were 20% more likely to be shared 
between conditions than eQTL lead variants. This observation was further supported by the fact 
that for approximately 50% of the eQTLs that appeared after stimulation, the corresponding 
caQTL was already present in the naive state. Altogether, these observations suggest that a 
large fraction of genetic variation influences “primed” regulatory elements that wait for an 
appropriate environmental signal before regulating gene expression. Importantly, observing that 
a caQTL appears before eQTL allows us to infer that the caQTL is likely to be causal for the 
eQTL and not vice versa. 
 
Multiple studies have shown that GWAS hits are enriched in gene regulatory regions that are 
often cell type specific (Maurano et al., 2012). Despite this observation, attempts to colocalise 
GWAS hits with specific eQTLs have had only limited success (Chun et al., 2016; Guo et al., 
2015; Zhu et al., 2016). Chun et al (Chun et al., 2016) propose that regulatory regions might be 
accessible in multiple cell types and conditions (because they are bound by lineage determining 
pioneer TFs), but they might regulate gene expression in a few specific conditions. Importantly, 
this is consistent with our observation that caQTLs are less condition specific than eQTLs and 
for ~50% of condition-specific eQTLs their effect can be seen on chromatin level already before 
stimulation. Some evidence for the importance of cell-type specific pioneer TFs in disease 
comes from type 2 diabetes (T2D), where liver-specific pioneer TF FoxA2 (Iwafuchi-Doi et al., 
2016) binding sites are enriched among fine-mapped T2D GWAS loci (Gaulton et al., 2015).  
 
Similarly to previous studies (Grubert et al., 2015; Kumasaka et al., 2016; Waszak et al., 2015), 
we also found widespread evidence of single caQTL variants regulating the accessibility of 
multiple dependent caQTL peaks, often multiple kb away from the master peak. In total, we 
were able to detect at least one dependent caQTL peak for ~10% of the master caQTL peaks, 
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although this number is likely to increase with larger sample sizes. Importantly, measuring 
chromatin accessibility in multiple conditions allowed us to also identified a small number of 
dependent peaks that appeared or disappeared with stimulation. A number of those occurred in 
the SPOPL-NXPH2 locus (Figure 5.14), where the appearance of dependent caQTL peaks 
correlated with lead variant also becoming an eQTL for the two genes. This is consistent with a 
recently established model of hierarchical enhancer activation where signal-dependent 
transcription factors bind at or near primed enhancers to activate gene expression (Heinz et al., 
2013; Romanoski et al., 2015).  
 
Finally, the fact the caQTL variants are enriched within the peak whose accessibility they 
regulate allowed us to identify a small set of likely causal variants for thousands of caQTL 
peaks. By combining caQTLs with colocalised eQTLs and GWAS hits this can also facilitate fine 
mapping causal variants for those associations as illustrated by the SPOPL-NXPH2 (Figure 
5.14) and PTK2B Alzheimer’s GWAS hit (Figure 5.15) examples.  
 
In summary, we have shown that mapping caQTLs in multiple conditions can provide insights 
into the principles of gene regulation and identify causal variants for eQTLs and GWAS hits. 
Larger sample sizes in multiple tissues and conditions together with methodological 
developments can undercover the true extent of dynamics between master and dependent 
peaks within multi-peak caQTLs. 
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6 Conclusions 
I have spent the past four years trying to understand how genetic differences between 
individuals lead to condition-specific differences in human macrophage gene expression. I have 
done this by first developing and validating a scalable cell culture model based on differentiating 
human induced pluripotent stem cells (iPSCs) into macrophages. I have subsequently used the 
model to study the genetics of gene expression and chromatin accessibility in macrophage 
response to IFNɣ stimulation and Salmonella infection. 
6.1 Using iPSC-derived cells to map QTLs for molecular traits 
Large iPSC generation initiatives such as the HipSci project (Kilpinen et al., 2016) provide both 
genetically and phenotypically well characterised cell lines from healthy individuals as well as 
from individuals with rare diseases. With the development of automated iPSC derivation and 
characterisation pipelines, the availability of these cell lines is likely to increase even further 
(Paull et al., 2015). Throughout the thesis, we have shown that it is feasible to use iPSC-derived 
macrophages to map QTLs for molecular traits such as gene expression and chromatin 
accessibility. Importantly, in Chapter 3 we have identified experimental factors (such as cell 
purity) that are responsible for a large amount of variability in the gene expression levels of 
iPSC-derived macrophages. These results can guide future QTL mapping experiments in iPSC-
derived macrophages, but it is currently not clear how generalisable these observations are to 
other cell types and differentiation protocols. 
 
Multiple studies have shown that a large fraction of eQTLs become visible only after specific 
environmental stimuli (Barreiro et al., 2012; Lee et al., 2014; Maranville et al., 2011) and even 
the duration of the stimulus can have a large effect (Fairfax et al., 2014). Furthermore, there can 
be a scores of relevant stimuli for any given cell type (Xue et al., 2014). Moreover, as we have 
shown in Chapters 4 and 5, applying two stimuli one after the other (e.g. IFNɣ + Salmonella) 
can reveal QTLs that are not visible with either of the stimuli alone. As a result, the logistics and 
the number of cells required for all relevant conditions can become prohibitively large for 
primary cells, especially if the cell type of interest is not easily accessible. IPSC-derived cells 
are free of these limitations because, in principle, large numbers of cells can be scalably 
produced from the same set of individuals over a long period of time. 
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A major limitation in expanding this approach to different cell types is the lack of reliable 
differentiation protocols for many of them. Secondly, even if the protocols exist, differentiated 
cells will always show some differences from their primary counterparts and the consequences 
of these differences are largely unknown. Furthermore, many differentiation protocols are highly 
complicated, contain multiple manual steps and require many different signalling molecules to 
be added at specific time points. Progress has been made towards automating iPSC 
differentiation, but only a small number of protocols have been successfully converted (Paull et 
al., 2015). 
 
Even though there is no theoretical limit to the number of cells that can be produced from iPSC 
differentiations, working with large numbers of cell considerably increases the cost and 
complexity of the experiments. Therefore, to make it feasible to study tens of different stimuli at 
multiple time points, the experimental assays need to scaled down to small cell numbers. 
Fortunately, progress has been made over the years in reducing the numbers of cells required 
by RNA-seq (Picelli et al., 2014), ATAC-seq (Corces et al., 2016) and ChIP-seq experiments 
(Lara-Astiaso et al., 2014). 
6.2 Alternative transcription QTLs 
It is clear that since the DNA does not leave the nucleus, the effect of GWAS variants on cellular 
and organismal phenotypes must be somehow mediated by RNA. The fact that only a small 
fraction of GWAS associations overlap coding sequence (Maurano et al., 2012) has led to a 
surge in gene expression QTL (eQTL) mapping studies. Although current eQTL mapping 
studies have found thousands of independent genetic variants associated with mRNA levels of 
different genes, the number of GWAS hits that can readily be explained by eQTLs has remained 
relatively modest. One possible reason might be that the disease-causing eQTLs are active only 
in very specific cell types and conditions that have not yet been profiled by current eQTL 
studies.  
 
Alternatively, GWAS variants might influence RNA level phenotypes other than the total gene 
expression level such as alternative transcript usage. We and others (Li et al., 2016a) have 
shown that eQTLs and transcript ratio QTLs (trQTLs) are predominantly independent from each 
other. A trQTL study in lymphoblastoid cell lines (LCLs) found that trQTL enrichment in GWAS 
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hits was comparable to eQTLs (Li et al., 2016a). Similarly, rare variants causing aberrant mRNA 
splicing have been linked to Mendelian disorders (Cummings et al., 2016).  
 
Alternative transcription can manifest in many different forms: alternative promoter usage, 
alternative splicing, alternative intron retention and alternative polyadenylation. In principle, if all 
possible alternative transcripts were annotated then all types of alternative transcription could 
be detected by quantifying transcript expression. There have been significant computational 
advances in recent years that have increased both the speed and accuracy of transcript 
expression quantification (Bray et al., 2016; Patro et al., 2016). However, as we have shown in 
Chapters 2 and 4, transcript annotations are still to a large degree incomplete. An alternative is 
to use approaches that rely less on reference transcript annotations and focus on reads 
mapping to exon-exon junctions instead. One such method is LeafCutter (Li et al., 2016b), but 
exactly because of its focus on junction reads it not able to detect changes to 5′ and 3′ 
untranslated regions or retained introns as we have shown in Chapter 4. On the other hand, 
using the reviseAnnotations tool developed in this thesis to split reference annotations into 
alternative 5′ and 3′ ends can be used to detect these events and approaches also exist to 
detect long 3′ UTRs de novo from RNA-seq data (Xia et al., 2014). An important area of future 
research will be to systematically analyse different types of alternative transcription events and 
characterise their genomic properties. Finally, combining better alternative transcription event 
annotations with RNA-seq data from hundreds of individuals will allow us to find trans-acting 
QTLs that regulate alternative transcription (Battle et al., 2014), thus providing new insights into 
the mechanisms of its regulation.  
 
RNA transcripts consist of single long molecules. However, an important open question is how 
often different aspects of alternative transcription (i.e. alternative promoters, alternative exons, 
alternative 3′ UTRs) are regulated by shared mechanisms versus how often they are regulated 
by independent mechanisms. Preliminary results from Chapters 2 and 4 suggest that 
independent regulation might be the default mode of action. Future alternative transcription QTL 
mapping studies can answer this question by looking how often single QTLs are associated to 
single alternative transcription events as opposed to influencing multiple parts of the gene. 
Finally, direct long-read RNA sequencing has the potential to greatly improve reference 
transcript annotations (Garalde et al., 2016). However, if most alternative transcription events 
are regulated independently of the rest of the transcript then quantifying full transcript 
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expression for QTL mapping might actually reduce power, especially if the gene has multiple 
linked alternative transcription QTLs such as the IRF5 example highlighted in Chapter 4.  
6.3 Information flow from DNA to protein 
We and others have shown that there is considerable overlap between chromatin accessibility 
and gene expression QTLs. An early study in LCLs estimated that as many as 55% per cent of 
the eQTLs were also chromatin accessibility QTLs (caQTLs) but only 16% of the caQTLs were 
also estimated to regulate gene expression (Degner et al., 2012). In Chapter 5 we showed that 
in ~50% cases the caQTL underlying a condition-specific eQTL was already present in the 
naive state. Thus, a fraction of the discrepancy highlighted by (Degner et al., 2012) could be 
explained by ‘primed’ caQTLs that are waiting for the right environmental signal to start 
regulating gene expression. This observation illustrates an important concept where the 
propagation of regulatory effects from one level to the next (chromatin to RNA) can be regulated 
by changes in the environment that presumably influence the activity of trans-acting factors.  
 
The situation is less clear for splicing and transcript ratio QTLs where we know less about what 
proportion are regulated at the chromatin level. While most variants disrupting canonical splice 
acceptor and donor sites and polyadenylation sites are unlikely to have any effect on the 
chromatin level, QTLs that influence alternative promoter usage could behave more like 
traditional eQTLs. Furthermore, there is evidence that DNA binding proteins such as CTCF can 
regulate splicing by influencing the pausing of RNA polymerase II (Shukla et al., 2011). Thus, 
this could be an interesting area of future research. 
 
However, the functional unit for protein coding genes is the protein and not the mRNA molecule. 
Thus, it is important to know how genetic effects propagate from mRNA to protein level. Two of 
the largest joint protein QTL (pQTL) and eQTL mapping studies to date have been performed in 
human LCLs (Battle et al., 2015) and mouse liver (Chick et al., 2016). However, neither of these 
studies have looked at relationship between alternative transcription and protein expression 
level independent of the gene expression level. Since the role of 3′ and 5′ UTR sequences in 
regulating translation is well established (Wilkie et al., 2003), this could be an interesting area of 
future research. For example, re-analysing RNA-seq and proteomics data from (Chick et al., 
2016) with splicing in mind might be a feasible starting point. 
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Another aspect that is completely unknown is if there is additional condition specificity on pQTL 
level beyond that observed at the mRNA level. For example, similarly to the constitutive caQTLs 
becoming eQTLs that we described in Chapter 4, it would be interesting to find constitutive 
eQTLs that become pQTLs after stimulation. If these eQTL-pQTL pairs do exist, a potential 
mechanism for them might come from the (Chick et al., 2016) study that identified an 
abundance of trans-acting pQTLs that were not present on the RNA level. They found that a 
large proportion of these QTLs could be explained by stoichiometric buffering whereby the 
expression level of a single protein in a larger complex influences the levels of other members 
of the same complex, probably because proteins bound in a complex are more stable than the 
unbound molecules. Thus a constitutive eQTL might become a pQTL in another condition when 
other members of the same complex are more highly expressed. 
6.4 What are we going to do with all of the QTLs? 
A major motivation for performing molecular QTL mapping studies is their potential to aid the 
interpretation of GWAS associations in order to identify causal genes and variants. However, 
even if a molecular QTL has been identified in the same region with a GWAS hit, it still remains 
challenging to distinguish a single shared causal variant driving both traits from two independent 
causal variants that are in high linkage disequilibrium. Although multiple statistical approaches 
have been developed to test colocalisation between associations (Giambartolomei et al., 2014; 
Zhu et al., 2016), they have limited power in regions with large number of variants, where it can 
be impossible to decide on the sharing of causal variants. The second challenge is pleiotropy, 
where the same causal variant influences too traits, but the traits themselves are not causally 
linked. For example, eQTLs can simultaneously regulate the expression of multiple gene at the 
same time. If the same causal variant is then associated with a complex trait then it might not 
possible to tell which gene mediates the GWAS associations based on statistical evidence 
alone. 
 
Although deciding if a given molecular trait (such as gene expression) is causally linked to a 
complex disease is challenging based on a single association alone, we can be more confident 
if we see multiple associations pointing in the same direction. For example, multiple 
independent genetic associations with lower levels of low density lipoprotein (LDL) in blood are 
all linked to reducing cardiovascular disease risk (Ference et al., 2016). This association has 
also been confirmed in clinical trials, where the administration LDL-lowering drugs (such as 
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statins and PCSK9 inhibitors) has been shown to reduce cardiovascular disease risk. Thus, one 
paradoxical conclusion is that we need to discover even more QTLs to be able to take the full 
advantage of all the QTLs that we have found thus far. 
 
However, even with larger studies we are unlikely to be able to characterise the function of all 
regulatory variants using QTL mapping approaches. This is especially true for rare variants and 
rare cell types that we do not know how to differentiate in vitro. Moreover, it is deeply 
unsatisfying if the only way we can predict the function of a non-coding genetic variant is to 
directly measure its activity experimentally. To achieve true understanding of the underlying 
biology, we need to be able to generalise from thousands of measured QTLs to new variants 
that have not been observed. Hence, in the long term, large QTL maps could provide us the 
necessary training data to build computational models that can predict the function of non-
coding variants. In that respect, progress has recently been made to predict the effect of genetic 
variation on chromatin accessibility and transcription factor binding (Alipanahi et al., 2015; 
Kelley et al., 2016; Zhou and Troyanskaya, 2015). Progress has also been made building 
models to link enhancers to their target genes (Marbach et al., 2016; Whalen et al., 2016) and 
this is an area where large condition-specific eQTL maps can provide valuable training data.  
6.5 From natural to engineered variation 
In my thesis, I have used iPSC-derived cells to study the consequences of common natural 
genetic variation. However, another promising avenue of future research is studying the 
consequences of engineered genetic variation, especially because iPSCs can be readily 
genetically modified using the CRISPR technology. The first opportunity here is to use IPSCs to 
study the consequences of specific engineered mutations at several phenotypic levels and in 
many different cell types. The main advantage of iPSCs over primary cells is that iPSCs are 
self-renewing, meaning that it will be possible to construct clonal cell lines with specific 
engineered mutations in many different genetic backgrounds. These lines can then be shared 
and compared between different laboratories. 
 
Another area where engineered genetic variation has a large potential are phenotypic screens. 
In this framework, a large library of mutant cells is first generated where each cell has a loss-of-
function mutation in a single gene (or a regulatory element). The cells then go through either 
positive or negative selection, after which it is possible to determine which mutations had either 
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advantageous or deleterious effect on the phenotype. CRISPR screens have successfully 
identified genes required for cancer survival (Munoz et al., 2016) as well as genes important in 
innate immune response (Parnas et al., 2015). An advantage of iPSCs is that a wide range of 
phenotypes and cell types can be used for screening that are currently not available. This 
includes developmental processes; otherwise inaccessible cell types as well was artificial 
reporter constructs that can be introduced into the cells. Consequently, studying both natural 
and engineered genetic variation in iPSCs has a great potential to uncover the genetic 
architecture of a large variety of human traits. 
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